
<html lang="en"     class="pb-page"  data-request-id="d4dbfbbb-7fc3-41ee-9933-9a060e62222f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm4001743;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2013.56.issue-6;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Preliminary Evaluation in Tumor Bearing Mice of New 18F-Labeled Arylsulfone Matrix Metalloproteinase Inhibitors as Tracers for Positron Emission Tomography" /></meta><meta name="dc.Creator" content="Francesca  Casalini" /></meta><meta name="dc.Creator" content="Lorenza  Fugazza" /></meta><meta name="dc.Creator" content="Giovanna  Esposito" /></meta><meta name="dc.Creator" content="Claudia  Cabella" /></meta><meta name="dc.Creator" content="Chiara  Brioschi" /></meta><meta name="dc.Creator" content="Alessia  Cordaro" /></meta><meta name="dc.Creator" content="Luca  D’Angeli" /></meta><meta name="dc.Creator" content="Antonietta  Bartoli" /></meta><meta name="dc.Creator" content="Azzurra M.  Filannino" /></meta><meta name="dc.Creator" content="Concetta V.  Gringeri" /></meta><meta name="dc.Creator" content="Dario L.  Longo" /></meta><meta name="dc.Creator" content="Valeria  Muzio" /></meta><meta name="dc.Creator" content="Elisa  Nuti" /></meta><meta name="dc.Creator" content="Elisabetta  Orlandini" /></meta><meta name="dc.Creator" content="Gianluca  Figlia" /></meta><meta name="dc.Creator" content="Angelo  Quattrini" /></meta><meta name="dc.Creator" content="Lorenzo  Tei" /></meta><meta name="dc.Creator" content="Giuseppe  Digilio" /></meta><meta name="dc.Creator" content="Armando  Rossello" /></meta><meta name="dc.Creator" content="Alessandro  Maiocchi" /></meta><meta name="dc.Description" content="New fluorinated, arylsulfone-based matrix metalloproteinase (MMP) inhibitors containing carboxylate as the zinc binding group were synthesized as radiotracers for positron emission tomography. Inhi..." /></meta><meta name="Description" content="New fluorinated, arylsulfone-based matrix metalloproteinase (MMP) inhibitors containing carboxylate as the zinc binding group were synthesized as radiotracers for positron emission tomography. Inhi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 19, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4001743" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4001743" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4001743" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4001743" /></link>
        
    
    

<title>Synthesis and Preliminary Evaluation in Tumor Bearing Mice of New 18F-Labeled Arylsulfone Matrix Metalloproteinase Inhibitors as Tracers for Positron Emission Tomography | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4001743" /></meta><meta property="og:title" content="Synthesis and Preliminary Evaluation in Tumor Bearing Mice of New 18F-Labeled Arylsulfone Matrix Metalloproteinase Inhibitors as Tracers for Positron Emission Tomography" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0009.jpeg" /></meta><meta property="og:description" content="New fluorinated, arylsulfone-based matrix metalloproteinase (MMP) inhibitors containing carboxylate as the zinc binding group were synthesized as radiotracers for positron emission tomography. Inhibitors were characterized by Ki for MMP-2 in the nanomolar range and by a fair selectivity for MMP-2/9/12/13 over MMP-1/3/14. Two of these compounds were obtained in the 18F-radiolabeled form, with radiochemical purity and yield suitable for preliminary studies in mice xenografted with a human U-87 MG glioblastoma. Target density in xenografts was assessed by Western blot, yielding Bmax/Kd = 14. The biodistribution of the tracer was dominated by liver uptake and hepatobiliary clearance. Tumor uptake of 18F-labeled MMP inhibitors was about 30% that of [18F]fluorodeoxyglucose. Accumulation of radioactivity within the tumor periphery colocalized with MMP-2 activity (evaluated by in situ zimography). However, specific tumor uptake accounted for only 18% of total uptake. The aspecific uptake was ascribed to the high binding affinity between the radiotracer and serum albumin." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4001743"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4001743">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4001743&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4001743&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4001743&amp;href=/doi/10.1021/jm4001743" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2676-2689</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400079a" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301721e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Preliminary Evaluation in Tumor Bearing Mice of New <sup>18</sup>F-Labeled Arylsulfone Matrix Metalloproteinase Inhibitors as Tracers for Positron Emission Tomography</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesca++Casalini">Francesca Casalini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lorenza++Fugazza">Lorenza Fugazza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giovanna++Esposito">Giovanna Esposito</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudia++Cabella">Claudia Cabella</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chiara++Brioschi">Chiara Brioschi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessia++Cordaro">Alessia Cordaro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luca++D%E2%80%99Angeli">Luca D’Angeli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonietta++Bartoli">Antonietta Bartoli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Azzurra+M.++Filannino">Azzurra M. Filannino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Concetta+V.++Gringeri">Concetta V. Gringeri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dario+L.++Longo">Dario L. Longo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valeria++Muzio">Valeria Muzio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisa++Nuti">Elisa Nuti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisabetta++Orlandini">Elisabetta Orlandini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gianluca++Figlia">Gianluca Figlia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angelo++Quattrini">Angelo Quattrini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lorenzo++Tei">Lorenzo Tei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Digilio">Giuseppe Digilio</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Armando++Rossello">Armando Rossello</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro++Maiocchi">Alessandro Maiocchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Science and Technological Innovation, Università del Piemonte Orientale “Amedeo Avogadro”, Viale T. Michel 11, I-15121 Alessandria, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Research and Development, Advanced Accelerator Applications, Via Ribes 5, I-10010 Colleretto Giacosa (TO), Italy</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Molecular Imaging Centre, University of Torino, Via Nizza 52, I-10126 Torino, Italy</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Centro Ricerche Bracco, Bracco Imaging S.p.A., Via Ribes 5, I-10010 Colleretto Giacosa (TO), Italy</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Pharmacy, University of Pisa, Via Bonanno 6, I-56126 Pisa, Italy</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">▽</span> <span class="aff-text">Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy</span></div><div class="corresp-info"><strong>*</strong>(G.D.) Phone + 39 0131 360371, fax + 39 0131 360250, e-mail <a href="/cdn-cgi/l/email-protection#90f7f9e5e3f5e0e0f5bef4f9f7f9fcf9ffd0fdf6febee5fef9e0fdfebef9e4"><span class="__cf_email__" data-cfemail="26414f53554356564308424f414f4a4f49664b40480853484f564b48084f52">[email protected]</span></a>; (A.R.) phone + 39 050 2219562, fax + 39 050 2219605, e-mail <a href="/cdn-cgi/l/email-protection#f9988b968ab99f988b94d78c97908990d7908d"><span class="__cf_email__" data-cfemail="4425362b3704222536296a312a2d342d6a2d30">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4001743&amp;href=/doi/10.1021%2Fjm4001743" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2676–2689</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 4, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 February 2013</li><li><span class="item_label"><b>Published</b> online</span>19 March 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 March 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4001743" title="DOI URL">https://doi.org/10.1021/jm4001743</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2676%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFrancesca%2BCasalini%252C%2BLorenza%2BFugazza%252C%2BGiovanna%2BEsposito%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D6%26contentID%3Djm4001743%26title%3DSynthesis%2Band%2BPreliminary%2BEvaluation%2Bin%2BTumor%2BBearing%2BMice%2Bof%2BNew%2B18F-Labeled%2BArylsulfone%2BMatrix%2BMetalloproteinase%2BInhibitors%2Bas%2BTracers%2Bfor%2BPositron%2BEmission%2BTomography%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2689%26publicationDate%3DMarch%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4001743"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">863</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4001743" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Preliminary Evaluation in Tumor Bearing Mice of New 18F-Labeled Arylsulfone Matrix Metalloproteinase Inhibitors as Tracers for Positron Emission Tomography&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Francesca&quot;,&quot;last_name&quot;:&quot;Casalini&quot;},{&quot;first_name&quot;:&quot;Lorenza&quot;,&quot;last_name&quot;:&quot;Fugazza&quot;},{&quot;first_name&quot;:&quot;Giovanna&quot;,&quot;last_name&quot;:&quot;Esposito&quot;},{&quot;first_name&quot;:&quot;Claudia&quot;,&quot;last_name&quot;:&quot;Cabella&quot;},{&quot;first_name&quot;:&quot;Chiara&quot;,&quot;last_name&quot;:&quot;Brioschi&quot;},{&quot;first_name&quot;:&quot;Alessia&quot;,&quot;last_name&quot;:&quot;Cordaro&quot;},{&quot;first_name&quot;:&quot;Luca&quot;,&quot;last_name&quot;:&quot;D’Angeli&quot;},{&quot;first_name&quot;:&quot;Antonietta&quot;,&quot;last_name&quot;:&quot;Bartoli&quot;},{&quot;first_name&quot;:&quot;Azzurra&quot;,&quot;last_name&quot;:&quot;M. Filannino&quot;},{&quot;first_name&quot;:&quot;Concetta&quot;,&quot;last_name&quot;:&quot;V. Gringeri&quot;},{&quot;first_name&quot;:&quot;Dario&quot;,&quot;last_name&quot;:&quot;L. Longo&quot;},{&quot;first_name&quot;:&quot;Valeria&quot;,&quot;last_name&quot;:&quot;Muzio&quot;},{&quot;first_name&quot;:&quot;Elisa&quot;,&quot;last_name&quot;:&quot;Nuti&quot;},{&quot;first_name&quot;:&quot;Elisabetta&quot;,&quot;last_name&quot;:&quot;Orlandini&quot;},{&quot;first_name&quot;:&quot;Gianluca&quot;,&quot;last_name&quot;:&quot;Figlia&quot;},{&quot;first_name&quot;:&quot;Angelo&quot;,&quot;last_name&quot;:&quot;Quattrini&quot;},{&quot;first_name&quot;:&quot;Lorenzo&quot;,&quot;last_name&quot;:&quot;Tei&quot;},{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Digilio&quot;},{&quot;first_name&quot;:&quot;Armando&quot;,&quot;last_name&quot;:&quot;Rossello&quot;},{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;Maiocchi&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;2676-2689&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4001743&quot;},&quot;abstract&quot;:&quot;New fluorinated, arylsulfone-based matrix metalloproteinase (MMP) inhibitors containing carboxylate as the zinc binding group were synthesized as radiotracers for positron emission tomography. Inhibitors were characterized by Ki for MMP-2 in the nanomolar range and by a fair selectivity for MMP-2/9/12/13 over MMP-1/3/14. Two of these compounds were obtained in the 18F-radiolabeled form, with radiochemical purity and yield suitable for preliminary studies in mice xenografted with a human U-87 MG glioblastoma. Target density in xenografts was assessed by Western blot, yielding Bmax/Kd = 14. The biodistribution of the tracer was dominated by liver uptake and hepatobiliary clearance. Tumor uptake of 18F-labeled MMP inhibitors was about 30% that of [18F]fluorodeoxyglucose. Accumulation of radioactivity within the tumor periphery colocalized with MMP-2 activity (evaluated by in situ zimography). However, specific tumor uptake accounted for only 18% of total uptake. The aspecific uptake was ascribed to the high bind&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4001743&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4001743" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4001743&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4001743" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4001743&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4001743" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4001743&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4001743&amp;href=/doi/10.1021/jm4001743" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4001743" /></input><a href="/doi/pdf/10.1021/jm4001743" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4001743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4001743%26sid%3Dliteratum%253Aachs%26pmid%3D23458498%26genre%3Darticle%26aulast%3DCasalini%26date%3D2013%26atitle%3DSynthesis%2Band%2BPreliminary%2BEvaluation%2Bin%2BTumor%2BBearing%2BMice%2Bof%2BNew%2B18F-Labeled%2BArylsulfone%2BMatrix%2BMetalloproteinase%2BInhibitors%2Bas%2BTracers%2Bfor%2BPositron%2BEmission%2BTomography%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D6%26spage%3D2676%26epage%3D2689%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290975" title="Biopolymers">Biopolymers</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jmcmar.2013.56.issue-6/production/jmcmar.2013.56.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">New fluorinated, arylsulfone-based matrix metalloproteinase (MMP) inhibitors containing carboxylate as the zinc binding group were synthesized as radiotracers for positron emission tomography. Inhibitors were characterized by <i>K</i><sub>i</sub> for MMP-2 in the nanomolar range and by a fair selectivity for MMP-2/9/12/13 over MMP-1/3/14. Two of these compounds were obtained in the <sup>18</sup>F-radiolabeled form, with radiochemical purity and yield suitable for preliminary studies in mice xenografted with a human U-87 MG glioblastoma. Target density in xenografts was assessed by Western blot, yielding <i>B</i><sub>max</sub>/<i>K</i><sub>d</sub> = 14. The biodistribution of the tracer was dominated by liver uptake and hepatobiliary clearance. Tumor uptake of <sup>18</sup>F-labeled MMP inhibitors was about 30% that of [<sup>18</sup>F]fluorodeoxyglucose. Accumulation of radioactivity within the tumor periphery colocalized with MMP-2 activity (evaluated by in situ zimography). However, specific tumor uptake accounted for only 18% of total uptake. The aspecific uptake was ascribed to the high binding affinity between the radiotracer and serum albumin.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>▲</span> Author Contributions</h4><p class="last">F.C. and L.F. contributed equally to this work</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Matrix metalloproteinases (MMPs) constitute a family of over 25 zinc- and calcium-dependent endopeptidases belonging to the superfamily of metzincines.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> As with many other proteins of the extracellular matrix (ECM), MMPs are secreted or membrane-bound proteins with a complex multidomain structure. The primary role of each MMP is the degradation of specific structural components of the ECM, such as the different types of fibrillar collagen (the preferred substrate of MMP-1/8/13/18), nonfibrillar collagen (MMP-2/9) and proteoglycans (MMP-3/7/10).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In addition, MMPs have several other regulatory functions, including the processing of tissue-specific bioactive molecules, such as chemokines, cytokines, growth factors, and even other MMPs and their tissue inhibitors (TIMPs).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> All together, MMPs have a pivotal role in tissue remodeling in normal conditions (angiogenesis, tissue repair, wound healing) as well as pathological states such as cancer, inflammation, and neurodegeneration. In oncology, the role of MMPs has long been studied and debated, and it is nowadays well-established that certain members of this family, most notably gelatinase A (MMP-2), can sustain all stages of tumor progression, including proliferation, migration, angiogenesis, invasion, and metastasis.<a onclick="showRef(event, 'ref3 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref5 ref6">(3, 5, 6)</a> In general, the relative level of each individual MMP increases with increasing tumor stage and is higher in malignant cancers than in normal or premalignant tissues, with maximum activity occurring at the tumor–stroma interface in areas of active invasion.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> On the other hand, there is emerging evidence that some other metalloproteinases like MMP-3, MMP-8, and MMP-26 seem to have antitumor properties and to be linked with protective functions.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> The specific role of each MMP in tumorigenesis and their extracellular localization makes these enzymes attractive candidates not only as targets for therapeutics<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> but also as biomarkers for the grading of cancers. Assessment of the activity of a specific subset of MMPs in the tumor microenvironment by clinically relevant imaging techniques (e.g., MRI, nuclear medicine, etc) would therefore be of great potential for the choice, calibration, and assessment of the efficacy of therapy.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a></div><div class="NLM_p">Due to their high sensitivity, nuclear medicine imaging techniques such as single photon emission computed tomography (SPECT) and positron emission tomography (PET)<a onclick="showRef(event, 'ref14 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref16">(14, 16)</a> are well-amenable to true molecular or metabolic imaging applications and are currently exploited in oncology protocols for imaging of receptors, assessment of amino acid uptake, and glucose metabolism.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> To obtain molecular images of MMPs, a number of broad-spectrum MMP inhibitors (MMPi) have been labeled with nuclides for either PET or SPECT imaging modality.<a onclick="showRef(event, 'ref14 ref20'); return false;" href="javascript:void(0);" class="ref ref14 ref20">(14, 20)</a> Most of the MMPi are based on the sulfonamido scaffold featuring a hydrophobic portion that inserts into the S<sub>1</sub>′ specificity pocket of the enzyme and a metal chelating moiety (the zinc binding group, ZBG) that blocks the enzyme by chelating the Zn(II) ion within the active site. Two inhibitors belonging to this class, namely, CGS 27023A and its close analogue CGS 25966, have been labeled with a variety of radionuclides, including <sup>123</sup>I/<sup>125</sup>I for SPECT<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and <sup>11</sup>C or <sup>18</sup>F for PET.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> Despite in vitro studies or studies aimed at the visualization of nontumor vascular lesions that were promising, those tracers evaluated for the in vivo visualization of tumors gave contrasting results, as nonspecific uptake or binding were often found.<a onclick="showRef(event, 'ref14 ref25'); return false;" href="javascript:void(0);" class="ref ref14 ref25">(14, 25)</a> Furumoto and co-workers<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> introduced the alkynyl carboxylate [<sup>18</sup>F]SAV03 and its methyl ester [<sup>18</sup>F]SAV03 M prodrug, the latter showing a tumor accumulation of radioactivity suitable for tumor visualization by PET. More recently, non-sulfonamido <sup>18</sup>F-labeled compounds have appeared, such as the [<sup>18</sup>F]aryltrifluoroborate analogue of marimastat, a peptidomimetic broad-spectrum MMPi.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The latter compound was evaluated on a well-characterized murine model of mammary carcinoma in vivo, and a low but detectable and specific uptake of the radiotracer was observed.</div><div class="NLM_p">Some studies highlighted that the use of broad-spectrum inhibitors can have shortcomings in the correct interpretation of positive imaging results, as the uptake cannot be unambiguously related to increased activity of specific subsets of MMPs.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Therefore, the development of inhibitors endowed with enhanced selectivity toward MMP subsets might be highly beneficial for diagnostic imaging. The selectivity of inhibitors can be enhanced, though often at the expense of potency, by substituting the largely used hydroxamate for carboxylate or other weaker Zn(II) chelators.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The use of non-hydroxamate inhibitors can be advantageous in other aspects, since hydroxamates are known to be metabolically unstable and can interfere with other enzymes whose function is dependent on transition metal ions. A recent example of non-hydroxamate PET agents was reported by Breyholz et al.,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> where pyrimidine-2,4,6-trione-based inhibitors with reduced lipophilicity have been radiolabeled with <sup>18</sup>F and biodistribution in mouse was evaluated.</div><div class="NLM_p">In this work we present three new fluorinated arylsulfone carboxylate inhibitors of MMPs and the radiochemistry used to obtain <sup>18</sup>F-labeled PET imaging agents. On the basis of previous promising results<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> obtained with phenylacetic carboxylates designed to selectively inhibit MMP-12, we have selected and suitably modified the scaffold A (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). This compound has been chosen for its good activity toward MMP-2 and selectivity over MMP-1, compared to the other carboxylates developed in that study. We have decided to insert the fluorine atom in the para position on the biphenylsulfone group on the basis of synthetic feasibility and data taken from literature. Moreover, it was already known<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> that an elongation in that position (P1′ substituent) could cause an increase of activity toward MMP-2 and a drop of activity for MMP-1. A selectivity over MMP-1 has been highly sought because this enzyme, together with MMP-14, has been hypothesized to cause the musculoskeletal syndrome (MSS) observed clinically with broad-spectrum inhibitors after long-term application.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Thus, fluorinated compounds <b>1a</b>, <b>1b</b>, and <b>1c</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) have been synthesized, their IC<sub>50</sub> values assessed in vitro with recombinant human MMPs, and radiolabeled with <sup>18</sup>F. A preliminary biodistribution of two of these radiotracers has been carried out in healthy athymic mice. Then the ability of the most promising tracer to label tumors in the murine U-87 MG glioblastoma model has been assessed and the specificity of tumor labeling evaluated.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1a</b>, <b>1b</b>, and <b>1c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KOH, Cu, H<sub>2</sub>O, MW. (b) <i>N</i>,<i>N</i>-Dimethylformamide di-<i>tert-</i>butylacetal, toluene, 90 °C. (c) Oxone, THF, MeOH, H<sub>2</sub>O. (d) 4-Hydroxy-phenylboronic acid (<b>6</b>), 4-(benzyloxy)phenylboronic acid (<b>5</b>), 4-fluorophenylboronic acid (<b>8</b>), or 4-amino-phenylboronic acid hydrochloride (<b>9</b>), Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, H<sub>2</sub>O, dioxane, 85 °C. (e) H<sub>2</sub>, Pd/C 10%, MeOH, AcOH. (f) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 82 °C. (g) TFA, DCM, 0 °C. (h) TFA, DCM, 0 °C. (i) Fluoroacetyl chloride, DIPEA, DMF. (l) TFA, DCM, 0 °C.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57044" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57044" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The O-ethylfluorinated carboxylate <b>1a</b> has been synthesized as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Thioether <b>2</b> was obtained through a microwave-assisted Cu-catalyzed Ulmann-type reaction as earlier reported in a precedent work of ours.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The carboxylate was then protected as <i>tert</i>-butyl ester via reaction with <i>N</i>,<i>N</i>-dimethylformamide di-<i>tert</i>-butyl acetal in toluene, yielding compound <b>3,</b> which was oxidized into sulfone <b>4</b> with oxone in a mixture of methanol, THF, and water. Arylsulfone <b>4</b> was then submitted to a palladium-catalyzed cross-coupling reaction (Suzuki conditions) with 4-hydroxyphenylboronic acid to give 4′-hydroxybiphenyl arylsulfone <b>6</b>. In order to improve the yield of this reaction and to overcome the troubles related to purification due to the presence of the highly reactive hydroxyl group, we alternatively synthesized the O-benzyl-protected biphenyl intermediate <b>5</b>, which was in turn converted into compound <b>6</b> by Pd/C-catalyzed hydrogenation. A substitution reaction of phenol <b>6</b> with 1-fluoro-2-tosyloxyethane in acetonitrile and K<sub>2</sub>CO<sub>3</sub> as base yielded the fluorinated-tailed <i>tert</i>-butyl ester <b>7</b>, which was converted into the carboxylic acid <b>1a</b> by deprotection with trifluoroacetic acid (TFA) in dichloromethane at 0 °C.</div><div class="NLM_p last">The synthesis of arylfluorinated carboxylate <b>1b</b> and fluorinated amide <b>1c</b> is also described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. 4-Bromoarylsulfone intermediate <b>4</b> was submitted to Suzuki coupling with 4-fluorophenylboronic acid or 4-aminophenylboronic acid, yielding respectively 4′-fluorinated ester <b>8</b> or 4′-amino ester <b>9</b>. Acid cleavage of compound <b>8</b> with TFA gave the corresponding carboxylate <b>1b</b>, while acetylation of <b>9</b> with fluoroacetyl chloride in the presence of <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) led to acetamido derivative <b>10</b>, which was in turn converted into carboxylate <b>1c</b> by acid hydrolysis.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Inhibition of Matrix Metalloproteinases</h3><div class="NLM_p">The final carboxylic acids were tested in vitro, with a fluorometric assay on purified enzymes, for their ability to inhibit MMPs (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>; see Table S1 in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> for values reported as inhibitor constant <i>K</i><sub>i</sub>). Inhibitor A was used as a reference compound. As can be seen from the data reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the substitution of the <i>p</i>-methoxy group with a 2-fluoroethoxy group in <b>1a</b> caused an increase in activity for MMP-2/9/12/13 compared to the reference compound. Namely, <b>1a</b> showed an IC<sub>50</sub> of 16 nM on MMP-2 (three times more potent than parent A) and an IC<sub>50</sub> of 107 nM on MMP-9 (seven times more potent than A). These are very good potency data considering the carboxylate nature of the ZBG. Moreover, this increased activity for deep S1′ pocket MMPs<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> like MMP-2/9/12/13 was accompanied by a drop of activity for MMP-1 and -14, whose inhibition was deemed to be responsible for MSS, and for MMP-3, considered as an antitarget in cancer therapy. Compounds <b>1b</b> and <b>1c</b>, bearing a fluorine atom and a 2-fluoroacetamido group in the para position on the biphenylsulfone moiety, respectively, showed a reduction in activity for all MMPs tested with respect to A. This effect was more marked with <b>1b</b>, which had an IC<sub>50</sub> of 230 nM on MMP-2 and 3600 nM on MMP-9. Compound <b>1c</b>, even if less active than A and <b>1a</b> on MMP-2 (IC<sub>50</sub> = 61 nM), presented a strong selectivity for this enzyme over all other tested MMPs.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> of Nonradioactive Fluorinated MMP Inhibitors against a Panel of MMPs and clogD Values</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="7" align="center" char="±">IC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">MMP-1</th><th class="colsep0 rowsep0" align="center" char="±">MMP-2</th><th class="colsep0 rowsep0" align="center" char="±">MMP-3</th><th class="colsep0 rowsep0" align="center" char="±">MMP-9</th><th class="colsep0 rowsep0" align="center" char="±">MMP-12</th><th class="colsep0 rowsep0" align="center" char="±">MMP-13</th><th class="colsep0 rowsep0" align="center" char="±">MMP-14</th><th class="colsep0 rowsep0" align="center" char=".">clogP<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">clogD<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">4400 ± 330</td><td class="colsep0 rowsep0" align="char" char="±">47 ± 3.4</td><td class="colsep0 rowsep0" align="char" char="±">7500 ± 750</td><td class="colsep0 rowsep0" align="char" char="±">730 ± 58</td><td class="colsep0 rowsep0" align="char" char="±">140 ± 22</td><td class="colsep0 rowsep0" align="char" char="±">78 ± 9.7</td><td class="colsep0 rowsep0" align="char" char="±">740 ± 58</td><td class="colsep0 rowsep0" align="char" char=".">4.44</td><td class="colsep0 rowsep0" align="char" char=".">1.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="char" char="±">18500 ± 1400</td><td class="colsep0 rowsep0" align="char" char="±">16 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">7100 ± 530</td><td class="colsep0 rowsep0" align="char" char="±">107 ± 18</td><td class="colsep0 rowsep0" align="char" char="±">44 ± 2.7</td><td class="colsep0 rowsep0" align="char" char="±">22 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">1600 ± 170</td><td class="colsep0 rowsep0" align="char" char=".">4.55</td><td class="colsep0 rowsep0" align="char" char=".">1.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="char" char="±">11500 ± 550</td><td class="colsep0 rowsep0" align="char" char="±">230 ± 15</td><td class="colsep0 rowsep0" align="char" char="±">67000 ± 5100</td><td class="colsep0 rowsep0" align="char" char="±">3600 ± 490</td><td class="colsep0 rowsep0" align="char" char="±">400 ± 22</td><td class="colsep0 rowsep0" align="char" char="±">386 ± 37</td><td class="colsep0 rowsep0" align="char" char="±">4800 ± 460</td><td class="colsep0 rowsep0" align="char" char=".">4.63</td><td class="colsep0 rowsep0" align="char" char=".">1.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1c</b></td><td class="colsep0 rowsep0" align="char" char="±">6100 ± 1400</td><td class="colsep0 rowsep0" align="char" char="±">61 ± 8</td><td class="colsep0 rowsep0" align="char" char="±">6800 ± 1000</td><td class="colsep0 rowsep0" align="char" char="±">1500 ± 83</td><td class="colsep0 rowsep0" align="char" char="±">500 ± 79</td><td class="colsep0 rowsep0" align="char" char="±">220 ± 15</td><td class="colsep0 rowsep0" align="char" char="±">4600 ± 1000</td><td class="colsep0 rowsep0" align="char" char=".">3.76</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values are the mean ± SD of three experiments.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">clogD represents the clogP of the compound at physiological pH, taking into account charged species. Values were calculated by the MOE (Molecular Operating Environment, CCG) software package.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Taken from ref <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">30</a>.</p></div></div></div><div class="NLM_p last">Overall, <b>1a</b> showed the best characteristics of activity and selectivity to be used as a probe in the glioblastoma tumor model. In fact, this compound, with nanomolar activity for MMP-2/9 and marked selectivity over MMP-1/3/14, should be able to bind tightly, but not covalently, to MMP-2/9 that are overexpressed in the U-87 MG human glioblastoma cell line.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> The concomitant inhibition of MMP-12 and MMP-13 should be beneficial, because also these enzymes have been recently found to be highly expressed in U-87 MG glioblastoma.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Interaction with Serum Albumin</h3><div class="NLM_p">The binding affinities of <b>1a</b> and <b>1c</b> to human serum albumin (HSA) have been assessed by <sup>19</sup>F NMR titration of 1.0 mM solutions of the inhibitors with HSA. A progressive downfield shift with line broadening of the <sup>19</sup>F NMR signal is observed up to a protein:ligand ratio of 0.4:1 (from −147.7 ppm to a limiting value of −146.9 ppm; signal A, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), and then a new broad <sup>19</sup>F NMR signal emerges from the noise at −146.3 ppm (signal B) and becomes more intense than signal A at higher protein:ligand ratios. This can be explained by considering multiple binding sites on albumin. Although the appearance of two peaks due to the albumin-bound ligand hampers a rigorous quantitative analysis of the titration curve, a rough estimation of the dissociation constant for the lower affinity site (site A) could still be obtained by computer fitting of the <sup>19</sup>F NMR titration curve according to a model in which each albumin molecule is treated as having <i>n</i> independent binding sites.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> An acceptable fitting could be obtained only by allowing <i>n</i> = 3 (i.e., three equivalent binding sites per albumin molecule), each having a dissociation constant <i>K</i><sub>d</sub> on the order of 140 μM. Thus, there are multiple equivalent lower affinity binding sites for <b>1a</b> on albumin (site A), and at least one binding site endowed with a higher affinity (site B). The <sup>19</sup>F NMR titration of <b>1c</b> with albumin gave similar results, with the ligand distributing between one lower affinity (<i>K</i><sub>d</sub> on the order of 10 μM) and one higher affinity binding site. These affinities for albumin are on the order of magnitude expected for organic anions containing a biphenyl moiety.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> On this basis it can be foreseen that, in blood, a significant fraction of the tracers will be in the form of albumin complexes, resulting in prolonged in vivo half-life but also decreased availability for MMP binding and inhibition.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. <sup>19</sup>F NMR spectra of <b>1a</b> [1.0 mM, phosphate-buffered saline (PBS), pH 7.4] with increasing concentrations of defatted human serum albumin (HSA). The concentration of protein is given on the left as millimoles per liter.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Radiosynthesis</h3><div class="NLM_p">The radiosynthesis of [<sup>18</sup>F]-<b>1a</b> is shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. As a first attempt, a two-step procedure was evaluated. The <sup>18</sup>F was previously introduced by nucleophilic substitution on the ethylene glycol ditosylate and the resulting 1-[<sup>18</sup>F]fluoro-2-tosyloxyethane was reacted with the intermediate <b>6</b> to give [<sup>18</sup>F]-<b>7</b> by nucleophilic substitution in the presence of sodium methoxide as base. This procedure provided a crude mixture in which the <i>tert</i>-butyl-protected compound [<sup>18</sup>F]-<b>7</b> accounted only for 10% of the total radioactivity, whereas the main product likely resulted from nucleophilic substitution of the methoxide ion on 1-[<sup>18</sup>F]fluoro-2-tosyloxyethane. NaH and K<sub>2</sub>CO<sub>3</sub> were also tested instead of methoxide, but they were not able to provide better yields. The poor yield of the <i>tert</i>-butyl-protected intermediate [<sup>18</sup>F]-<b>7</b>, which should be further deprotected and finally purified, prompted us to devise an alternative route for the radiosynthesis of [<sup>18</sup>F]-<b>1a</b>. To improve the effectiveness and speed up the reaction time, the radiosynthesis of [<sup>18</sup>F]-<b>1a</b> was reduced to a one-step procedure starting from tosyl intermediate <b>11</b>, synthesized by treatment of phenol <b>6</b> with an excess of glycol ditosylate<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and potassium carbonate. Direct nucleophilic substitution of tosylate provided, after acidic removal of the <i>tert</i>-butyl protective group, compound [<sup>18</sup>F]-<b>1a</b> with a moderate overall radiochemical yield (RCY) (10% ± 4%, n.d.c.) but radiochemical purity as high as 98% ± 2%, within a total synthesis time of 70 min. Specific activity (end of synthesis, EOS) was 5 GBq/μmol.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Radiosynthesis of Tracers [<sup>18</sup>F]-<b>1a</b> and [<sup>18</sup>F]-<b>1c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1)C<sub>2</sub>H<sub>4</sub>(OTs)<sub>2</sub>, [<sup>18</sup>F]K(K 222)F, 100 °C; (2) MeONa, 120 °C. (b) TFA, CH<sub>3</sub>CN, rt. (c) C<sub>2</sub>H<sub>4</sub>(OTs)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 82 °C. (d) (1) [<sup>18</sup>F]K(K 222)F, 105 °C; (2) TFA, CH<sub>3</sub>CN, rt. (e) Chloroacetylchloride or bromoacetylbromide, DIPEA, DMF. (f) (1)[<sup>18</sup>F]K(K 222)F, 130 °C; (2) TFA, CH<sub>3</sub>CN, rt.</p></p></figure><div class="NLM_p last">For the radiosynthesis of [<sup>18</sup>F]-<b>1c</b>, both chloro derivative <b>12</b> and bromo derivative <b>13</b> were prepared by acetylation of the 4-aminoarylsulfone <b>9</b> with chloroacetyl chloride or bromoacetyl bromide, respectively, in <i>N</i>,<i>N</i>-dimethyklformamids (DMF) with DIPEA as the base. Only the chloro precursor <b>12</b> proveded effective in providing <i>tert</i>-butyl-protected [<sup>18</sup>F]-<b>1c</b> by nucleophilic substitution of the halogen atom (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Following deprotection in acidic conditions, [<sup>18</sup>F]-<b>1c</b> was obtained with a RCY of 3% ± 1% (n.d.c) and radiochemical purity of 100%, within a total synthesis time of 60 min. Specific activity (EOS) was 12 GBq/μmol.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Biological Characterization of Matrix Metalloproteinase Activity in Tumor Xenografts and Assessment of Target Site Density</h3><div class="NLM_p">Gelatin zymography of whole tumor extracts (resection done within 12 h after PET scans, <i>n</i> = 4) confirmed that, at the time of PET scans, the levels of MMP-2 and MMP-9 were high (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D), with MMP-9 gelatinolytic bands being more intense than those of MMP-2. To assess the distribution of gelatinase activity within the tumor mass, unfixed frozen xenografts (<i>n</i> = 6) were excised and serial cryosections (10 μm thick) were subjected in parallel to hematoxylin/eosin (HE) staining or in situ zymography with dye-quenched (DQ) gelatin (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A–C). HE sections clearly showed that U-87 MG xenografted tumors are typically composed by a necrotic core with visible cell debris and an external rim with high cellularity. In situ zymograms made on adjacent slices showed that the MMP activity is uniformly distributed in the extracellular space within the high cellularity tumor periphery, whereas it is almost completely absent in the necrotic core. It is worth emphasizing that in situ zymography detects MMP-2 and MMP-9 in the active form only. However, minor contributions from other MMP members (for instance, collagenases) cannot be excluded.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Fluorescence arising from the breakdown of DQ gelatin was almost completely abolished by treating the tumor slices with MMP inhibitors such as ethylenediaminetetraacetic acid (EDTA) or 1,10-phenanthroline, indicating that endoproteases other than MMPs give a negligible fluorescence background (data not shown).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Section of U-87 MG tumor stained with hematoxylin/eosin taken across the boundary between the tumor core (Co) and the tumor rim (Ri). Scale bar 54.6 μm. (B) In situ DQ-gelatin zymography of a tumor section adjacent to that shown in panel A. Gelatinolytic activity by confocal fluorescence microscopy appears as green fluorescence on a black background. Scale bar 54.6 μm. (C) In situ DQ-gelatin zymography of a tumor section taken across a high cellularity tumor region, showing diffuse gelatinase activity. Scale bar 54.6 μm. (D) Gelatin zymography of U-87 MG tumor homogenates. Tumors were excised from mice within 12 h after [<sup>18</sup>F]-<b>1a</b> PET scans. Results from four individuals are shown. (E) Western blot assay for MMP-2. The lanes on the left are from four tumor extracts seeded at 20 μg of protein. Bands of active MMP-2 and proMMP-2 are visible. The lanes on the right are relative to true rhMMP-2 (active form) used to build a calibration curve, seeded at 10–60 ng of MMP-2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As zymographic techniques are hardly amenable to quantitative analysis, the assessment of target site density in tissue (<i>B</i><sub>max</sub>) was accomplished by Western blotting (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>E). MMP-2 has been chosen for quantification because the radiotracer [<sup>18</sup>F]-<b>1a</b> showed the maximum binding affinity for this member of the MMP family (<i>K</i><sub>d</sub><i> = </i>15 nM; see Table S1 in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). As available antibodies cannot distinguish between the zymogen and active form, MMP-2 appeared as two resolved bands centered at a MW of about 70 kDa, corresponding to the zymogen (high MW) and the active form (low MW). A calibration curve has been built by running standard rhMMP-2 (active form) in the same gel, within a loading range of 10–60 ng. The densitometric response was linear within this range. Densitometric readings of tumor extracts (<i>n</i> = 4) were converted into nanograms of MMP2 per microgram of protein by means of such a calibration curve. Whole tumor extracts yielded a total concentration of MMP-2 of 1.5 ± 0.3 ng of MMP2/μg of protein, corresponding to 0.021 nmol of MMP2/mg of protein. This value refers to total MMP-2 in whole tumor extracts, that is, the cumulative concentration of zymogen and active forms. This can be converted to concentration in the whole tumor by considering that 1 fmol of MMP2/mg of protein corresponds to 0.1 nM concentration,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> yielding a total MMP-2 concentration of 2.1 μM. The ratio between the densitometric reading of active MMP-2 against total MMP-2 revealed that 34% ± 13% of total MMP-2 (corresponding to a tissue concentration of 0.7 μM) is in the active form. However, active MMP-2 as far as detected by Western blotting is contributed by truly active MMP-2 and MMP-2 whose activity was inhibited by TIMPs in tissue (sodium dodecyl sulfate–polyacrylamide gel electrophoresis, SDS–PAGE, dissociates those inhibition complexes and does not allow us to distinguish between inhibited and noninhibited forms). Therefore, a tissue concentration of 0.7 μM would be an overestimation of the accessible site density. Literature data indicates that 6–15% of MMP-2 is in the active form in glioblastomas.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Studies on the levels of circulating MMP-2 in blood (i.e., substantially released from tumor bearing sites) show that activated forms are about 10% of total MMPs.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> For an average value of 10%, the active MMP-2 in tissue (i.e., the target site density <i>B</i><sub>max</sub>) will be 210 nM (average over the whole tumor mass). A receptor binding potential (<i>B</i><sub>max</sub>/<i>K</i><sub>d</sub>) of 14.1 can be eventually obtained, which is encouraging for imaging purposes.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> This value must be regarded as a lower limit. The actual value in the tumor rim could be higher, if it is considered that (i) <i>B</i><sub>max</sub> has been calculated as the average for the whole tumor mass, while in situ zymograms clearly showed accumulation of active MMP-2 within the tumor periphery; (ii) this calculation does not take into account MMPs other than MMP-2, which can also contribute to <i>B</i><sub>max</sub>; and (iii) recovery of MMP-2 by the mild tissue extraction procedure we employed is likely incomplete.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Biodistribution and Tumor Uptake: Initial Small Animal Studies</h3><div class="NLM_p">For biodistribution studies, 6–8 week old healthy CD1 nude mice were intravenously injected with a typical dose of 7.4 MBq of [<sup>18</sup>F]-<b>1a</b> (<i>n</i> = 3) or its <i>tert</i>-butyl ester [<sup>18</sup>F]-<b>7</b> (<i>n</i> = 2) or [<sup>18</sup>F]-<b>1c</b> (<i>n</i> = 2). [<sup>18</sup>F]-<b>7</b> was included in biodistribution studies because it represents the pro-tracer form of [<sup>18</sup>F]-<b>1a</b> and, by analogy with findings by Furumoto and co-workers,<a onclick="showRef(event, 'ref26 ref48'); return false;" href="javascript:void(0);" class="ref ref26 ref48">(26, 48)</a> it might be endowed with a better uptake in tumor and less accumulation in the liver compared with the active [<sup>18</sup>F]-<b>1a</b> form. Dynamic PET scans were performed and images were reconstructed at several time points within a time window of 2.5 h. [<sup>18</sup>F]-<b>1a</b> and [<sup>18</sup>F]-<b>1c</b> showed similar pharmacokinetic profiles that are essentially characterized by fast uptake of radioactivity by the liver followed by delayed accumulation in the gut (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). A peak of activity in the liver is reached within 10 min postinjection (with maximum percentage injected dose per gram of tissue, % ID/g, of 11.2 and 11.0 for [<sup>18</sup>F]-<b>1a</b> and [<sup>18</sup>F]-<b>1c</b>, respectively), and then the radioactivity levels off at about 8.5% ID/g ([<sup>18</sup>F]-<b>1a</b>) and 6.1% ID/g ([<sup>18</sup>F]-<b>1c</b>) after 45 min. The radioactivity steadily accumulates in the duodenum and small intestine, from 2.5% ID/g (10 min, [<sup>18</sup>F]-<b>1a</b>) and 2.4% ID/g (10 min, [<sup>18</sup>F]-<b>1c</b>) to about 13.1 and 12.4% ID/g at 140 min postinjection. The increase of radioactivity in the small intestine appears to be linked with the decrease in the liver. Both [<sup>18</sup>F]<b>-1a</b> and [<sup>18</sup>F]-<b>1c</b> clearly show transit through the gallbladder, which emerges in images reconstructed at 30 min as a bright spot well-contrasted from surrounding hepatic tissues (Figure S1 in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). [<sup>18</sup>F]-<b>7</b> shows approximately the same time–activity course as [<sup>18</sup>F]-<b>1a</b> and [<sup>18</sup>F]-<b>1c</b>, but the uptake in liver and gastrointestinal tract is higher (21.6% ID/g and 4.1% ID/g after 10 min, respectively) and the uptake by the gallbladder cannot be clearly seen. For all tracers, time–activity curves suggest hepatobiliary clearance, which is in line with the hydrophobic nature of the tracers. A relationship between high radioactivity levels in the bile and uptake in the duodenum has been observed for other <sup>18</sup>F radiotracers based on amphiphilic, sulfonamide-type MMP inhibitors.<a onclick="showRef(event, 'ref23 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref26">(23, 26)</a> Uptake of radioactivity in the head has been evaluated by static PET scans performed 2.5 h postinjection. Brain uptake was comparable to background (data not shown), indicating that the compound cannot cross the blood–brain barrier. No accumulation of radioactivity in the skeleton was observed, indicating that the tracers are metabolically stable toward defluorination and do not release [<sup>18</sup>F]fluoride.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Biodistribution of (■) [<sup>18</sup>F]-<b>1a</b>, (*) [<sup>18</sup>F]-<b>7</b>, and (○) [<sup>18</sup>F]-<b>1c</b> in healthy nude mice. Time–activity curves for liver, gut, and gallbladder are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ligand [<sup>18</sup>F]-<b>1a</b> was selected to study the uptake of radioactivity in a human glioblastoma mouse model, as this ligand presents the best trade-off between the MMP inhibition profile and efficiency of radiosynthesis. No particular advantage, in terms of biodistribution, was observed by using its protracer form, [<sup>18</sup>F]-<b>7</b>. Human glioblastoma U-87 MG cells were subcutaneously injected in the left flank of 6-week-old athymic CD1 female nude mice. Tumors having a volume of about 200–300 mm<sup>3</sup> typically developed after 1 week. The time course of tumor uptake determined with dynamic PET scans (over a time span of 2.5 h) revealed that the radioactivity within the tumor reached a level of 1.1% ID/g at 10 min, leveling off at 1.7% ID/g at about 100 min postinjection (data not shown). On this basis, further PET images aimed at a more detailed assessment of [<sup>18</sup>F]-<b>1a</b> tumor uptake were performed in the static mode 100 min after tracer injection. This timing scheme was deemed to be an acceptable trade-off between accumulation of radioactivity into the tumor and minimization of background in neighboring regions (mainly due to the high uptake and retention of the tracer in the liver).</div><div class="NLM_p">To confirm tumor localization and viability, glioblastoma-bearing mice (<i>n</i> = 5) were subjected to a [<sup>18</sup>F]-<b>1a</b> PET scan sequentially followed by a [<sup>18</sup>F]FDG scan, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A. The uptake of [<sup>18</sup>F]-<b>1a</b> within the tumor was 1.40% ± 0.15% ID/g, approximately 3 times lower than that of [<sup>18</sup>F]-FDG (4.39% ± 0.28% ID/g). Tumors grown to a small volume (<200 mm<sup>3</sup>) showed a uniform intratumor distribution of both [<sup>18</sup>F]-<b>1a</b> and [<sup>18</sup>F]FDG, whereas larger tumors (250–560 mm<sup>3</sup>) showed a preferential accumulation of tracers in the rim as compared to the core (a sample PET image is given in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). Within larger tumors, [<sup>18</sup>F]-<b>1a</b> appeared to have a more marked accumulation within the rim as compared to [<sup>18</sup>F]FDG (Table S2 in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <sup>18</sup>F PET images of the abdomen of nude mice subcutaneously grafted with a human U-87 MG glioblastoma. Red arrows show the tumor in different slices. (A) PET images obtained by sequential administration of [<sup>18</sup>F]-<b>1a</b> (upper row) and [<sup>18</sup>F]FDG (bottom row), showing colocalization of tracer uptake. The [<sup>18</sup>F]-<b>1a</b> scan was acquired 100 min post-tracer injection; [<sup>18</sup>F]FDG was injected immediately after completion of the [<sup>18</sup>F]-<b>1a</b> scan and the image was acquired 45 min post-[<sup>18</sup>F]FDG injection. Both scans were static acquisitions (injected dose 7.4 MBq, acquisition time 30 min). (B) PET images obtained by sequential administration of [<sup>18</sup>F]-<b>1a</b> (upper row) and [<sup>18</sup>F]FDG (bottom row), in a mouse that received 40 mg/kg of the broad-spectrum MMP inhibitor ilomastat 30 min before injection of [<sup>18</sup>F]-<b>1a</b>. The timing scheme and injected doses are the same as in panel A. Percentage injected dose per gram of tissue (% ID/g) values from these images are detailed in Table S2 in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To address the specificity of MMP targeting, a group of mice (<i>n</i> = 6) was treated with the broad-spectrum MMP inhibitor ilomastat (also known as GM6001)<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> to saturate the MMPs active sites and make them unavailable to [<sup>18</sup>F]-<b>1a</b> (<i>K</i><sub>i</sub> of ilomastat toward MMPs is generally lower than that of [<sup>18</sup>F]-<b>1a</b>, as the ZBG of the former inhibitor is hydroxamate). The inhibitor was administered intraperitoneally at a dose of 40–160 mg/kg, 30 min before injection of [<sup>18</sup>F]-<b>1a</b> to allow it to enter the systemic circulation. PET images (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B) essentially revealed the same features found without blocking of MMPs with the cold inhibitor. The quantitative evaluation of percentage injected dose per gram of tissue (% ID/g) revealed a small but appreciable effect of preblocking MMPs on radioactivity uptake (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The difference of [<sup>18</sup>F]-<b>1a</b> uptake in the tumor rim between preblocked and unblocked tumors was borderline statistically significant (Student’s <i>t</i> test <i>p</i> = 0.054). However, statistical significance was definitively achieved (Student’s <i>t</i> test <i>p</i> = 0.014) if the ratio between the uptake of [<sup>18</sup>F]-<b>1a</b> (tumor rim) and the uptake of [<sup>18</sup>F]FDG (whole tumor) was considered (in the following, such uptake ratio will be abbreviated as UR). This clearly indicates that the radioactivity of [<sup>18</sup>F]-<b>1a</b> in the tumor rim is due to a combination of specific (enhanced retention of [<sup>18</sup>F]-<b>1a</b> due to true binding to target MMPs) and aspecific contributions. The difference between the average uptake of [<sup>18</sup>F]-<b>1a</b> in preblocked/unblocked tumors was used to estimate the relative contributions of specific/aspecific uptake, yielding about 18% specific binding over total uptake.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Average percentage injected dose per gram of tissue (% ID/g) measured in [<sup>18</sup>F]-<b>1a</b> PET images in mice pretreated (gray columns) or not (white columns) with the broad-spectrum MMP inhibitor ilomastat (data listed in Table S2 in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). (Left <i>y</i>-axis) Comparisons of the uptake of [<sup>18</sup>F]-<b>1a</b> over the whole tumor, the tumor rim, or the tumor core. (Right <i>y</i>-axis) Comparison of the uptake ratio UR is shown. (UR is defined as the ratio between uptake of [<sup>18</sup>F]-<b>1a</b> in the tumor rim and uptake of [<sup>18</sup>F]FDG within the whole tumor; see text for details.) Error bars represent standard errors. Student’s <i>t</i> test <i>p</i>-values are given where differences are statistically significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">One of the advantages to using MMPs as a molecular target for an imaging agent is that these enzymes are secreted and activated in the extracellular environment, avoiding the need to transfer the radiolabeled probe to intracellular compartments.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, there are also disadvantages linked to the large number of MMP family members that might obscure the detection of those members that are more descriptive of a disease. Therefore, selectivity of the radiotracer for a subset of MMP members can be advantageous. Among the fluorinated arylsulfone MMP inhibitors we have presented, <b>1a</b> showed the best MMP affinity profile, being endowed with nanomolar activity for MMP-2/9/12/13 and a marked selectivity over MMP-1/3/14. To verify whether such affinity is sufficient for MMP imaging in our U-87 MG glioblastoma mouse model, we estimated <i>B</i><sub>max</sub> and <i>B</i><sub>max</sub>/<i>K</i><sub>d</sub> in the tumor. Under the hypothesis that active MMP-2 was the only target, <i>B</i><sub>max</sub>/<i>K</i><sub>d</sub> of 14.1 could be obtained. This is encouraging for imaging MMP activity with [<sup>18</sup>F]-<b>1a</b>, because a <i>B</i><sub>max</sub>/<i>K</i><sub>d</sub> ratio ≥ 10 has been shown to be sufficient for imaging with radiotracers having nanomolar affinities.<a onclick="showRef(event, 'ref43 ref46'); return false;" href="javascript:void(0);" class="ref ref43 ref46">(43, 46)</a></div><div class="NLM_p">On the other hand, the biodistribution profiles of the tracers were dominated by high uptake/retention by the liver, predominance of hepatobiliary excretion, and strong interaction with albumin. These features are linked to the hydrophobic (<b>7</b>) or anionic, amphiphilic (<b>1a</b>, <b>1c</b>) chemical nature of our PET tracers. The hepatobiliary clearance route poses a serious limitation on the use of our tracers for imaging purposes, because it leads to high background radioactivity in the liver and gastrointestinal tract, which might obscure detection of nearby regions with true high MMP activity. This drawback is rather common to <sup>18</sup>F-conjugated small-molecule MMP inhibitors and stems from the fact that hydrophobic groups are essential for the ligand to be conferred with a suitable MMP binding affinity and specificity.<a onclick="showRef(event, 'ref23 ref24 ref27'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref27">(23, 24, 27)</a> Although there are some examples of improved biodistribution by lowering the overall log D of the tracer, for instance through insertion of small PEG chains at suitable positions, the effect on the ability of the resulting tracers to target MMPs in vivo has still to be assessed.<a onclick="showRef(event, 'ref29 ref51'); return false;" href="javascript:void(0);" class="ref ref29 ref51">(29, 51)</a></div><div class="NLM_p">Despite the nonoptimal biodistribution, [<sup>18</sup>F]-<b>1a</b> showed detectable uptake in xenografted U-87 MG glioblastoma, reaching a level of 1.40% ID/g (whole tumor). The uptake levels of the compound tested were appreciably lower than those of [<sup>18</sup>F]FDG (4.39% ID/g, whole tumor) but slightly larger or very similar with respect to those of other carboxylate-based small-molecule radiotracers targeted to MMPs.<a onclick="showRef(event, 'ref26 ref52'); return false;" href="javascript:void(0);" class="ref ref26 ref52">(26, 52)</a> PET images of U-87 MG glioblastomas showed that [<sup>18</sup>F]-<b>1a</b> localizes in the tumor rim more specifically than [<sup>18</sup>F]FDG does. Such difference can be due to the very different physicochemical properties of [<sup>18</sup>F]-<b>1a</b> (negatively charged, hydrophobic) as compared to [<sup>18</sup>F]FDG (neutral, very hydrophilic), possibly affecting their diffusion within the tumor. However, the peripheral localization of [<sup>18</sup>F]-<b>1a</b> is well consistent with the intratumor localization of MMP activity, as in situ zymography of U-87 xenografts showed that MMP activity is rather uniform in the extracellular space within the tumor rim (showing high cellularity), whereas it disappears within the necrotic core (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). This finding is in agreement with maximum gelatinase activity being typically found at the leading invasive edge of solid tumors.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> However, it must also be considered that [<sup>18</sup>F]-<b>1a</b> has a micromolar affinity for albumin binding, and because albumin is the most abundant serum protein (reaching a concentration of 35 mg/mL in mice), the tracer can be considered to be largely bound to albumin in blood. The albumin/radiotracer complex, either circulating within the neo-formed blood vessels or being retained through the EPR effect in the perivascular extracellular space, might be considered as the major aspecific source of radioactivity retention within the tumor rim.</div><div class="NLM_p last">Assessment of the specific-to-aspecific ratio of tracer accumulation has been done by comparing the uptake of [<sup>18</sup>F]-<b>1a</b> with/without preblockage of MMP active sites by the cold, broad-spectrum MMP inhibitor ilomastat. A similar approach has been successfully used to assess the specificity of tumor labeling by other MMP-directed radiotracers, including a <sup>18</sup>F-labeled version of the broad-spectrum MMP inhibitor marimastat.<a onclick="showRef(event, 'ref27 ref52'); return false;" href="javascript:void(0);" class="ref ref27 ref52">(27, 52)</a> Interestingly, we found a small but statistically significant difference in the uptake ratio (UR) between preblocked and unblocked tumors. The UR represents a normalization of the tumor uptake of the MMP-targeted tracer by the metabolic activity within the tumor itself, as far as evaluated by [<sup>18</sup>F]FDG uptake. This normalization gives a better evaluation of the specific-to-aspecific ratio than the direct comparison between absolute tumor uptake (% ID/g) of the MMP-targeted tracer, essentially because the nonspecific uptake within a group of nonidentical tumors can be scaled out. The difference between average uptakes of [<sup>18</sup>F]-<b>1a</b> in preblocked/unblocked tumors yields that as much as 18% of total uptake may be considered as specific. It is hard to discuss this result against those for analogous MMP-targeted tracers because, to the best of our knowledge, no other explicit figures are available from literature, and specificity of uptake has been treated mostly in a qualitative way. Indeed, a large number of MMP-targeted tracers studied in the past decade were deemed to give disappointing results in vivo because of insufficient uptake specificity.<a onclick="showRef(event, 'ref20 ref25'); return false;" href="javascript:void(0);" class="ref ref20 ref25">(20, 25)</a> In a recent work with marimastat labeled with <sup>18</sup>F through nonconventional aryltrifluoroborate radiochemistry (Marimastat-ArBF<sub>3</sub>), a high specificity of tumor uptake has been found. Although no explicit number is given, a specificity of 60–70% can be inferred from graphs reported therein.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> A very recent work dealing with a fluorescent-labeled, hydroxamate MMP inhibitor (Cy5.5-AF489) yielded a specificity of about 30%.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Both Marimastat-ArBF<sub>3</sub> and Cy5.5-AF489 are very hydrophilic, hydroxamic-based compounds with inhibition potencies in the nanomolar range, suggesting that the more hydrophilic the tracers are, the more favorable the tumor uptake specificity is. However, care must be exercised in making more quantitative comparisons, as tumor types, staging, and MMP expression profiles are widely different among these and our study.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41646" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41646" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, our <sup>18</sup>F-labeled probe has the advantage of some selectivity toward a panel of MMPs, but the potential for imaging MMPs activity in vivo is strongly limited by the low specificity of tumor uptake and high uptake in the liver and gastrointestinal tract (GIT). This study also underlines that, besides optimization of the tracer hydrophobicity (log D) for better biodistribution, minimization of the affinity for serum albumin also has to be pursued to achieve highly efficient and specific tumor labeling. The latter aspect has never been considered in past studies. A very subtle balance of structural features is then required for an optimal balance between specificity toward selected MMP members, specificity of tumor uptake, and acceptable biodistribution. Functionalization of the arylsulfone scaffold at carefully selected positions with hydrophilic groups, such as mini-PEG chains,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> or modification of the net charge of the molecule could be viable routes to achieve this.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20245" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20245" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Synthesis of Precursors and <sup>19</sup>F-Labeled Inhibitors: General Procedures</h3><div class="NLM_p"><sup>1</sup>H, <sup>19</sup>F, and <sup>13</sup>C NMR spectra were determined with a JEOL ECP 400 (<sup>1</sup>H at 400, <sup>13</sup>C at 100 MHz) spectrometer or with a Bruker Avance III 500 MHz spectrometer (<sup>1</sup>H at 500 MHz, <sup>13</sup>C at 125 MHz, <sup>19</sup>F at 470 MHz). <sup>1</sup>H and <sup>13</sup>C chemical shifts (δ) are reported in parts per million referenced to tetramethylsilane by using the residual signal of deuterated solvents as a secondary reference. Coupling constants <i>J</i> are reported in hertz (Hz). <sup>13</sup>C NMR spectra were acquired with broadband proton decoupling. <sup>19</sup>F chemical shifts were referenced to CFCl<sub>3</sub> (δ = 0 ppm). The following abbreviations are used: singlet (s), doublet (d), triplet (t), double–doublet (dd), broad (br), and multiplet (m). Where indicated, the elemental compositions of the compounds agreed to within ±0.4% of the calculated value. Chromatographic separations were performed on silica gel columns by flash column chromatography (Merck silica gel 60, 230 ± 400 mesh) or by use of Isolute Flash Si II cartridges (Biotage). Reactions were followed by thin-layer chromatography (TLC) on Merck aluminum silica gel (5554) sheets that were visualized under a UV lamp (254 nm). Evaporation was performed in vacuo (rotating evaporator). Sodium sulfate was always used as the drying agent. Microwave-assisted reactions were run in a CEM Discover LabMate microwave synthesizer. Mass spectra with electrospray ionization (ES) were recorded on a SQD 3100 mass detector (Waters), operating in positive- or negative-ion mode, with methanol as the carrier solvent. The purity of the final compounds was determined by reverse-phase HPLC on a 1525 Waters liquid chromatograph with a Waters Atlantis C18 column (150 mm × 4.6 mm, 5 μm,); solvent A, H<sub>2</sub>O/TFA 0.1%; solvent B, CH<sub>3</sub>CN/TFA 0.1%; gradient of A from 40% to 80% in 18 min at a flow rate of 1 mL/min over a total run of 30 min (UV monitoring at the fixed wavelength of 254 nm). The purity of every compound synthesized was determined by the ratio of the integrated HPLC peak area for the compound of interest over the integrated HPLC peak area for all peaks. Purities were >95% if not specified otherwise.</div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 2-[2-(4-Bromophenylthio)phenyl]acetic Acid (<b>2</b>)</h4><div class="NLM_p last">A sealed tube containing 2-iodophenylacetic acid (1g, 3.82 mmol), 4-bromobenzenethiol (721.7 mg, 3.82 mmol), potassium hydroxide (427.8 mg, 7.64 mmol), copper powder (24.27 mg, 0.382 mmol), and water (1.9 mL) was submitted to microwave irradiation (two cycles of 6 min each at power 180 W, <i>T</i><sub>max</sub> = 140 °C, 100 psi); the sample was cooled during irradiation with a flow of compressed air. The obtained suspension was dissolved in a solution of 2 N KOH and then filtered. The filtrate was acidified with 1 N HCl, and the formed precipitate was filtered and dried under reduced pressure (<i>T</i> = 50 °C) to give a white precipitate (960 mg, 2.97 mmol, 77% yield).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>tert</i>-Butyl 2-[2-(4-Bromophenylthio)phenyl]acetate (<b>3</b>)</h4><div class="NLM_p last">A solution of the carboxylic acid <b>2</b> (2.2 g, 6.81 mmol) in dry toluene (13.07 mL) containing <i>N</i>,<i>N</i>-dimethylformamide di-<i>tert</i>-butyl acetal (4.70 mL, 27.23 mmol) was heated at 95 °C while refluxing. After 3 h, toluene was evaporated and the product was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 18:1) to afford a yellow oil (830 mg, 2.19 mmol, 32% yield).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>tert</i>-Butyl 2-[2-(4-Bromophenylsulfonyl)phenyl]acetate (<b>4</b>)</h4><div class="NLM_p last">To a stirred solution of sulfide <b>3</b> (800 mg, 2.109 mmol) in methanol (10.55 mL) and THF (31.64 mL) was added a solution of oxone [25 g, 42.18 mmol in water (42 mL)]. After 20 h of stirring, THF was evaporated in vacuo, the suspension was diluted with water, and the product was extracted with EtOAc. Organic phases were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to yield a white solid (990 mg, quantitative yield).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Procedure for Synthesis of Compounds <b>5</b> and <b>6</b></h4><div class="NLM_p">To a stirred solution of arylbromide <b>4</b> (200 mg, 0.486 mmol) in water (1.07 mL) and dioxane (4.86 mL) under N<sub>2</sub> atmosphere were added 4-hydroxyphenylboronic acid or 4-(benzyloxy)phenylboronic acid (0.535 mmol), potassium phosphate tribasic (340.45 mg, 1.604 mmol), and tetrakis(triphenylphosphine)palladium(0) (28 mg, 0.0243 mmol). The mixture was refluxed at 85 °C under stirring for 5 h, and then the reaction was quenched with a saturated solution of NaHCO<sub>3</sub> and the product was extracted with EtOAc. Organic phases were then washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo.</div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> <i>tert</i>-Butyl 2-{2-[4′-(Benzyloxy)biphenyl-4-ylsulfonyl]phenyl}acetate (<b>5</b>)</h5><div class="NLM_p last">The crude product was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 8:1) by use of an Isolute Si II cartridge (Biotage) to afford a white solid (43% yield).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> <i>tert</i>-Butyl 2-[2-(4′-Hydroxybiphenyl-4-ylsulfonyl)phenyl]acetate (<b>6</b>)</h5><div class="NLM_p last">The title compound obtained from intermediate <b>4</b> was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 4:1) by use of an Isolute Si II cartridge (Biotage) to give a light brown oil (24% yield). Alternatively, a solution of compound <b>5</b> (0.758 mmol) in MeOH (54.3 mL) was stirred under hydrogen atmosphere in the presence of 10% Pd–C (1:2 w/w) and glacial acetic acid (54.3 mL) for 17 h at room temperature. The resulting mixture was filtered on Celite and the filtrate was evaporated under reduced pressure to afford a yellow oil (70% yield).</div></div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>tert</i>-Butyl 2-{2-[4′-(2-Fluoroethoxy)biphenyl-4-ylsulfonyl]phenyl}acetate (<b>7</b>)</h4><div class="NLM_p last">A suspension of phenol <b>6</b> (33 mg, 0.078 mmol), 1-fluoro-2-tosyloxyethane (22.07 mg, 0.1 mmol), and potassium carbonate (21.57 mg, 0.156 mmol) in CH<sub>3</sub>CN (1 mL) was refluxed overnight under nitrogen atmosphere. The mixture was diluited with EtOAc and washed with water. EtOAc was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to yield a yellow oil (29 mg, 0.06 mmol, 80% yield).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-{2-[4′-(2-Fluoroethoxy)biphenyl-4-ylsulfonyl]phenyl}acetic acid (<b>1a</b>)</h4><div class="NLM_p last">To a 0 °C solution of <i>tert</i>-butyl ester <b>7</b> in dry CH<sub>2</sub>Cl<sub>2</sub> was added dropwise trifluoroacetic acid. The reaction was stirred at 0 °C for 5 h and then TFA was evaporated. The crude product was purified by trituration with Et<sub>2</sub>O and <i>n</i>-hexane to afford a light pink solid (16.4 mg, 0.04 mmol, 64% yield). <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>) δ 4.07 (s, 2H); 4.33 (m, <sup>2</sup><i>J</i><sub>H–H</sub> = 4.03 Hz, <sup>3</sup><i>J</i><sub>H–F</sub> = 29.29 Hz, 2H); 4.79 (m, <sup>2</sup><i>J</i><sub>H–H</sub> = 4.03 Hz, <sup>3</sup><i>J</i><sub>H–F</sub> = 47.60 Hz, 2H) 7.09 (d, <i>J</i> = 8.79 Hz, 2H); 7.47–7.49 (m, 1H); 7.56–7.60 (m, 1H); 7.63–7.71 (m, 1H); 7.68 (d, <i>J</i> = 7.89 Hz, 2H); 7.83 (d, <i>J</i> = 8.79 Hz, 2H); 7.94 (d, <i>J</i> = 8.79 Hz, 2H); 8.17–8.19 (m, 1H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>) δ 37.61, 67.42, 67.62, 81.24, 82.92, 115.20; 127.19, 128.02, 128.19, 128.63129.68, 131.65, 133.57, 134.08, 134.64140.00, 145.39, 159.46, 170.72. <sup>19</sup>F NMR (acetone-<i>d</i><sub>6</sub>) δ −224.50 (m, 1F). MS for C<sub>22</sub>H<sub>19</sub>FO<sub>5</sub>S: <i>m</i>/<i>z</i> calcd 414.55; found 437.19 [M + Na]<sup>+</sup>, 453.13 [M + K]<sup>+</sup>. Anal. Calcd for C<sub>22</sub>H<sub>19</sub>FO<sub>5</sub>S: C, 63.76; H, 4.62. Found: C, 63.52; H, 4.44. HPLC: retention time 9.93 min, purity 98.02%.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>tert</i>-Butyl 2-[2-(4′-Fluorobiphenyl-4-ylsulfonyl)phenyl]acetate (<b>8</b>)</h4><div class="NLM_p last">The title compound was prepared starting from arylbromide <b>4</b> and 4-fluorophenylboronic acid following the same procedure used for compounds <b>5</b> and <b>6.</b> The crude product was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 9:1) by use of an Isolute Si II cartridge (Biotage) to give a colorless oil (70% yield).</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>tert</i>-Butyl 2-[2-(4′-Aminobiphenyl-4-ylsulfonyl)phenyl]acetate (<b>9</b>)</h4><div class="NLM_p last">The title compound was prepared starting from arylbromide <b>4</b> and 4-aminophenylboronic acid following the same procedure used for compounds <b>5</b> and <b>6.</b> The crude product was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 4:1) by use of an Isolute Si II cartridge (Biotage) to give a foaming solid (75% yield).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-[2-(4′-Fluorobiphenyl-4-ylsulfonyl)phenyl]acetic acid (<b>1b</b>)</h4><div class="NLM_p last">The title compound was prepared following the same procedure used for compound <b>1a.</b> The crude product was purified by trituration with Et<sub>2</sub>O and <i>n</i>-hexane to afford a white solid (63% yield). <sup>1</sup>H NMR, 500 MHz (acetone-<i>d</i><sub>6</sub>) δ 4.11 (s, 2H); 7.29 (t, <i>J</i> = 8.31 Hz, 2H); 7.50–7.52 (m, 1H); 7.60–7.62 (m, 1H); 7.67–7.68 (m, 1H); 7.78 (dd, <i>J</i><sub>1</sub> = 5.43 Hz, <i>J</i><sub>2</sub> = 8.82 Hz, 2H); 7.87 (d, <i>J</i> = 8.32 Hz, 2H); 8.00 (d, <i>J</i> = 8.32 Hz, 2H); 8.21–8.23 (m, 1H). <sup>13</sup>C NMR, 500 MHz (acetone-<i>d</i><sub>6</sub>) δ 37.57, 115.76, 115.93, 127.69, 127.96, 128.14, 129.35, 129.42, 129.66, 133.57, 134.00134.62, 135.38, 135.41, 136.76, 140.66, 162.20, 164.15, 170.69. <sup>19</sup>F NMR, 470 MHz (acetone-<i>d</i><sub>6</sub>) δ −115.20 (m, 1F). MS for C<sub>20</sub>H<sub>15</sub>FO<sub>4</sub>S: <i>m</i>/<i>z</i> calcd 370.39; found 371.18 [M + H]<sup>+</sup>, 741.24 [2 M + H]<sup>+</sup>. Anal. Calcd for C<sub>20</sub>H<sub>15</sub>FO<sub>4</sub>S: C, 64.85; H, 4.08. Found: C, 63.73; H, 4.00. HPLC: retention time 10.1 min, purity 97.9%</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>tert</i>-Butyl 2-{2-[4′-(2-Fluoroacetamido)biphenyl-4-ylsulfonyl]phenyl}acetate (<b>10</b>)</h4><div class="NLM_p last">To a solution of compound <b>9</b> (134 mg, 0.32 mmol) in dry DMF (3.2 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (71.6 μL, 0.95 mmol) and then fluoroacetyl chloride (0.95 mmol). The mixture was stirred at room temperature overnight, and then the reaction was taken up with water and the product was extracted with EtOAc. Organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. The crude product was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 3:1) to afford a yellow oil (121 mg, 0.250 mmol, 78% yield).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-{2-[4′-(2-Fluoroacetamido)biphenyl-4-ylsulfonyl]phenyl}acetic Acid (<b>1c</b>)</h4><div class="NLM_p last">The title compound was prepared following the same procedure used for compound <b>1a.</b> The crude product was purified by trituration with Et<sub>2</sub>O and <i>n</i>-hexane to afford a light brown solid (62% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.94 (s, 2H); 5.00 (d, <sup>3</sup><i>J</i><sub>H–F</sub> = 45.66 Hz, 2H); 7.43–7.45 (m, 1H); 7.57–7.59 (m, 1H); 7.65–7.68 (m, 1H); 7.72 (d, <i>J</i> = 8.75 Hz, 2H); 7.79 (d, <i>J</i> = 8.75 Hz, 2H); 7.88 (s, 4H); 7.95 (d, <i>J</i> = 8.05 Hz, 1H); 8.04 (br s, 1H) 8.09–8.11 (m, 1H); 10.24 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 38.41, 79.68, 81.10, 120.69, 127.74, 128.09, 128.30, 128.58, 128.97, 129.81, 130.57, 133.82, 134.22, 134.65, 134.89, 139.21, 139.38, 139.80, 144.94, 166.53, 166.68, 171.87. <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) −225.14 (t, <sup>3</sup><i>J</i><sub>H–F</sub> = 45.66 Hz, 1F). MS for C<sub>22</sub>H<sub>18</sub>FNO<sub>5</sub>S: <i>m</i>/<i>z</i> calcd 427.45; found 450.20 [M + Na]<sup>+</sup>, 877.35 [2M + Na]<sup>+</sup>. Anal. Calcd for C<sub>22</sub>H<sub>18</sub>FNO<sub>5</sub>S: C, 61.82; H, 4.24; N, 3.28. Found: C, 61.60; H, 4.17; N, 3.33. HPLC: retention time 6.3 min, purity 97.8%.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>tert</i>-Butyl 2-(2-{4′-[2-(Tosyloxy)ethoxy]biphenyl-4-ylsulfonyl}phenyl)acetate (<b>11</b>)</h4><div class="NLM_p last">A suspension of phenol <b>6</b> (48 mg, 0.113 mmol), glycol-1,2-ditosylate (125.77, 0.339 mmol) and potassium carbonate (15.62 mg, 0.113 mmol) in CH<sub>3</sub>CN (3 mL) was refluxed under nitrogen atmosphere for 16 h. The mixture was then diluted with EtOAc and washed with water, and the combined organic phases were then dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. The crude product was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 4:1) by use of an Isolute Si II cartridge (Biotage) to yield a light brown solid (37.2 mg, 0.06 mmol, 53% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.36 (s, 9H); 2.42 (s, 3H); 3.93 (s, 9H); 4.18 (t, <i>J</i> = 5.13 Hz, 2H); 4.37 (t, <i>J</i> = 5.13 Hz, 2H); 6.86 (d, <i>J</i> = 8.79 Hz, 2H); 7.31–7.34 (m, 3H); 7.43–7.47 (m, 3H); 7.53–7.56 (m, 1H); 7.61 (d, <i>J</i> = 8.79 Hz, 2H); 7.80 (d, <i>J</i> = 8.06 Hz, 2H); 7.88 (d, <i>J</i> = 8.42 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 21.73, 28.06, 29.77, 39.49, 65.66, 68.07, 81.34, 115.21, 127.31, 127.82, 128.09, 181.14, 128.56, 129.96, 133.44, 134.52, 139.42, 139.70, 145.09, 145.50, 158.65, 169.72. MS for C<sub>33</sub>H<sub>34</sub>O<sub>8</sub>S<sub>2</sub>: <i>m</i>/<i>z</i> calcd 622.75; found 645.30 [M + Na]<sup>+</sup>, 1267.42 [2M + Na]<sup>+</sup>. HPLC: retention time 20.28 min, purity 99.73%.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>tert</i>-Butyl 2-{2-[4′-(2-Chloroacetamido)biphenyl-4-ylsulfonyl]phenyl}acetate (<b>12</b>)</h4><div class="NLM_p last">The title compound was obtained starting from intermediate <b>9</b> and chloroacetyl chloride following the same procedure used for compound <b>10</b>. The crude product was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 3:1) to afford a yellow oil (70% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.36 (s, 9H); 3.93 (s, 2H); 4.20 (s, 2H); 7.31–7.33 (m, 1H); 7.44–7.48 (m, 1H); 7.55 (d, <i>J</i> = 8.79 Hz, 2H); 7.62–7.67 (m, 5H); 7.91 (d, <i>J</i> = 8.79 Hz, 2H); 8.15–8.17 (m, 1H); 8.31 (br s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 28.07, 39.50, 53.86, 81.40, 120.57, 127.58, 127.86, 128.12, 128.20, 129.97, 133.47, 133.60, 134.53, 135.95, 137.23, 139.30, 140.24, 145.17, 169.72. MS for C<sub>26</sub>H<sub>26</sub>ClNO<sub>5</sub>S: <i>m</i>/<i>z</i> calcd 500.01; found 522.16 [M + Na]<sup>+</sup>. HPLC: retention time 14.3 min, purity 98.2%.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>tert</i>-Butyl 2-{2-[4′-(2-Bromoacetamido)biphenyl-4-ylsulfonyl]phenyl}acetate (<b>13</b>)</h4><div class="NLM_p last">The title compound was obtained starting from intermediate <b>9</b> and bromoacetyl bromide following the same procedure used for compound <b>10</b>. The crude product was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 5:1) by use of an Isolute Si II cartridge (Biotage) to afford a brown oil (57% yield).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Radiosynthesis</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Production of [<sup>18</sup>F]Fluoride Ions</h4><div class="NLM_p last">No-carrier-added (nca) [<sup>18</sup>F]fluoride was produced after irradiation of [<sup>18</sup>O]H<sub>2</sub>O by the <sup>18</sup>O(p, n)<sup>18</sup>F nuclear reaction in a 16.5 MeV cyclotron (PET Trace GE Medical System). The [<sup>18</sup>F ]fluoride was delivered to the computer-controlled synthesizer Tracerlab FX<sub>FN</sub> (GE Medical System) and was passed through an anion-exchange resin (Sep-Pak Light Waters Accell Plus QMA cartridge). [<sup>18</sup>F]Fluoride ions were eluted from the resin in the reactor with a mixture of 22 mg of Kryptofix 2.2.2 (K 222) and 3 mg of K<sub>2</sub>CO<sub>3</sub> in 0.3 mL of ultrapure water and 0.3 mL of acetonitrile. Subsequently, the aqueous [<sup>18</sup>F]K(K 222)F solution was evaporated to dryness by azeotropic distillation at 90 °C in vacuo.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>tert</i>-Butyl [<sup>18</sup>F]-2-{2-[4′-(2-Fluoroethoxy)biphenyl-4-ylsulfonyl]phenyl}acetate ([<sup>18</sup>F]-<b>7</b>)</h4><div class="NLM_p last">Three milligrams of ethylene glycol ditosylate dissolved in 1 mL of acetonitrile and the dried [<sup>18</sup>F]K(K222) residue were heated at 100 °C for 10 min in the reaction vessel of the synthesis module. Then the mixture was cooled, diluted with 4 mL of water for injection, and passed through a C18 Sep-Pak cartridge. The product was eluted with 2 mL of an acetonitrile/water mixture (3:2 v/v). After evaporation, a solution of 2 mg of <b>6</b> in 500 μL of DMSO/MeOH (4/1 v/v) and 0.28 mg of MeONa (10% excess) was added. The fluoroethylation was carried out at 120 °C for 12 min. The crude product was recovered without further purification, but the target compound accounted for only 10% of total radioactivity.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> [<sup>18</sup>F]-2-{2-[4′-(2-Fluoroethoxy)biphenyl-4-ylsulfonyl]phenyl}acetic Acid ([<sup>18</sup>F]-<b>1a</b>): One-Step Procedure</h4><div class="NLM_p last">Two milligrams of precursor <b>11</b> in 1 mL of acetonitrile was added to the dried [<sup>18</sup>F]K(K 222)F residue, and the mixture was heated at 105 °C for 10 min to allow the nucleophilic substitution. After cooling, the mixture was diluted with 10 mL of water and loaded on a C18 Sep-Pak cartridge for the intermediate purification step. The cartridge was washed with 2 mL of 10% EtOH and then eluted with 1.5 mL of 60% EtOH. After evaporation, a solution of 600 μL of TFA and 500 μL of acetonitrile was added and the deprotection was carried out at room temperature for 10 min. The mixture was diluted with 6 mL of water, loaded on a second C18 Sep-Pak cartridge, and washed with 2 mL of 10% EtOH. The cartridge was eluted with 1.5 mL of 60% EtOH. The following steps were performed manually. The final mixture was further purified by Oasis HLB plus cartridge: the cartridge was washed with 1 mL of 40% EtOH, and the product was finally eluted with 0.6 mL of 60% EtOH.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> [<sup>18</sup>F]-2-{2-[4′-(2-Fluoroacetamido)biphenyl-4-ylsulfonyl]phenyl}acetic Acid ([<sup>18</sup>F]-<b>1c</b>)</h4><div class="NLM_p last">Three milligrams of precursor <b>12</b> in 1 mL of acetonitrile was added to the dried [<sup>18</sup>F]K(K 222)F residue. The mixture was heated at 130 °C for 12 min to allow the nucleophilic substitution. After cooling, the mixture was diluted with 6 mL of water and loaded on a C18 Sep-Pak cartridge for the intermediate purification step. The cartridge was washed with 2 mL of 10% EtOH and then eluted with 1.5 mL of EtOH. After solvent evaporation, a solution of 600 μL of TFA and 500 μL of acetonitrile was added and the deprotection was carried out at room temperature for 10 min. The solution was diluted with 6 mL of water, loaded on a second C18 Sep-Pak cartridge, and washed with 2 mL of 10% EtOH. The cartridge was finally eluted with 1.5 mL of EtOH . The final ethanol solution was evaporated and the residue was diluted with phosphate buffer.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> MMP Inhibition Assay</h3><div class="NLM_p last">Recombinant human MMP-14 catalytic domain was a kind gift of Professor Gillian Murphy (Department of Oncology, University of Cambridge, U.K.). Pro-MMP-1, pro-MMP-2, pro-MMP-9, pro-MMP-3, and pro-MMP-13 were purchased from Calbiochem. Pro-MMP-12 was purchased from R&D Systems. Proenzymes were activated immediately prior to use with 2 mM <i>p</i>-aminophenylmercuric acetate (APMA): 2 mM for 1 h at 37 °C for MMP-2 and MMP-1, 1 mM for 1 h at 37 °C for MMP-9 and MMP-13. Pro-MMP-3 was activated with trypsin (5 μg/mL) for 30 min at 37 °C, followed by soybean trypsin inhibitor (SBTI) (62 μg/mL). Pro-MMP-12 was autoactivated by incubating in FAB buffer for 30 h at 37 °C. For assay measurements, the inhibitor stock solutions (DMSO, 10 mM) were further diluted, at seven different concentrations (0.01 nM–300 μM) for each MMP in the fluorometric assay buffer (FAB buffer: 50 mM Tris, pH = 7.5, 150 mM NaCl, 10 mM CaCl<sub>2</sub>, 0.05% Brij 35, and 1% DMSO). Activated enzyme (final concentration 0.5 nM for MMP-2, 1.3 nM for MMP-9, 0.3 nM for MMP-13, 5.0 nM for MMP-3, 1.0 nM for MMP-14, 2.0 nM for MMP-1, and 1.0 nM for MMP-12) and inhibitor solutions were incubated in the assay buffer for 4 h at 25 °C. After the addition of a 200 μM solution of the fluorogenic substrate Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH<sub>2</sub> (Sigma) for MMP-3 and Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH<sub>2</sub> (Bachem) for all other enzymes in DMSO (final concentration 2 μM), the hydrolysis was monitored every 15 s for 20 min, the increase in fluorescence (λ<sub>ex</sub> = 325 nm, λ<sub>em</sub> = 395 nm) was recorded on a Molecular Devices SpectraMax Gemini XS plate reader. The assays were performed in triplicate in a total volume of 200 μL/well in 96-well microtiter plates (Corning, black, NBS). Control wells lack inhibitor. The MMP inhibition activity was expressed in relative fluorescent units (RFU). Percent inhibition was calculated from control reactions without the inhibitor. IC<sub>50</sub> was determined from the formula <i>v</i><sub>i</sub>/<i>v</i><sub>0</sub> = 1/(1 + [I]/IC<sub>50</sub>), where <i>v</i><sub>i</sub> is the initial velocity of substrate cleavage in the presence of the inhibitor at concentration [I] and <i>v</i><sub>0</sub> is the initial velocity in the absence of inhibitor. Results were analyzed by use of SoftMax Pro 4.7.1 software (Molecular Devices) and GraFit 4 software (Erithecus Software).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <sup>19</sup>F NMR Studies</h3><div class="NLM_p last"><sup>19</sup>F NMR spectra were acquired on a Bruker Avance III spectrometer operating at 11.7 T (corresponding to Larmor frequencies of 470 and 500 MHz for <sup>19</sup>F and <sup>1</sup>H, respectively), equipped with a double-resonance <i>Z</i>-gradient 5 mm BBFO probe, allowing for observation of the <sup>19</sup>F nucleus with decoupling of <sup>1</sup>H. Proton-decoupled <sup>19</sup>F NMR spectra were acquired with a 90° <sup>19</sup>F excitation pulse, spectral width of 220 ppm, 128K complex data points, and relaxation delay of 2.5 s. The number of scans was increased from 64 (free ligand) to 16 384 (protein:ligand 3:1) to get a suitable signal-to-noise ratio all over the titration. Sample temperature was kept at 310.0 K. Ligand (final concentration 1.0 mM) was dissolved in 50 μL of DMSO and brought to 1.0 mL with PBS (pH 7.4) containing 10% D<sub>2</sub>O for field/frequency lock. The solution also contained TFA as the <sup>19</sup>F NMR chemical shift internal standard (δ = 0 ppm). Human serum albumin (fatty acid-free) was sequentially added to this solution, either in 10 μL aliquots (0.36 mM in PBS) or as the solid powder, up to protein:ligand ratio of 3:1.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Cell Culture and Mouse U-87 MG Glioblastoma Tumor Model</h3><div class="NLM_p last">Human glioblastoma cells (U-87 MG) were supplied by ATCC (U-87 MG, ATCC HTB-14). ATCC has performed authentication and quality-control tests on the cell line according to Technical Bulletin 8. Cells were grown in Eagle’s minimum essential medium (EMEM) supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 IU/mL penicillin, and 100 μg/mL streptomycin. U-87 MG cells were collected and washed two times with PBS. Five million U-87 MG cells were resuspended in 0.1 mL of EMEM/Matrigel 1:1 and injected subcutaneously in the left flank of each 6-week-old female mouse. Tumor development was followed daily after inoculation by caliper measurement once the mass was established until the day of the PET experiment or sacrifice (typically within 10–15 days postinoculation).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Gelatin Zymography</h3><div class="NLM_p last">Tumors were removed from mice within 12 h from the PET scan and immediately frozen at −80 °C. Tumors were manually ground under dry ice and added to 50 μL of 1% Triton X-100 lysis buffer; the mixture was sonicated on ice, and the supernatant was collected by centrifugation (4 °C). An aliquot (20 μL) of the supernatant was mixed with sample buffer [250 mM Tris-HCl pH 6.8, 10% sodium dodecyl sulfate (SDS), 10% glycerol, and 0.4% bromophenol blue] and run on 10% SDS–polyacrylamide gel containing 0.1% gelatin at 150 V and room temperature for 85 min. The gel was washed twice (5 min) with distilled water, washed twice (30 min) with the renaturing buffer (50 mM Tris, 0.1 M NaCl, and 2.5% Triton X-100) to remove SDS, and rinsed twice (5 min) with deionized water. The gel was incubated for 24 h at 37 °C with the developing buffer consisting of 50 mM Tris-HCl, pH 7.4, 10 mM CaCl<sub>2</sub>, and 0.5 μM ZnCl<sub>2</sub>). After washings, gels were stained with 0.5% Coomassie blue. Gelatinolytic activity was identified as a white band on blue background. The 72 kDa band corresponds to MMP-2 and the 92 kDa band to MMP-9.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> In Situ DQ-Gelatin Zymography and Hematoxylin/Eosin Staining</h3><div class="NLM_p">Six U-87 MG glioblastoma xenografts resected from mice that were not subjected to PET scans were frozen immediately after resection in isopentane/liquid nitrogen freezing bath and kept at −80 °C. Cryosections (10 μm thick) from vehicle- or ilomastat-treated tumors were serially cut for either in situ zymography or hematoxylin/eosin (HE) staining, transferred onto microscope slides, and air-dried for 30 min. DQ-gelatin (Enzcheck, Molecular Probes) was diluted in zymography buffer (50 mM Tris-HCl, 150 mM NaCl, and 0.2 mM sodium azide, pH 7.6) at a final concentration of 10 μg/mL, and sections were incubated at 37 °C for 30 min. As negative controls, DQ-gelatin was omitted or  10 mM 1,10-phenanthroline (Enzcheck, Molecular Probes) or 100 mM EDTA was added to the DQ-gelatin solution. After incubation, slides were fixed in 4% paraformaldehyde for 10 min, rinsed in PBS, and then mounted with Vectashield mounting medium (Vector Laboratories). Three fields per section were acquired by use of a confocal microscope (Leica SP5, Leica Microsystems), and the signal intensity was quantified with ImageJ software and normalized to the background.</div><div class="NLM_p last">For HE staining, 10-μm-thick cryosections were transferred onto microscope slides and air-dried for 30 min. After being rinsed in water, sections were stained with eosin for 30 s and hematoxylin for 1 min, dehydrated in increasing strengths of ethanol, and then cleared in xylene for 20 min. Slides were finally mounted with Eukitt mounting medium (Electron Microscopy Sciences), and images were acquired on a light microscope (Olympus BX51, Segrate, Italy).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Western Blotting</h3><div class="NLM_p last">Six U-87 MG glioblastoma xenografts resected from mice that were not subjected to PET scans or treatment with MMP inhibitors were frozen immediately after resection in isopentane/liquid nitrogen freezing bath and kept at −80 °C. To extract proteins, each tumor was weighed, placed in a mortar, and finely powdered with a pestle in the presence of liquid nitrogen. The powder obtained was suspended in 0.5 mL of lysis buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 1 mM EDTA, 100 mM KF, 10% glycerol, 1 mM MgCl<sub>2</sub>, 1% Triton X-100, and protease inhibitors), vortexed for 60 s, and then left on ice for 40 min. Afterward the solution was sonicated for few minutes and then centrifuged at 14000<i>g</i> at 4 °C for 10 min. The supernatant containing the soluble protein fraction was assayed for protein content by means of the BCA (bicinchoninic acid) method (Pierce, Thermo Fisher Scientific). Total extracts were diluted 1:1 in sample buffer (60 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, and bromophenol blue) and 20 μg/lane was loaded on a 10% polyacrylamide gel (Bio-Rad) to assay MMP-2; electrophoresis was performed under denaturing conditions with 2% β-mercaptoethanol. To obtain a standard calibration curve for the quantification, recombinant human MMP-2 (Calbiochem, Merck Millipore) was loaded in the same gel at concentrations of 10–20–40–60 ng. Proteins within the gel were transferred onto a nitrocellulose membrane (GE Healthcare) and the blotting was performed by incubation, after blocking for 1 h in 5% skim milk in Tris-buffered saline with Tween-20 (TBS-T: 10 mM Tris-HCl, pH 7.4, 0.1 M NaCl, and 0.1% Tween-20), with the antibodies of interest (anti-MMP-2, Abcam) for 3 h at a concentration of 1 μg/mL in 5% skim milk in TBS-T. The membrane was then rinsed in TBS-T for 1 h, incubated with the secondary antibody (peroxidase-conjugated goat anti-rabbit horseradish, Merck Millipore) at a concentration of 0.1 μg/mL in 5% skim milk in TBS-T for 1 h, and rinsed again. Specific signal was visualized as a single or multiple band by the ECL detection method (enhanced chemiluminescence, GE Healthcare), based on the emission of light during the peroxidase-catalyzed oxidation of diacylhydrazide luminol. The emitted light is captured on a photographic film (Kodak, Sigma–Aldrich) for qualitative and semiquantitative analysis. Densitometric image analysis to evaluate the relative amount of protein staining was performed with Fiji-Win32 software.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> PET Images</h3><div class="NLM_p">PET images were acquired on a YAP-(S)PET scanner (I.SE. Ingegneria dei Sistemi Elettronici s.r.l., Pisa, Italy) designed for small animals.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Animals were anesthetized by inhalation of 0.5–2% isofluorane (100% O<sub>2</sub>), placed on the scanner bed in prone position, and injected in the tail vein (via catheter) with [<sup>18</sup>F]MPPi or [<sup>18</sup>F]fluoro-2-deoxyglucose ([<sup>18</sup>F]FDG) at a typical dose of 7.4 MBq (200 μCi, in 0.15–0.30 mL of PBS). The residual dose in the syringe was measured to verify the effective injected dose. For biodistribution studies, each tracer was tested on 2–3 healthy animals (nude mice 6–8 weeks old). Dynamic PET scans were performed from tracer injection up to 2.5 h to evaluate tracer distribution and to produce time–activity curves of liver, gut, kidneys, and gallbladder. Due to the detector’s array dimension, only the part of the body within 4 cm and centered on the abdomen was imaged. At the end of the dynamic acquisition, a static acquisition (acquisition time 30 min) centered on the head of the animal was performed. PET images aimed at assessing tumor uptake of the <sup>18</sup>F-labeled MMPi were performed when the tumor size reached a volume of 150–500 mm<sup>3</sup>. The PET scan were obtained by static acquisition (acquisition time 30 min) performed 100 min after the i.v. injection of  [<sup>18</sup>F]MMPi (typically 7.4 MBq). At the end of [<sup>18</sup>F]MMPi static acquisition, the animal received 7.4 MBq of [<sup>18</sup>F]FDG via the catheter placed in the tail vein; care was taken not to move the animal. [<sup>18</sup>F]FDG PET scans (static mode, 30 min) were performed 45 min after tracer injection. For inhibition studies, ilomastat at a dose of 40–160 mg/kg was injected intraperitoneally 30 min before PET acquisition.</div><div class="NLM_p last">A 3D data acquisition mode and an expectation maximization (EM) algorithm with 30 iterations for image reconstruction were used; the resulting voxel size was 0.5 × 0.5 × 2 mm<sup>3</sup>. No corrections were made for attenuation and scatter. The images were visualized with dedicated software (<a href="http://www.pmod.com/" class="extLink">http://www.pmod.com/</a>, last access 26/10/2011) in the three planes (transaxial, sagittal, and coronal). For semiquantitative evaluation, data from a 63 mL cylinder phantom-filled with [<sup>18</sup>F]fluoride (7.4 MBq) were acquired on the PET scanner and reconstructed with the same protocol used for the animal studies. From this scan, a system calibration factor was calculated by dividing the known activity concentration in the phantom by the measured mean counts per voxel in the reconstructed PET images. The calibration factor was used to convert the raw counts measured by the scanner into activity concentration. Region of interest (ROI) were manually drawn on the tumor/organ of interest in the transaxial images. <sup>18</sup>F-Tracer uptake was corrected for decay and quantified by using the percentage injected dose per gram of tissue (% ID/g) calculated according to the expression<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/jm-2013-001743_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>where <i>C</i><sub>T</sub> is the radioactivity in the ROI (in megabecquerels per milliliter of tissue), <i>W</i><sub>T</sub> (in grams) and <i>V</i><sub>T</sub> (in milliliters) are the mass and volume of the considered tissue (the <i>V</i><sub>T</sub>/<i>W</i><sub>T</sub> ratio has been assumed to be 1 mg/mL; see ref <a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">55</a>), and <i>D</i><sub>inj</sub> is the injected dose of radiotracer (in megabecquerels).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45"><a href="/doi/suppl/10.1021/jm4001743">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86858" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86858" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Two tables, listing inhibitor potency as <i>K</i><sub>i</sub> and % ID/g after tumor uptake of [<sup>18</sup>F]-<b>1a</b> and [<sup>18</sup>F]FDG; one figure with PET images showing passage of the tracers through the gallbladder; and additional text with analytical and spectroscopic data for compounds <b>2</b>–<b>10</b> and <b>13</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4001743/suppl_file/jm4001743_si_001.pdf">jm4001743_si_001.pdf (266.01 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm4001743" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02774" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02774" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Digilio</span> - <span class="hlFld-Affiliation affiliation">Department of Science and Technological
Innovation, Università del Piemonte Orientale
“Amedeo Avogadro”, Viale T. Michel 11,
I-15121 Alessandria, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular Imaging Centre, University of Torino, Via Nizza 52, I-10126 Torino,
Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a1c6c8d4d2c4d1d1c48fc5c8c6c8cdc8cee1ccc7cf8fd4cfc8d1cccf8fc8d581c0d3ced2e1c7c0d3cc8fd4cfc8d1c88fc8d5"><span class="__cf_email__" data-cfemail="ccaba5b9bfa9bcbca9e2a8a5aba5a0a5a38ca1aaa2e2b9a2a5bca1a2e2a5b8">[email protected]</span> <span class="__cf_email__" data-cfemail="3a5b4855497a5c5b4857144f54534a5314534e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Armando Rossello</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, University of Pisa, Via Bonanno
6, I-56126 Pisa, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#43242a3630263333266d272a242a2f2a2c032e252d6d362d2a332e2d6d2a376322312c30032522312e6d362d2a332a6d2a37"><span class="__cf_email__" data-cfemail="6a0d031f190f1a1a0f440e030d030603052a070c04441f04031a070444031e">[email protected]</span> <span class="__cf_email__" data-cfemail="9afbe8f5e9dafcfbe8f7b4eff4f3eaf3b4f3ee">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesca Casalini</span> - <span class="hlFld-Affiliation affiliation">Department of Science and Technological
Innovation, Università del Piemonte Orientale
“Amedeo Avogadro”, Viale T. Michel 11,
I-15121 Alessandria, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorenza Fugazza</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Advanced Accelerator Applications, Via Ribes 5, I-10010
Colleretto Giacosa (TO), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanna Esposito</span> - <span class="hlFld-Affiliation affiliation">Molecular Imaging Centre, University of Torino, Via Nizza 52, I-10126 Torino,
Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudia Cabella</span> - <span class="hlFld-Affiliation affiliation">Centro Ricerche Bracco, Bracco Imaging S.p.A., Via Ribes 5, I-10010 Colleretto
Giacosa (TO), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiara Brioschi</span> - <span class="hlFld-Affiliation affiliation">Centro Ricerche Bracco, Bracco Imaging S.p.A., Via Ribes 5, I-10010 Colleretto
Giacosa (TO), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessia Cordaro</span> - <span class="hlFld-Affiliation affiliation">Centro Ricerche Bracco, Bracco Imaging S.p.A., Via Ribes 5, I-10010 Colleretto
Giacosa (TO), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luca D’Angeli</span> - <span class="hlFld-Affiliation affiliation">Molecular Imaging Centre, University of Torino, Via Nizza 52, I-10126 Torino,
Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonietta Bartoli</span> - <span class="hlFld-Affiliation affiliation">Molecular Imaging Centre, University of Torino, Via Nizza 52, I-10126 Torino,
Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Azzurra M. Filannino</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Advanced Accelerator Applications, Via Ribes 5, I-10010
Colleretto Giacosa (TO), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Concetta V. Gringeri</span> - <span class="hlFld-Affiliation affiliation">Department of Science and Technological
Innovation, Università del Piemonte Orientale
“Amedeo Avogadro”, Viale T. Michel 11,
I-15121 Alessandria, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dario L. Longo</span> - <span class="hlFld-Affiliation affiliation">Molecular Imaging Centre, University of Torino, Via Nizza 52, I-10126 Torino,
Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valeria Muzio</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Advanced Accelerator Applications, Via Ribes 5, I-10010
Colleretto Giacosa (TO), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisa Nuti</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, University of Pisa, Via Bonanno
6, I-56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisabetta Orlandini</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, University of Pisa, Via Bonanno
6, I-56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gianluca Figlia</span> - <span class="hlFld-Affiliation affiliation">Institute of Experimental Neurology,
Division of Neuroscience, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angelo Quattrini</span> - <span class="hlFld-Affiliation affiliation">Institute of Experimental Neurology,
Division of Neuroscience, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorenzo Tei</span> - <span class="hlFld-Affiliation affiliation">Department of Science and Technological
Innovation, Università del Piemonte Orientale
“Amedeo Avogadro”, Viale T. Michel 11,
I-15121 Alessandria, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro Maiocchi</span> - <span class="hlFld-Affiliation affiliation">Centro Ricerche Bracco, Bracco Imaging S.p.A., Via Ribes 5, I-10010 Colleretto
Giacosa (TO), Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d657e3149-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge Dr. Gabriele Dati (San Raffaele Scientific Institute, Milan), Dr. Juan Carlos Cutrin (Molecular Biotechnology Centre, Turin), and Dr. Claudio Cassino (DiSIT) for technical assistance and helpful discussion. Economic and scientific support from Regione Piemonte (Bando CIPE 2007 “Converging Technologies”) project “BIO_THER: Modeling Oncogenic Pathways: from Bioinformatics to Diagnosis and Therapy”, from “Fondazione per le Biotecnologie” (FBT, Turin, Italy) and from Italian Ministry of University and Scientific Research (PRIN 2007, MIUR) is gratefully acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> Abbreviations Used</h2><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloproteinases</p></td></tr><tr><td class="NLM_term">ECM</td><td class="NLM_def"><p class="first last">rxtracellular matrix</p></td></tr><tr><td class="NLM_term">TIMP</td><td class="NLM_def"><p class="first last">tissue inhibitor of metalloproteinase</p></td></tr><tr><td class="NLM_term">MMPi</td><td class="NLM_def"><p class="first last">inhibitor of matrix metalloproteinase</p></td></tr><tr><td class="NLM_term">ZBG</td><td class="NLM_def"><p class="first last">zinc binding group</p></td></tr><tr><td class="NLM_term">HSA</td><td class="NLM_def"><p class="first last">human serum albumin</p></td></tr><tr><td class="NLM_term">GIT</td><td class="NLM_def"><p class="first last">gastrointestinal tract</p></td></tr><tr><td class="NLM_term">FDG</td><td class="NLM_def"><p class="first last">fluorodeoxyglucose</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoracetic acid</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">poly(ethylene glycol)</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">RCY</td><td class="NLM_def"><p class="first last">radiochemical yield</p></td></tr><tr><td class="NLM_term">RCP</td><td class="NLM_def"><p class="first last">radiochemical purity</p></td></tr><tr><td class="NLM_term">EOS</td><td class="NLM_def"><p class="first last">end of synthesis</p></td></tr><tr><td class="NLM_term">HE</td><td class="NLM_def"><p class="first last">hematoxylin and eosin</p></td></tr><tr><td class="NLM_term">DQ gelatin</td><td class="NLM_def"><p class="first last">dye-quenched gelatin</p></td></tr><tr><td class="NLM_term">UR</td><td class="NLM_def"><p class="first last">uptake ratio</p></td></tr><tr><td class="NLM_term">n.d.c.</td><td class="NLM_def"><p class="first last">non decay corrected</p></td></tr><tr><td class="NLM_term">EPR</td><td class="NLM_def"><p class="first last">Enhanced Permeability and Retention</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48067" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48067" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 55 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Massova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotra, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases: structures, evolution, and diversification</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1096%2Ffasebj.12.12.1075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=9737711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADyaK1cXlvFWnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=1075-1095&author=I.+Massovaauthor=L.+P.+Kotraauthor=R.+Fridmanauthor=S.+Mobashery&title=Matrix+metalloproteinases%3A+structures%2C+evolution%2C+and+diversification"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases: structures, evolution, and diversification</span></div><div class="casAuthors">Massova, Irina; Kotra, Lakshmi P.; Fridman, Rafael; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1075-1095</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A comprehensive sequence alignment of 64 members of the family of matrix metalloproteinases (MMPs) for the entire sequences, and subsequently the catalytic and the hemopexin-like domains, was performed.  The 64 MMPs were selected from plants, invertebrates, and vertebrates.  The analyses disclosed that as many as 23 distinct subfamilies of these proteins are known to exist.  Information from the sequence alignments was correlated with structures, both crystallog. as well as computational, of the catalytic domains for the 23 representative members of the MMP family.  A survey of the metal-binding sites and 2 loops contg. variable sequences of amino acids, which are important for substrate interactions, are discussed.  The collective data support the proposal that the assembly of the domains into multidomain enzymes was likely to be an early evolutionary event.  This was followed by diversification, perhaps in parallel among the MMPs, in a subsequent evolutionary time scale.  Anal. indicates that a retrograde structure simplification may have accounted for the evolution of MMPs with simple domain constituents, such as matrilysin, from the larger and more elaborate enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpgSZYQa5oO7Vg90H21EOLACvtfcHk0lj6_z0JDNGi5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvFWnur4%253D&md5=764760a88db783063076c9c4c37f5757</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.12.12.1075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.12.12.1075%26sid%3Dliteratum%253Aachs%26aulast%3DMassova%26aufirst%3DI.%26aulast%3DKotra%26aufirst%3DL.%2BP.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DMatrix%2520metalloproteinases%253A%2520structures%252C%2520evolution%252C%2520and%2520diversification%26jtitle%3DFASEB%2520J.%26date%3D1998%26volume%3D12%26spage%3D1075%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Nagase, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woessner, J. F.,  Jr.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x"> (</span><span class="NLM_issue">31</span><span class="NLM_x">) </span> <span class="NLM_fpage">21491</span><span class="NLM_x">–</span> <span class="NLM_lpage">21494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=21491-21494&issue=31&author=H.+H.+Nagaseauthor=J.+F.+Woessner&title=Matrix+metalloproteinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DH.%2BH.%26aulast%3DWoessner%26aufirst%3DJ.%2BF.%26atitle%3DMatrix%2520metalloproteinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26issue%3D31%26spage%3D21491%26epage%3D21494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hoekstra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskens, F. A. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verweij, J.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinase inhibitors: Current developments and future perspectives</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=415-427&author=R.+Hoekstraauthor=F.+A.+L.+M.+Eskensauthor=J.+Verweij&title=Matrix+metalloproteinase+inhibitors%3A+Current+developments+and+future+perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoekstra%26aufirst%3DR.%26aulast%3DEskens%26aufirst%3DF.%2BA.%2BL.%2BM.%26aulast%3DVerweij%26aufirst%3DJ.%26atitle%3DMatrix%2520metalloproteinase%2520inhibitors%253A%2520Current%2520developments%2520and%2520future%2520perspectives%26jtitle%3DOncologist%26date%3D2001%26volume%3D6%26spage%3D415%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Parks, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Boado, Y. S.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases as modulators of inflammation and innate immunity</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1038%2Fnri1418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=15286728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=617-229&author=W.+C.+Parksauthor=C.+L.+Wilsonauthor=Y.+S.+L%C3%B3pez-Boado&title=Matrix+metalloproteinases+as+modulators+of+inflammation+and+innate+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases as modulators of inflammation and innate immunity</span></div><div class="casAuthors">Parks, William C.; Wilson, Carole L.; Lopez-Boado, Yolanda S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">617-629</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  As their name implies, matrix metalloproteinases are thought to be responsible for the turnover and degrdn. of the extracellular matrix.  However, matrix degrdn. is neither the sole nor the main function of these proteinases.  Indeed, as the authors discuss here, recent findings indicate that matrix metalloproteinases act on pro-inflammatory cytokines, chemokines and other proteins to regulate varied aspects of inflammation and immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBtb_YA4ZbNbVg90H21EOLACvtfcHk0lj6_z0JDNGi5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFWktrc%253D&md5=2f0172ac025916666fda425f6869c360</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnri1418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1418%26sid%3Dliteratum%253Aachs%26aulast%3DParks%26aufirst%3DW.%2BC.%26aulast%3DWilson%26aufirst%3DC.%2BL.%26aulast%3DL%25C3%25B3pez-Boado%26aufirst%3DY.%2BS.%26atitle%3DMatrix%2520metalloproteinases%2520as%2520modulators%2520of%2520inflammation%2520and%2520innate%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2004%26volume%3D4%26spage%3D617%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Egeblad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werb, Z.</span><span> </span><span class="NLM_article-title">New functions for the matrix metalloproteinases in cancer progression</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1038%2Fnrc745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=11990853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1KktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=161-174&author=M.+Egebladauthor=Z.+Werb&title=New+functions+for+the+matrix+metalloproteinases+in+cancer+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">New functions for the matrix metalloproteinases in cancer progression</span></div><div class="casAuthors">Egeblad, Mikala; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) have long been assocd. with cancer-cell invasion and metastasis.  This provided the rationale for clin. trials of MMP inhibitors, unfortunately with disappointing results.  We now know, however, that the MMPs have functions other than promotion of invasion, have substrates other than components of the extracellular matrix, and that they function before invasion in the development of cancer.  With this knowledge in hand, can we rethink the use of MMP inhibitors in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtDQGs5M_BzLVg90H21EOLACvtfcHk0li5PUiW4rci0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1KktL8%253D&md5=56dd558362155cb25c9adbea4d478aa8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc745%26sid%3Dliteratum%253Aachs%26aulast%3DEgeblad%26aufirst%3DM.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DNew%2520functions%2520for%2520the%2520matrix%2520metalloproteinases%2520in%2520cancer%2520progression%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lampert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machein, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machein, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conca, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, B.</span><span> </span><span class="NLM_article-title">Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2FS0002-9440%2810%2965586-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=9708803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADyaK1cXls1ejtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1998&pages=429-437&author=K.+Lampertauthor=U.+Macheinauthor=M.+R.+Macheinauthor=W.+Concaauthor=H.+H.+Peterauthor=B.+Volk&title=Expression+of+matrix+metalloproteinases+and+their+tissue+inhibitors+in+human+brain+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors</span></div><div class="casAuthors">Lampert, Klaus; Machein, Uwe; Machein, Marcia Regina; Conca, Walter; Peter, Hans Hartmut; Volk, Benedikt</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">429-437</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">The expression patterns of 15 matrix metalloproteinases (MMPs) and 3 TIMP proteins in gliomas, medulloblastomas, and normal brain tissue were investigated.  By Northern blot anal., the authors found increased levels of mRNAs encoding for gelatinase A, gelatinase B, 2 membrane-type MMPs (mt1- and mt2-MMP), and TIMP-1 in glioblastomas and medulloblastomas.  The authors obsd. a significant increase of mt1-MMP, gelatinase A, gelatinase B, and TIMP-1 in glioblastomas as compared with low-grade astrocytomas, anaplastic astrocytomas, and normal brain.  In medulloblastomas, the expression of mt1-MMP, mt2-MMP, and gelatinase A were also increased, but to a lesser extent than that obsd. in glioblastomas.  These data were confirmed at the protein level by immunostaining anal.  Moreover, substrate gel electrophoresis showed that the activated forms of gelatinases A and B were present in glioblastomas and medulloblastomas.  These results suggest that increased expression of mt1-MMP/gelatinase A is closely related to the malignant progression obsd. in gliomas.  Furthermore, the present study demonstrates, apparently for the 1st time, that medulloblastomas express high levels of MMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrknU4W5xX61rVg90H21EOLACvtfcHk0li5PUiW4rci0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls1ejtro%253D&md5=481a77b1d7826332056287d0d6ca8a2b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2965586-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252965586-1%26sid%3Dliteratum%253Aachs%26aulast%3DLampert%26aufirst%3DK.%26aulast%3DMachein%26aufirst%3DU.%26aulast%3DMachein%26aufirst%3DM.%2BR.%26aulast%3DConca%26aufirst%3DW.%26aulast%3DPeter%26aufirst%3DH.%2BH.%26aulast%3DVolk%26aufirst%3DB.%26atitle%3DExpression%2520of%2520matrix%2520metalloproteinases%2520and%2520their%2520tissue%2520inhibitors%2520in%2520human%2520brain%2520tumors%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1998%26volume%3D153%26spage%3D429%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sternlicht, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergers, G.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects</span> <span class="citation_source-journal">Emerging Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1517%2F14728222.4.5.609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1yntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2000&pages=609-633&author=M.+D.+Sternlichtauthor=G.+Bergers&title=Matrix+metalloproteinases+as+emerging+targets+in+anticancer+therapy%3A+status+and+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases as emerging targets in anticancer therapy: Status and prospects</span></div><div class="casAuthors">Sternlicht, Mark D.; Bergers, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Therapeutic Targets</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">609-633</span>CODEN:
                <span class="NLM_cas:coden">ETTAF7</span>;
        ISSN:<span class="NLM_cas:issn">1460-0412</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 193 refs.  A major hallmark of malignant disease is the capacity of cancer cells to cross tissue boundaries and spread to distant sites throughout the body.  Extracellular matrix-degrading enzymes are thus required to break down structural barriers to invasion and metastasis.  Extensive and compelling evidence indicates that several members of the matrix metalloproteinase (MMP) family of enzymes play a key role in this regard and forms the rationale for the development and testing of compds. that can inhibit their proteolytic activity.  In addn., data now indicate that MMPs contribute to other aspects of cancer, including angiogenesis and the initial stages of tumor development, thus expanding the potential clin. utility of MMP inhibitors (MMPIs).  Conversely, some MMPs may defy cancer progression and others may not participate in cancer, but undoubtedly play normal physiol. roles.  These possibilities and the mechanisms underlying the influence of MMPs in cancer must be understood and considered in the design of therapeutic agents in order to optimize their efficacy and minimize their toxicity.  Herein we review the biol. and regulation of the MMPs, their roles in cancer development and progression, the status of preclin. and clin. efforts aimed at inhibiting their activity and the challenges and promise ahead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1658CpkSWbLVg90H21EOLACvtfcHk0li5PUiW4rci0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1yntrc%253D&md5=853b013d4eacb8c9dfd855cc4b03e690</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F14728222.4.5.609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.4.5.609%26sid%3Dliteratum%253Aachs%26aulast%3DSternlicht%26aufirst%3DM.%2BD.%26aulast%3DBergers%26aufirst%3DG.%26atitle%3DMatrix%2520metalloproteinases%2520as%2520emerging%2520targets%2520in%2520anticancer%2520therapy%253A%2520status%2520and%2520prospects%26jtitle%3DEmerging%2520Ther.%2520Targets%26date%3D2000%26volume%3D4%26spage%3D609%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Deryugina, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quigley, J. P.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases and tumor metastasis</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1007%2Fs10555-006-7886-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=16680569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28Xktlaksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=9-34&author=E.+I.+Deryuginaauthor=J.+P.+Quigley&title=Matrix+metalloproteinases+and+tumor+metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases and tumor metastasis</span></div><div class="casAuthors">Deryugina, Elena I.; Quigley, James P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-34</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Functions of individual matrix metalloproteinases (MMPs) differentially expressed by tumor cells and stromal cells, are finely regulated by their spatial as well as temporal interactions with distinct cellular and extracellular components of the tumor microenvironment and also distant pre-metastatic sites.  Certain aspects of MMP involvement in tumor metastasis such as tumor-induced angiogenesis, tumor invasion, and establishment of metastatic foci at the secondary site, have received extensive attention that resulted in an overwhelming amt. of exptl. and observational data in favor of crit. roles of MMPs in these processes.  In particular, dependency of tumor angiogenesis on the activity of MMPs, esp. that of MMP-9, renders this step possibly the most effective target of synthetic MMP inhibitors.  MMP functioning in other stages of metastasis, including the escape of individual tumor cells from the primary tumor, their intravasation, survival in circulation, and extravasation at the secondary site, have not yet received enough consideration, resulting in insufficient or controversial data.  The major pieces of evidence that are most compelling and clearly det. the role and involvement of MMPs in the metastatic cascade are provided by mol. genetic studies employing knock-out or transgenic animals and tumor cell lines, modified to overexpress or down-regulate a specific MMP.  Findings from all of these studies implicate different functional mechanisms for both tumor and stromal MMPs during distinct steps of the metastatic cascade and indicate that MMPs can exhibit pro-metastatic as well as anti-metastatic roles depending on their nature and the exptl. setting.  This dual function of individual MMPs in metastasis has become a major focus of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHgz1mKKQU_rVg90H21EOLACvtfcHk0lhADsvVzkJUZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xktlaksr4%253D&md5=3588c87412b94392428829338d4e0535</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs10555-006-7886-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-006-7886-9%26sid%3Dliteratum%253Aachs%26aulast%3DDeryugina%26aufirst%3DE.%2BI.%26aulast%3DQuigley%26aufirst%3DJ.%2BP.%26atitle%3DMatrix%2520metalloproteinases%2520and%2520tumor%2520metastasis%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2006%26volume%3D25%26spage%3D9%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">López-Otín, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palavalli, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span> </span><span class="NLM_article-title">Protective roles of matrix metalloproteinases: From mouse models to human cancer</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1-6&issue=22&author=C.+L%C3%B3pez-Ot%C3%ADnauthor=L.+H.+Palavalliauthor=Y.+Samuels&title=Protective+roles+of+matrix+metalloproteinases%3A+From+mouse+models+to+human+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Ot%25C3%25ADn%26aufirst%3DC.%26aulast%3DPalavalli%26aufirst%3DL.%2BH.%26aulast%3DSamuels%26aufirst%3DY.%26atitle%3DProtective%2520roles%2520of%2520matrix%2520metalloproteinases%253A%2520From%2520mouse%2520models%2520to%2520human%2520cancer%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26issue%3D22%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Martin, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matrisian, L. M.</span><span> </span><span class="NLM_article-title">The other side of MMPs: Protective roles in tumor progression</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1007%2Fs10555-007-9089-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=17717634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yktLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=717-724&author=M.+D.+Martinauthor=L.+M.+Matrisian&title=The+other+side+of+MMPs%3A+Protective+roles+in+tumor+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The other side of MMPs: Protective roles in tumor progression</span></div><div class="casAuthors">Martin, Michelle D.; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">717-724</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinase (MMP) family of extracellular proteinases have long been assocd. with cancer invasion and metastasis by virtue of their ability to collectively degrade all components of the extracellular matrix (ECM).  The general belief that overexpression of a specific MMP, either by tumor cells or the surrounding stroma, is pro-tumorigenic led to the development of synthetic MMP inhibitors for the treatment of cancer.  However, there is an increasing amt. of literature demonstrating that the expression of certain MMPs, either at the primary or the metastatic site, provides a beneficial and protective effect in multiple stages of cancer progression.  Here, we review the evidence for protective effects of MMPs and contrast this with pro-tumorigenic effects of either the same enzyme, or a different MMP of the same family.  These studies highlight the importance of targeting specific MMPs for cancer treatment, and point to a potential reason why clin. trials of pharmaceutical inhibitors for MMPs were disappointing.  In order to effectively target MMPs in cancer progression, a better understanding of both their pro- and anti-tumorigenic effects is required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqngvilAdN6_LVg90H21EOLACvtfcHk0lhADsvVzkJUZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yktLbK&md5=f661343c1137fcd0e2e6a5968e250476</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs10555-007-9089-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-007-9089-4%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BD.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DThe%2520other%2520side%2520of%2520MMPs%253A%2520Protective%2520roles%2520in%2520tumor%2520progression%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2007%26volume%3D26%26spage%3D717%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Overall, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleifeld, O.</span><span> </span><span class="NLM_article-title">Tumor microenvironment e opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1038%2Fnrc1821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=16498445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=227-239&author=C.+M.+Overallauthor=O.+Kleifeld&title=Tumor+microenvironment+e+opinion%3A+validating+matrix+metalloproteinases+as+drug+targets+and+anti-targets+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour microenvironment - Opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span></div><div class="casAuthors">Overall, Christopher M.; Kleifeld, Oded</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-239</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) mediate homeostasis of the extracellular environment.  They have multiple signaling activities that are commonly altered during tumorigenesis and that might serve as intervention points for anticancer drugs.  However, there are many criteria to consider in validating MMPs as drug targets and for the development of MMP inhibitors.  The inhibition of some MMPs could have pro-tumorigenic effects (making them anti-targets), counterbalancing the benefits of target inhibition.  These effects might partially account for the failure of MMP inhibitors in clin. trials.  What are the major challenges in MMP target validation and MMP-inhibitor-drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc3iBQEggRc7Vg90H21EOLACvtfcHk0lhADsvVzkJUZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D&md5=3edfeca153a62c759443d0893a6212e2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrc1821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1821%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DKleifeld%26aufirst%3DO.%26atitle%3DTumor%2520microenvironment%2520e%2520opinion%253A%2520validating%2520matrix%2520metalloproteinases%2520as%2520drug%2520targets%2520and%2520anti-targets%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D227%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Whittaker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gearing, A. J. H.</span><span> </span><span class="NLM_article-title">Design and therapeutic application of matrix metalloproteinase inhibitors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2735</span><span class="NLM_x">–</span> <span class="NLM_lpage">2776</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr9804543" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADyaK1MXls1Kku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2735-2776&author=M.+Whittakerauthor=C.+D.+Floydauthor=P.+Brownauthor=A.+J.+H.+Gearing&title=Design+and+therapeutic+application+of+matrix+metalloproteinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors</span></div><div class="casAuthors">Whittaker, Mark; Floyd, Christopher D.; Brown, Peter; Gearing, Andrew J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2735-2776</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 389 refs.  MMP inhibitors may be an important new class of therapeutic agents for the treatment of diseases characterized by excessive extracellular matrix degrdn. and/or remodelling, such as cancer and chronic inflammatory diseases such as rheumatoid arthritis, atherosclerosis, and MS.  This review describes progress in the design of MMP inhibitors and outlines the results of early clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGACjaK8AEZbVg90H21EOLACvtfcHk0lh60U0GWtwlQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXls1Kku7c%253D&md5=e226080188f791f5d1ce8c61b64ad33a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcr9804543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9804543%26sid%3Dliteratum%253Aachs%26aulast%3DWhittaker%26aufirst%3DM.%26aulast%3DFloyd%26aufirst%3DC.%2BD.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DGearing%26aufirst%3DA.%2BJ.%2BH.%26atitle%3DDesign%2520and%2520therapeutic%2520application%2520of%2520matrix%2520metalloproteinase%2520inhibitors%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26spage%3D2735%26epage%3D2776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span> </span><span class="NLM_article-title">Development of matrix metalloproteinase inhibitors in cancer therapy</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1093%2Fjnci%2F93.3.178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=11158186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlKiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2001&pages=178-193&issue=3&author=M.+Hidalgoauthor=S.+G.+Eckhardt&title=Development+of+matrix+metalloproteinase+inhibitors+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Development of matrix metalloproteinase inhibitors in cancer therapy</span></div><div class="casAuthors">Hidalgo, Manuel; Eckhardt, S. Gail</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">178-193</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 189 refs.  The matrix metalloproteinases (MMPs) are a family of zinc-dependent proteinases involved in the degrdn. of the extracellular matrix.  The MMPs have been implicated in the processes of tumor growth, invasion, and metastasis; are frequently over-expressed in malignant tumors; and have been assocd. with an aggressive malignant phenotype and adverse prognosis in patients with cancer.  A no. of MMP inhibitors are being developed for the treatment of cancer.  The most extensively studied class of MMP inhibitors includes collagen peptidomimetics and nonpeptidomimetic inhibitors of the MMP active site, tetracycline derivs., and bisphosphonates.  The hydroxamate peptidomimetic inhibitor batimastat and its orally bioavailable analog marimastat, which bind covalently to the zinc atom at the MMP-active site, were the first MMP inhibitors to be studied in detail.  Marimastat is currently being studied in randomized clin. trials.  The nonpeptidic MMP inhibitors were synthesized in an attempt to improve the oral bioavailability and pharmaceutical properties of the peptidic inhibitors.  Several members of this class of compds. are undergoing evaluation in phase III clin. trials.  The tetracyclines and, particularly, the nonantibiotic chem. modified tetracyclines, interfere with several aspects of MMP expression and activation and inhibit tumor growth and metastases in preclin. models.  A representative agent of this class, Col-3, is currently undergoing phase I clin. trials.  The development of the MMP inhibitors, like that of other targeted and predominantly antiproliferative compds., poses a challenge because the paradigms that have governed the design of clin. oncol. trials may not be relevant to this new class of agents.  The anticipated need for long-term administration of these drugs, together with their cytostatic mechanism of action, will require novel clin. trial design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgnRed5mDw9LVg90H21EOLACvtfcHk0lh60U0GWtwlQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlKiurw%253D&md5=0094a1ba5e55ca5268f41eec2c8d8480</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F93.3.178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F93.3.178%26sid%3Dliteratum%253Aachs%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26atitle%3DDevelopment%2520of%2520matrix%2520metalloproteinase%2520inhibitors%2520in%2520cancer%2520therapy%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2001%26volume%3D93%26issue%3D3%26spage%3D178%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Scherer, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matrisian, L. M.</span><span> </span><span class="NLM_article-title">Imaging matrix metalloproteinases in cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1007%2Fs10555-008-9152-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=18465089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A280%3ADC%252BD1cnhtl2rug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=679-690&author=R.+L.+Schererauthor=J.+O.+McIntyreauthor=L.+M.+Matrisian&title=Imaging+matrix+metalloproteinases+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging matrix metalloproteinases in cancer</span></div><div class="casAuthors">Scherer Randy L; McIntyre J Oliver; Matrisian Lynn M</div><div class="citationInfo"><span class="NLM_cas:title">Cancer metastasis reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">679-90</span>
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    </div><div class="casAbstract">Early detection of both primary tumors and metastatic disease remains a major challenge in the diagnosis and staging of cancer.  The recognition of the role of MMPs in both the growth and metastasis of tumors has guided the development not only of therapeutic strategies utilizing synthetic, small-molecule MMP inhibitors (MMPIs), but has also catalyzed methods to detect and image tumors in vivo by means of tumor-associated proteolytic activity.  These imaging approaches target MMPs involved in cancer progression via contrast agents linked to MMPIs or to MMP selective and specific substrates with sensitivity enhanced by amplification during enzymatic processing.  This review draws attention to a variety of strategies utilized to image MMP activity in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCS5EIFkE3jzslzEEsg76ufW6udTcc2eYsGcxhO_bLy7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cnhtl2rug%253D%253D&md5=c9bfca5d65fdb217296703dee9bfafdd</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9152-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9152-9%26sid%3Dliteratum%253Aachs%26aulast%3DScherer%26aufirst%3DR.%2BL.%26aulast%3DMcIntyre%26aufirst%3DJ.%2BO.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DImaging%2520matrix%2520metalloproteinases%2520in%2520cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D679%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, W.</span><span> </span><span class="NLM_article-title">Molecular imaging of proteases in cancer</span> <span class="citation_source-journal">Cancer Growth Metastasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGgtbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=13-27&author=Y.+Yangauthor=H.+Hongauthor=Y.+Zhangauthor=W.+Cai&title=Molecular+imaging+of+proteases+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular imaging of proteases in cancer</span></div><div class="casAuthors">Yang, Yunan; Hong, Hao; Zhang, Yin; Cai, Weibo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Growth and Metastasis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-27</span>CODEN:
                <span class="NLM_cas:coden">CGMACQ</span>;
        ISSN:<span class="NLM_cas:issn">1179-0644</span>.
    
            (<span class="NLM_cas:orgname">Libertas Academica</span>)
        </div><div class="casAbstract">A review.  Proteases play important roles during tumor angiogenesis, invasion, and metastasis.  Various mol. imaging techniques have been employed for protease imaging: optical (both fluorescence and bioluminescence), magnetic resonance imaging (MRI), single-photon emission computed tomog. (SPECT), and positron emission tomog. (PET).  In this review, we will summarize the current status of imaging proteases in cancer with these techniques.  Optical imaging of proteases, in particular with fluorescence, is the most intensively validated and many of the imaging probes are already com. available.  It is generally agreed that the use of activatable probes is the most accurate and appropriate means for measuring protease activity.  Mol. imaging of proteases with other techniques (i.e. MRI, SPECT, and PET) has not been well-documented in the literature which certainly deserves much future effort.  Optical imaging and mol. MRI of protease activity has very limited potential for clin. investigation.  PET/SPECT imaging is suitable for clin. investigation; however the optimal probes for PET/SPECT imaging of proteases in cancer have yet to be developed.  Successful development of protease imaging probes with optimal in vivo stability, tumor targeting efficacy, and desirable pharmacokinetics for clin. translation will eventually improve cancer patient management.  Not limited to cancer, these protease-targeted imaging probes will also have broad applications in other diseases such as arthritis, atherosclerosis, and myocardial infarction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTpa-8YaMCNrVg90H21EOLACvtfcHk0lh60U0GWtwlQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGgtbrO&md5=bbe1c4cdb559b523ff6dbe42f3613244</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26atitle%3DMolecular%2520imaging%2520of%2520proteases%2520in%2520cancer%26jtitle%3DCancer%2520Growth%2520Metastasis%26date%3D2009%26volume%3D2%26spage%3D13%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyholz, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höltke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopka, K.</span><span> </span><span class="NLM_article-title">Molecular imaging of matrix metalloproteinases in vivo using small molecule inhibitors for SPECT and PET</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2819</span><span class="NLM_x">–</span> <span class="NLM_lpage">2838</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.2174%2F092986706778522002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=17073631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVamsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2819-2838&author=S.+Wagnerauthor=H.+J.+Breyholzauthor=A.+Faustauthor=C.+H%C3%B6ltkeauthor=B.+Levkauauthor=O.+Schoberauthor=M.+Sch%C3%A4fersauthor=K.+Kopka&title=Molecular+imaging+of+matrix+metalloproteinases+in+vivo+using+small+molecule+inhibitors+for+SPECT+and+PET"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular imaging of matrix metalloproteinases in vivo using small molecule inhibitors for SPECT and PET</span></div><div class="casAuthors">Wagner, S.; Breyholz, H.-J.; Faust, A.; Hoeltke, C.; Levkau, B.; Schober, O.; Schaefers, M.; Kopka, K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2819-2838</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a family of zinc- and calcium-dependent secreted or membrane anchored endopeptidases.  MMPs are involved in many physiol. processes but also take part in the pathophysiol. mechanisms responsible for a wide range of diseases.  Pathol. expression and activation of MMPs are assocd. with cancer, atherosclerosis, stroke, arthritis, periodontal disease, multiple sclerosis and liver fibrosis.  Thus, noninvasive visualisation and quantification of MMP activity in vivo are of great interest in basic research and clin. application.  This can be achieved by scintigraphic mol. imaging techniques such as single photon emission computed tomog. (SPECT) and positron emission tomog. (PET) provided suitable radiolabeled tracers exist, e.g. radioactive inhibitors of matrix metalloproteinases (MMPIs).  The approach to monitor MMP activity in vivo using radiolabeled small mol. inhibitors suitable for SPECT and PET is summarised in this review.  Briefly, latest advances in scintigraphic imaging are introduced and followed by a report about the enzyme class of MMPs.  The involvement of MMPs in cancer and atherosclerosis is exemplified and small mol. MMPIs are classified.  Subsequently, the development of radiolabeled small mol. MMPIs, their synthesis and in vitro and in vivo evaluation is reviewed.  Finally, an outlook on the clin. potential of labeled MMPIs in diagnostic algorithms is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxH3rvZ6YLa7Vg90H21EOLACvtfcHk0lgguKS8yq1yDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVamsrbM&md5=ab3f540c8c740d3b7100e288d3699272</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F092986706778522002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706778522002%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DBreyholz%26aufirst%3DH.%2BJ.%26aulast%3DFaust%26aufirst%3DA.%26aulast%3DH%25C3%25B6ltke%26aufirst%3DC.%26aulast%3DLevkau%26aufirst%3DB.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DKopka%26aufirst%3DK.%26atitle%3DMolecular%2520imaging%2520of%2520matrix%2520metalloproteinases%2520in%2520vivo%2520using%2520small%2520molecule%2520inhibitors%2520for%2520SPECT%2520and%2520PET%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D2819%26epage%3D2838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Pimlott, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, A.</span><span> </span><span class="NLM_article-title">Molecular tracers for the PET and SPECT imaging of disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1039%2FB922628C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=20818455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=149-162&author=S.+L.+Pimlottauthor=A.+Sutherland&title=Molecular+tracers+for+the+PET+and+SPECT+imaging+of+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular tracers for the PET and SPECT imaging of disease</span></div><div class="casAuthors">Pimlott, Sally L.; Sutherland, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">149-162</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The development of positron emission tomog. (PET) and single photon emission computed tomog. (SPECT) imaging continues to grow due to the ability of these techniques to allow the non-invasive in vivo visualisation of biol. processes at the mol. and cellular levels.  As well as finding application for the diagnosis of disease, these techniques have also been used in the drug discovery process.  Crucial to the growth of these techniques is the continued development of mol. probes that can bind to the target biol. receptor with high selectivity.  This tutorial review describes the use of PET and SPECT for mol. imaging and highlights key strategies for the development of mol. probes for the imaging of both cancer and neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlgAhRywJDGLVg90H21EOLACvtfcHk0lgguKS8yq1yDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7fN&md5=9c9fc25429408a89e9eaca6550fe7bad</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2FB922628C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB922628C%26sid%3Dliteratum%253Aachs%26aulast%3DPimlott%26aufirst%3DS.%2BL.%26aulast%3DSutherland%26aufirst%3DA.%26atitle%3DMolecular%2520tracers%2520for%2520the%2520PET%2520and%2520SPECT%2520imaging%2520of%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D149%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cherry, S. R.; Sorenson, J. A.; Phelps, M. E.</span> <span class="citation_source-book">Physics in Nuclear Medicine</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Saunders</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=S.+R.+Cherry&author=J.+A.+Sorenson&author=M.+E.+Phelps&title=Physics+in+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCherry%26aufirst%3DS.%2BR.%26btitle%3DPhysics%2520in%2520Nuclear%2520Medicine%26pub%3DSaunders%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kubota, K.</span><span> </span><span class="NLM_article-title">From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology</span> <span class="citation_source-journal">Ann. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1007%2FBF02988499" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=471-486&issue=15&author=K.+Kubota&title=From+tumor+biology+to+clinical+PET%3A+A+review+of+positron+emission+tomography+%28PET%29+in+oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2FBF02988499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02988499%26sid%3Dliteratum%253Aachs%26aulast%3DKubota%26aufirst%3DK.%26atitle%3DFrom%2520tumor%2520biology%2520to%2520clinical%2520PET%253A%2520A%2520review%2520of%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520in%2520oncology%26jtitle%3DAnn.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D6%26issue%3D15%26spage%3D471%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Cai, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambhir, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">How molecular imaging is speeding up antiangiogenic drug development</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2624</span><span class="NLM_x">–</span> <span class="NLM_lpage">2633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1158%2F1535-7163.MCT-06-0395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=17121909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1els7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2624-2633&issue=11&author=W.+Caiauthor=J.+Raoauthor=S.+G.+Gambhirauthor=X.+Chen&title=How+molecular+imaging+is+speeding+up+antiangiogenic+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">How molecular imaging is speeding up antiangiogenic drug development</span></div><div class="casAuthors">Cai, Weibo; Rao, Jianghong; Gambhir, Sanjiv S.; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2624-2633</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Drug development is a long process that generally spans about 10 to 15 years.  The shift in recent drug discovery to novel agents against specific mol. targets highlights the need for more robust mol. imaging platforms.  Using mol. probes, mol. imaging can aid in many steps of the drug development process, such as providing whole body readout in an intact system, decreasing the workload and speeding up drug development/validation, and facilitating individualized anticancer treatment monitoring and dose optimization.  The main focus of this review is the recent advances in tumor angiogenesis imaging, and the targets include vascular endothelial growth factor and vascular endothelial growth factor receptor, integrin αv{szligbeta}3, matrix metalloproteinase, endoglin (CD105), and E-selectin.  Through tumor angiogenesis imaging, it is expected that a robust platform for understanding the mechanisms of tumor angiogenesis and evaluating the efficacy of novel antiangiogenic therapies will be developed, which can help antiangiogenic drug development in both the preclin. stage and the clin. settings.  Mol. imaging has enormous potential in improving the efficiency of the drug development process, including the specific area of antiangiogenic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBkSAL-X0hILVg90H21EOLACvtfcHk0lgguKS8yq1yDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1els7jE&md5=1c0d66d382ceb62a38d240d674be4e0a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0395%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DW.%26aulast%3DRao%26aufirst%3DJ.%26aulast%3DGambhir%26aufirst%3DS.%2BG.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DHow%2520molecular%2520imaging%2520is%2520speeding%2520up%2520antiangiogenic%2520drug%2520development%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26issue%3D11%26spage%3D2624%26epage%3D2633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kopka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyholz, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riemann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trub, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilbert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span> </span><span class="NLM_article-title">Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">31</span><span class="NLM_x">) </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2Fj.nucmedbio.2003.08.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=257-267&issue=31&author=K.+Kopkaauthor=H.+J.+Breyholzauthor=S.+Wagnerauthor=M.+P.+Lawauthor=B.+Riemannauthor=S.+Schr%C3%B6erauthor=M.+Trubauthor=B.+Guilbertauthor=B.+Levkauauthor=O.+Schoberauthor=M.+Sch%C3%A4fers&title=Synthesis+and+preliminary+biological+evaluation+of+new+radioiodinated+MMP+inhibitors+for+imaging+MMP+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2003.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2003.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DKopka%26aufirst%3DK.%26aulast%3DBreyholz%26aufirst%3DH.%2BJ.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DLaw%26aufirst%3DM.%2BP.%26aulast%3DRiemann%26aufirst%3DB.%26aulast%3DSchr%25C3%25B6er%26aufirst%3DS.%26aulast%3DTrub%26aufirst%3DM.%26aulast%3DGuilbert%26aufirst%3DB.%26aulast%3DLevkau%26aufirst%3DB.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520preliminary%2520biological%2520evaluation%2520of%2520new%2520radioiodinated%2520MMP%2520inhibitors%2520for%2520imaging%2520MMP%2520activity%2520in%2520vivo%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2004%26volume%3D2%26issue%3D31%26spage%3D257%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Fei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Q.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sledge, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, G. D.</span><span> </span><span class="NLM_article-title">Synthesis of MMP inhibitor radiotracer [<sup>11</sup>C]CGS-25966, a new potential PET tumor imaging agent</span> <span class="citation_source-journal">J. Label. Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1002%2Fjlcr.675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Wms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=343-351&author=X.+Feiauthor=Q.-H.+Zhengauthor=X.+Liuauthor=J.-Q.+Wangauthor=K.+L.+Stoneauthor=K.+D.+Millerauthor=G.+W.+Sledgeauthor=G.+D.+Hutchins&title=Synthesis+of+MMP+inhibitor+radiotracer+%5B11C%5DCGS-25966%2C+a+new+potential+PET+tumor+imaging+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of MMP inhibitor radiotracer [11C]CGS 25966, a new potential PET tumor imaging agent</span></div><div class="casAuthors">Fei, Xiangshu; Zheng, Qi-Huang; Liu, Xuan; Wang, Ji-Quan; Stone, K. Lee; Miller, Kathy D.; Sledge, George W.; Hutchins, Gary D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-351</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">[11C]CGS 25966, a novel radiolabeled matrix metalloproteinase (MMP) inhibitor, has been synthesized for evaluation as new potential positron emission tomog. (PET) tumor imaging agent.  The precursor was labeled by [11C]methyl triflate through O-[11C]methylation method at the hydroxyl position of phenol under basic conditions and isolated by HPLC purifn. to produce pure target compd. in 15-25% radiochem. yield, based on 11CO2, decay cor. to end of bombardment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp71kvLw0dgNrVg90H21EOLACvtfcHk0lirEce9EXp3iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Wms74%253D&md5=0f55e2dfc2d4caf18f89fc20093e3c32</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.675%26sid%3Dliteratum%253Aachs%26aulast%3DFei%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DQ.-H.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.-Q.%26aulast%3DStone%26aufirst%3DK.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DSledge%26aufirst%3DG.%2BW.%26aulast%3DHutchins%26aufirst%3DG.%2BD.%26atitle%3DSynthesis%2520of%2520MMP%2520inhibitor%2520radiotracer%2520%255B11C%255DCGS-25966%252C%2520a%2520new%2520potential%2520PET%2520tumor%2520imaging%2520agent%26jtitle%3DJ.%2520Label.%2520Compd.%2520Radiopharm.%26date%3D2003%26volume%3D46%26spage%3D343%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyholz, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höltke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haufe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopka, K.</span><span> </span><span class="NLM_article-title">Novel fluorinated derivatives of the broad-spectrum MMP inhibitors <i>N</i>-hydroxy-2(<i>R</i>)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5752</span><span class="NLM_x">–</span> <span class="NLM_lpage">5764</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0708533" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5752-5764&author=S.+Wagnerauthor=H.-J.+Breyholzauthor=M.+P.+Lawauthor=A.+Faustauthor=C.+H%C3%B6ltkeauthor=S.+Schr%C3%B6erauthor=G.+Haufeauthor=B.+Levkauauthor=O.+Schoberauthor=M.+Sch%C3%A4fersauthor=K.+Kopka&title=Novel+fluorinated+derivatives+of+the+broad-spectrum+MMP+inhibitors+N-hydroxy-2%28R%29-%5B%5B%284-methoxyphenyl%29sulfonyl%5D%28benzyl%29-+and+%283-picolyl%29-amino%5D-3-methyl-butanamide+as+potential+tools+for+the+molecular+imaging+of+activated+MMPs+with+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0708533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0708533%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DBreyholz%26aufirst%3DH.-J.%26aulast%3DLaw%26aufirst%3DM.%2BP.%26aulast%3DFaust%26aufirst%3DA.%26aulast%3DH%25C3%25B6ltke%26aufirst%3DC.%26aulast%3DSchr%25C3%25B6er%26aufirst%3DS.%26aulast%3DHaufe%26aufirst%3DG.%26aulast%3DLevkau%26aufirst%3DB.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DKopka%26aufirst%3DK.%26atitle%3DNovel%2520fluorinated%2520derivatives%2520of%2520the%2520broad-spectrum%2520MMP%2520inhibitors%2520N-hydroxy-2%2528R%2529-%255B%255B%25284-methoxyphenyl%2529sulfonyl%255D%2528benzyl%2529-%2520and%2520%25283-picolyl%2529-amino%255D-3-methyl-butanamide%2520as%2520potential%2520tools%2520for%2520the%2520molecular%2520imaging%2520of%2520activated%2520MMPs%2520with%2520PET%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5752%26epage%3D5764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyholz, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höltke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopka, K.</span><span> </span><span class="NLM_article-title">A new <sup>18</sup>F-labelled derivative of the MMP inhibitor CGS 27023A for PET: Radiosynthesis and initial small-animal PET studies</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2Fj.apradiso.2008.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=19167232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitVSjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2009&pages=606-610&author=S.+Wagnerauthor=H.-J.+Breyholzauthor=C.+H%C3%B6ltkeauthor=A.+Faustauthor=O.+Schoberauthor=M.+Sch%C3%A4fersauthor=K.+Kopka&title=A+new+18F-labelled+derivative+of+the+MMP+inhibitor+CGS+27023A+for+PET%3A+Radiosynthesis+and+initial+small-animal+PET+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A new 18F-labelled derivative of the MMP inhibitor CGS 27023A for PET: Radiosynthesis and initial small-animal PET studies</span></div><div class="casAuthors">Wagner, Stefan; Breyholz, Hans-Joerg; Hoeltke, Carsten; Faust, Andreas; Schober, Otmar; Schaefers, Michael; Kopka, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">606-610</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The CGS 27023A deriv. (R)-2-(N-((6-fluoropyridin-3-yl)methyl)-4-methoxyphenyl-sulfonamido)-N-hydroxy-3-methylbutanamide (1a) was identified as a very potent matrix metalloproteinase inhibitor.  Here, we describe a one-step radiosynthesis of the target compd. [18F]1a.  The syntheses of [18F]1a resulted in a radiochem. yield of 12.1±5.9% (decay-cor.), a radiochem. purity of 98.8±0.6%, and a specific activity of 39±27 GBq/μmol at the end of synthesis within 160±18 min from the end of radionuclide prodn. (n=5).  Initial small-animal PET studies in wild-type mice (C57/BL6) showed no unfavorable tissue accumulation of [18F]1a.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRtREV2ihWjLVg90H21EOLACvtfcHk0lirEce9EXp3iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitVSjs7Y%253D&md5=50db9034eb7927c2545f366ad45de56b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2008.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2008.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DBreyholz%26aufirst%3DH.-J.%26aulast%3DH%25C3%25B6ltke%26aufirst%3DC.%26aulast%3DFaust%26aufirst%3DA.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DKopka%26aufirst%3DK.%26atitle%3DA%2520new%252018F-labelled%2520derivative%2520of%2520the%2520MMP%2520inhibitor%2520CGS%252027023A%2520for%2520PET%253A%2520Radiosynthesis%2520and%2520initial%2520small-animal%2520PET%2520studies%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2009%26volume%3D67%26spage%3D606%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Van de Wiele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltenfreiter, R.</span><span> </span><span class="NLM_article-title">Imaging probes targeting matrix metalloproteinases</span> <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1089%2Fcbr.2006.21.409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=17105415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2ns7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=409-417&issue=5&author=C.+Van+de+Wieleauthor=R.+Oltenfreiter&title=Imaging+probes+targeting+matrix+metalloproteinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Update: Imaging Probes Targeting Matrix Metalloproteinases</span></div><div class="casAuthors">Van de Wiele, Christophe; Oltenfreiter, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">409-417</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  During the past few years, several imaging probes targeting matrix metalloproteinases (MMPs) have been developed.  Most of these probes have been validated in animal models.  Overall, results derived from most of these studies have been disappointing.  Whether or not this relates to shortcomings of the imaging probes used or to the set-up of the reported studies is currently unclear.  Firstly, MMPs targeted in these studies, MMP-1, -2 and -9, are cell secreted and their expression is known to vary extensively within one tumor type, depending on the stage of development of the tumor and on the presence of naturally occurring TIMPs.  Given the lack of data on the levels of MMP expression by inoculated tumor tissue at the time of imaging in most studies reported, it cannot be excluded that the neg. results reported are, in fact, false-neg. imaging results.  Secondly, given that most of the agents used for imaging are intrinsically broad-spectrum agents, their higher affinity for specific subsets of MMPs does not necessarily imply that a pos. imaging result also corresponds to overexpression of specific subsets of MMPs, as suggested in some papers published.  Accordingly, well-characterized tumor models need to be developed for the purpose of validating currently available, as well as future, MMP-imaging probes.  So far, only 111In-DTPA-N-TIMP-2 has been injected in patients, resp. suffering from Kaposi Sarcoma.  Imaging results obtained with this agent proved disappointing.  Imaging results obtained with other MMP-targeting probes in patients are awaited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD4ZDx2Fz6obVg90H21EOLACvtfcHk0lgEiOcOSYg8pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2ns7fN&md5=172e587433a288f9acef46f9befa7a00</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2006.21.409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2006.21.409%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWiele%26aufirst%3DC.%26aulast%3DOltenfreiter%26aufirst%3DR.%26atitle%3DImaging%2520probes%2520targeting%2520matrix%2520metalloproteinases%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2006%26volume%3D21%26issue%3D5%26spage%3D409%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Furomoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ido, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, H.</span><span> </span><span class="NLM_article-title">Tumor detection using <sup>18</sup>F-labeled matrix metalloproteinase-2 inhibitor</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2FS0969-8051%2802%2900393-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=12623110" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=119-125&author=S.+Furomotoauthor=K.+Takashimaauthor=K.+Kubotaauthor=T.+Idoauthor=R.+Iwataauthor=H.+Fukuda&title=Tumor+detection+using+18F-labeled+matrix+metalloproteinase-2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2802%2900393-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252802%252900393-1%26sid%3Dliteratum%253Aachs%26aulast%3DFuromoto%26aufirst%3DS.%26aulast%3DTakashima%26aufirst%3DK.%26aulast%3DKubota%26aufirst%3DK.%26aulast%3DIdo%26aufirst%3DT.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DFukuda%26aufirst%3DH.%26atitle%3DTumor%2520detection%2520using%252018F-labeled%2520matrix%2520metalloproteinase-2%2520inhibitor%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D119%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">auf dem Keller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellac, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ting, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harwig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappelhoff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruth, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bénard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overall, C. M.</span><span> </span><span class="NLM_article-title">Novel matrix metalloproteinase inhibitor [<sup>18</sup>F]marimastat-aryltrifluoroborate as a probe for in vivo positron emission tomography imaging in cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">7562</span><span class="NLM_x">–</span> <span class="NLM_lpage">7569</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=7562-7569&author=U.+auf+dem+Kellerauthor=C.+L.+Bellacauthor=Y.+Liauthor=Y.+Louauthor=P.+F.+Langeauthor=R.+Tingauthor=C.+Harwigauthor=R.+Kappelhoffauthor=S.+Dedharauthor=M.+J.+Adamauthor=T.+J.+Ruthauthor=F.+B%C3%A9nardauthor=D.+M.+Perrinauthor=C.+M.+Overall&title=Novel+matrix+metalloproteinase+inhibitor+%5B18F%5Dmarimastat-aryltrifluoroborate+as+a+probe+for+in+vivo+positron+emission+tomography+imaging+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dauf%2Bdem%2BKeller%26aufirst%3DU.%26aulast%3DBellac%26aufirst%3DC.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DLange%26aufirst%3DP.%2BF.%26aulast%3DTing%26aufirst%3DR.%26aulast%3DHarwig%26aufirst%3DC.%26aulast%3DKappelhoff%26aufirst%3DR.%26aulast%3DDedhar%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DM.%2BJ.%26aulast%3DRuth%26aufirst%3DT.%2BJ.%26aulast%3DB%25C3%25A9nard%26aufirst%3DF.%26aulast%3DPerrin%26aufirst%3DD.%2BM.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DNovel%2520matrix%2520metalloproteinase%2520inhibitor%2520%255B18F%255Dmarimastat-aryltrifluoroborate%2520as%2520a%2520probe%2520for%2520in%2520vivo%2520positron%2520emission%2520tomography%2520imaging%2520in%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D7562%26epage%3D7569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Skiles, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonnella, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeng, A. Y.</span><span> </span><span class="NLM_article-title">The design, structure and clinical update of small molecular weight matrix metalloproteinase inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2911</span><span class="NLM_x">–</span> <span class="NLM_lpage">2977</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.2174%2F0929867043364018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=15544483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVyntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=2911-2977&author=J.+W.+Skilesauthor=N.+C.+Gonnellaauthor=A.+Y.+Jeng&title=The+design%2C+structure+and+clinical+update+of+small+molecular+weight+matrix+metalloproteinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors</span></div><div class="casAuthors">Skiles, Jerry W.; Gonnella, Nina C.; Jeng, Arco Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2911-2977</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a family of zinc-contg. enzymes involved in the degrdn. and remodeling of extracellular matrix proteins.  Under normal physiol. conditions, the activities of these enzymes are well-regulated by endogenous tissue inhibitors of metalloproteinases (TIMPs).  Chronic stimulation of MMP activities due to an imbalance in the levels of MMPs and TIMPs was implicated in the pathogenesis of a variety of diseases such as cancer, osteoarthritis, and rheumatoid arthritis.  Thus, MMP inhibitors are expected to be useful for the treatment of these disorders.  Because of their importance in a variety of pathol. conditions, a no. of small mol. wt. MMP inhibitors have entered clin. trials in humans.  However, the results of these trials were extremely disappointing and have led many investigators to conclude that MMP inhibitors have no therapeutic benefit in human cancer.  To date, the 1st generation MMP inhibitors exhibited poor bioavailability while 2nd-generation compds. revealed that prolonged treatment caused musculoskeletal pain and inflammation or had a lack of efficacy.  This article describes the design of small mol. wt. MMP inhibitors, a brief description of available 3-dimensional MMP structures, a review of the proposed therapeutic utility of MMP inhibitors, and a clin. update of compds. that have entered clin. trials in humans.  The exptl. detd. structures used in the structure-based design of MMP inhibitors are thoroughly covered.  Major emphasis is on recently published and/or patented potent MMP inhibitors, from approx. Jan. 2000 to Apr. 2003, and their pharmacol. properties.  Protein inhibitors of these proteolytic enzymes, i.e. TIMPs, will not be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0LYPCikT-orVg90H21EOLACvtfcHk0lgEiOcOSYg8pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVyntbg%253D&md5=10e7288182d59fadf4691d1bf3795533</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F0929867043364018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364018%26sid%3Dliteratum%253Aachs%26aulast%3DSkiles%26aufirst%3DJ.%2BW.%26aulast%3DGonnella%26aufirst%3DN.%2BC.%26aulast%3DJeng%26aufirst%3DA.%2BY.%26atitle%3DThe%2520design%252C%2520structure%2520and%2520clinical%2520update%2520of%2520small%2520molecular%2520weight%2520matrix%2520metalloproteinase%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D2911%26epage%3D2977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Breyholz, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riemann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höltke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopka, K.</span><span> </span><span class="NLM_article-title">Radiofluorinated pyrimidine-2,4,6-triones as molecular probes for noninvasive MMP-targeted imaging</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=777-789&author=H.-J.+Breyholzauthor=S.+Wagnerauthor=A.+Faustauthor=B.+Riemannauthor=C.+H%C3%B6ltkeauthor=S.+Hermannauthor=O.+Schoberauthor=M.+Sch%C3%A4fersauthor=K.+Kopka&title=Radiofluorinated+pyrimidine-2%2C4%2C6-triones+as+molecular+probes+for+noninvasive+MMP-targeted+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreyholz%26aufirst%3DH.-J.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DFaust%26aufirst%3DA.%26aulast%3DRiemann%26aufirst%3DB.%26aulast%3DH%25C3%25B6ltke%26aufirst%3DC.%26aulast%3DHermann%26aufirst%3DS.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DKopka%26aufirst%3DK.%26atitle%3DRadiofluorinated%2520pyrimidine-2%252C4%252C6-triones%2520as%2520molecular%2520probes%2520for%2520noninvasive%2520MMP-targeted%2520imaging%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D777%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Nuti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casalini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avramova, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlandini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cercignani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amelio, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uggeri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossello, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6347</span><span class="NLM_x">–</span> <span class="NLM_lpage">6361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900335a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6347-6361&author=E.+Nutiauthor=L.+Panelliauthor=F.+Casaliniauthor=S.+I.+Avramovaauthor=E.+Orlandiniauthor=S.+Santamariaauthor=S.+Nencettiauthor=T.+Tuccinardiauthor=A.+Martinelliauthor=G.+Cercignaniauthor=N.+D%E2%80%99Amelioauthor=A.+Maiocchiauthor=F.+Uggeriauthor=A.+Rossello&title=Design%2C+synthesis%2C+biological+evaluation%2C+and+NMR+studies+of+a+new+series+of+arylsulfones+as+selective+and+potent+matrix+metalloproteinase-12+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm900335a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900335a%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DPanelli%26aufirst%3DL.%26aulast%3DCasalini%26aufirst%3DF.%26aulast%3DAvramova%26aufirst%3DS.%2BI.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DSantamaria%26aufirst%3DS.%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DCercignani%26aufirst%3DG.%26aulast%3DD%25E2%2580%2599Amelio%26aufirst%3DN.%26aulast%3DMaiocchi%26aufirst%3DA.%26aulast%3DUggeri%26aufirst%3DF.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520NMR%2520studies%2520of%2520a%2520new%2520series%2520of%2520arylsulfones%2520as%2520selective%2520and%2520potent%2520matrix%2520metalloproteinase-12%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6347%26epage%3D6361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uccello-Barretta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossello, A.</span><span> </span><span class="NLM_article-title">Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (<i>R</i>)- and (<i>S</i>)-<i>N</i>-hydroxy-2-(<i>N</i>-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4260</span><span class="NLM_x">–</span> <span class="NLM_lpage">4276</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=4260-4276&author=T.+Tuccinardiauthor=A.+Martinelliauthor=E.+Nutiauthor=P.+Carelliauthor=F.+Balzanoauthor=G.+Uccello-Barrettaauthor=G.+Murphyauthor=A.+Rossello&title=Amber+force+field+implementation%2C+molecular+modelling+study%2C+synthesis+and+MMP-1%2FMMP-2+inhibition+profile+of+%28R%29-+and+%28S%29-N-hydroxy-2-%28N-isopropoxybiphenyl-4-ylsulfonamido%29-3-methylbutanamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DCarelli%26aufirst%3DP.%26aulast%3DBalzano%26aufirst%3DF.%26aulast%3DUccello-Barretta%26aufirst%3DG.%26aulast%3DMurphy%26aufirst%3DG.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DAmber%2520force%2520field%2520implementation%252C%2520molecular%2520modelling%2520study%252C%2520synthesis%2520and%2520MMP-1%252FMMP-2%2520inhibition%2520profile%2520of%2520%2528R%2529-%2520and%2520%2528S%2529-N-hydroxy-2-%2528N-isopropoxybiphenyl-4-ylsulfonamido%2529-3-methylbutanamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D4260%26epage%3D4276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komurasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, M.</span><span> </span><span class="NLM_article-title">Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): <i>N</i>-sulfonylamino acid derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9707582" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=640-649&author=Y.+Tamuraauthor=F.+Watanabeauthor=T.+Nakataniauthor=K.+Yasuiauthor=M.+Fujiauthor=T.+Komurasakiauthor=H.+Tsuzukiauthor=R.+Maekawaauthor=T.+Yoshiokaauthor=K.+Kawadaauthor=K.+Sugitaauthor=M.+Ohtani&title=Highly+selective+and+orally+active+inhibitors+of+type+IV+collagenase+%28MMP-9+and+MMP-2%29%3A+N-sulfonylamino+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1021%2Fjm9707582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9707582%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DF.%26aulast%3DNakatani%26aufirst%3DT.%26aulast%3DYasui%26aufirst%3DK.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DKomurasaki%26aufirst%3DT.%26aulast%3DTsuzuki%26aufirst%3DH.%26aulast%3DMaekawa%26aufirst%3DR.%26aulast%3DYoshioka%26aufirst%3DT.%26aulast%3DKawada%26aufirst%3DK.%26aulast%3DSugita%26aufirst%3DK.%26aulast%3DOhtani%26aufirst%3DM.%26atitle%3DHighly%2520selective%2520and%2520orally%2520active%2520inhibitors%2520of%2520type%2520IV%2520collagenase%2520%2528MMP-9%2520and%2520MMP-2%2529%253A%2520N-sulfonylamino%2520acid%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D640%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yodo, M.</span><span> </span><span class="NLM_article-title">Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1723</span><span class="NLM_x">–</span> <span class="NLM_lpage">1738</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980514x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1723-1738&author=R.+Kiyamaauthor=Y.+Tamuraauthor=F.+Watanabeauthor=H.+Tsuzukiauthor=M.+Ohtaniauthor=M.+Yodo&title=Homology+modeling+of+gelatinase+catalytic+domains+and+docking+simulations+of+novel+sulfonamide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1021%2Fjm980514x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980514x%26sid%3Dliteratum%253Aachs%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DTamura%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DF.%26aulast%3DTsuzuki%26aufirst%3DH.%26aulast%3DOhtani%26aufirst%3DM.%26aulast%3DYodo%26aufirst%3DM.%26atitle%3DHomology%2520modeling%2520of%2520gelatinase%2520catalytic%2520domains%2520and%2520docking%2520simulations%2520of%2520novel%2520sulfonamide%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1723%26epage%3D1738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Becker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barta, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedell, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bond, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carron, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easton, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freskos, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funckes-Shippy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockerman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munie, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swearingen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villamil, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span> </span><span class="NLM_article-title">Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6653</span><span class="NLM_x">–</span> <span class="NLM_lpage">6680</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100669j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGjtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6653-6680&author=D.+P.+Beckerauthor=T.+E.+Bartaauthor=L.+J.+Bedellauthor=T.+L.+Boehmauthor=B.+R.+Bondauthor=J.+Carrollauthor=C.+P.+Carronauthor=G.+A.+DeCrescenzoauthor=A.+M.+Eastonauthor=J.+N.+Freskosauthor=C.+L.+Funckes-Shippyauthor=M.+Heronauthor=S.+Hockermanauthor=C.+P.+Howardauthor=J.+R.+Kieferauthor=M.+H.+Liauthor=K.+J.+Mathisauthor=J.+J.+McDonaldauthor=P.+P.+Mehtaauthor=G.+E.+Munieauthor=T.+Sunyerauthor=C.+A.+Swearingenauthor=C.+I.+Villamilauthor=D.+Welschauthor=J.+M.+Williamsauthor=Y.+Yuauthor=J.+Yao&title=Orally+active+MMP-1+sparing+%CE%B1-tetrahydropyranyl+and+%CE%B1-piperidinyl+sulfone+matrix+metalloproteinase+%28MMP%29+inhibitors+with+efficacy+in+cancer%2C+arthritis%2C+and+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Active MMP-1 Sparing α-Tetrahydropyranyl and α-Piperidinyl Sulfone Matrix Metalloproteinase (MMP) Inhibitors with Efficacy in Cancer, Arthritis, and Cardiovascular Disease</span></div><div class="casAuthors">Becker, Daniel P.; Barta, Thomas E.; Bedell, Louis J.; Boehm, Terri L.; Bond, Brian R.; Carroll, Jeffery; Carron, Chris P.; De Crescenzo, Gary A.; Easton, Alan M.; Freskos, John N.; Funckes-Shippy, Chris L.; Heron, Marcia; Hockerman, Susan; Howard, Carol Pearcy; Kiefer, James R.; Li, Madeleine H.; Mathis, Karl J.; McDonald, Joseph J.; Mehta, Pramod P.; Munie, Grace E.; Sunyer, Teresa; Swearingen, Craig A.; Villamil, Clara I.; Welsch, Dean; Williams, Jennifer M.; Yu, Ying; Yao, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6653-6680</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-hydroxy aryloxyarylsulfonyl pyrancarboxamides and piperidinecarboxamides such as I (R = MeOCH2CH2, cyclopropyl) are prepd. as selective matrix metalloproteinase (MMP) inhibitors avoiding nonselective MMP (in particular, MMP-1) inhibition for use as antitumor, antiarthritic, and cardiovascular agents.  The inhibition of MMPs 1, 2, 3, 7, 8, 9, 13, and 14 by N-hydroxy aryloxyarylsulfonyl pyrancarboxamides and piperidinecarboxamides is detd. as well as their calcd. lipophilicities; the pharmacokinetics, inhibition of human prostate, breast, and lung cancer cells, inhibition of cartilage degrdn., inhibition of ventricular dilation after myocardial infarction, and DSC calorimetric measurements for selected compds. are detd.  I (R = MeOCH2CH2) (SC-78080/SD-2590) was selected for development as an anticancer agent, while I (R = cyclopropyl) and an N-hydroxy trifluoromethylphenoxyphenylsulfonyl pyrancarboxamide were selected as backup compds.  The structure of I (R = MeOCH2CH2) bound to MMP-13 is detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY0b9GTt27EbVg90H21EOLACvtfcHk0lhYQrdygOc1Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGjtbnJ&md5=0ee6c0fea7d5e86ff75095615dac8ec6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm100669j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100669j%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DD.%2BP.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DBedell%26aufirst%3DL.%2BJ.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DBond%26aufirst%3DB.%2BR.%26aulast%3DCarroll%26aufirst%3DJ.%26aulast%3DCarron%26aufirst%3DC.%2BP.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DEaston%26aufirst%3DA.%2BM.%26aulast%3DFreskos%26aufirst%3DJ.%2BN.%26aulast%3DFunckes-Shippy%26aufirst%3DC.%2BL.%26aulast%3DHeron%26aufirst%3DM.%26aulast%3DHockerman%26aufirst%3DS.%26aulast%3DHoward%26aufirst%3DC.%2BP.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DM.%2BH.%26aulast%3DMathis%26aufirst%3DK.%2BJ.%26aulast%3DMcDonald%26aufirst%3DJ.%2BJ.%26aulast%3DMehta%26aufirst%3DP.%2BP.%26aulast%3DMunie%26aufirst%3DG.%2BE.%26aulast%3DSunyer%26aufirst%3DT.%26aulast%3DSwearingen%26aufirst%3DC.%2BA.%26aulast%3DVillamil%26aufirst%3DC.%2BI.%26aulast%3DWelsch%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DJ.%26atitle%3DOrally%2520active%2520MMP-1%2520sparing%2520%25CE%25B1-tetrahydropyranyl%2520and%2520%25CE%25B1-piperidinyl%2520sulfone%2520matrix%2520metalloproteinase%2520%2528MMP%2529%2520inhibitors%2520with%2520efficacy%2520in%2520cancer%252C%2520arthritis%252C%2520and%2520cardiovascular%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6653%26epage%3D6680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Whittaker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gearing, A. J.</span><span> </span><span class="NLM_article-title">Design and therapeutic application of matrix metalloproteinase inhibitors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2735</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr9804543" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2735-76&issue=9&author=M.+Whittakerauthor=C.+D.+Floydauthor=P.+Brownauthor=A.+J.+Gearing&title=Design+and+therapeutic+application+of+matrix+metalloproteinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcr9804543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9804543%26sid%3Dliteratum%253Aachs%26aulast%3DWhittaker%26aufirst%3DM.%26aulast%3DFloyd%26aufirst%3DC.%2BD.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DGearing%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520therapeutic%2520application%2520of%2520matrix%2520metalloproteinase%2520inhibitors%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26issue%3D9%26spage%3D2735%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Rao, J. S.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of glioma invasiveness: the role of proteases</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1038%2Fnrc1121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=12835669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltVSqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=489-501&author=J.+S.+Rao&title=Molecular+mechanisms+of+glioma+invasiveness%3A+the+role+of+proteases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of glioma invasiveness: the role of proteases</span></div><div class="casAuthors">Rao, Jasti S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-501</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The invasive nature of brain-tumor cells makes an important contribution to the ineffectiveness of current treatment modalities, as the remaining tumor cells inevitably infiltrate the surrounding normal brain tissue, which leads to tumor recurrence.  Such local invasion remains an important cause of mortality and underscores the need to understand in more detail the mechanisms of tumor invasiveness.  Several proteases influence the malignant characteristics of gliomas - could their inhibition prove to be a useful therapeutic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0Ihtmy-XyXLVg90H21EOLACvtfcHk0lhEdqd8dNWXWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltVSqtr8%253D&md5=c4c2ca8344cdb4d7cac76899e319f7dc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrc1121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1121%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DJ.%2BS.%26atitle%3DMolecular%2520mechanisms%2520of%2520glioma%2520invasiveness%253A%2520the%2520role%2520of%2520proteases%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D489%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Kargiotis, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chetty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gondi, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsung, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gujrati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakka, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyritsis, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, J. S.</span><span> </span><span class="NLM_article-title">Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4830</span><span class="NLM_x">–</span> <span class="NLM_lpage">4840</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=4830-4840&author=O.+Kargiotisauthor=C.+Chettyauthor=C.+S.+Gondiauthor=A.+J.+Tsungauthor=D.+H.+Dinhauthor=M.+Gujratiauthor=S.+S.+Lakkaauthor=A.+P.+Kyritsisauthor=J.+S.+Rao&title=Adenovirus-mediated+transfer+of+siRNA+against+MMP-2+mRNA+results+in+impaired+invasion+and+tumor-induced+angiogenesis%2C+induces+apoptosis+in+vitro+and+inhibits+tumor+growth+in+vivo+in+glioblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKargiotis%26aufirst%3DO.%26aulast%3DChetty%26aufirst%3DC.%26aulast%3DGondi%26aufirst%3DC.%2BS.%26aulast%3DTsung%26aufirst%3DA.%2BJ.%26aulast%3DDinh%26aufirst%3DD.%2BH.%26aulast%3DGujrati%26aufirst%3DM.%26aulast%3DLakka%26aufirst%3DS.%2BS.%26aulast%3DKyritsis%26aufirst%3DA.%2BP.%26aulast%3DRao%26aufirst%3DJ.%2BS.%26atitle%3DAdenovirus-mediated%2520transfer%2520of%2520siRNA%2520against%2520MMP-2%2520mRNA%2520results%2520in%2520impaired%2520invasion%2520and%2520tumor-induced%2520angiogenesis%252C%2520induces%2520apoptosis%2520in%2520vitro%2520and%2520inhibits%2520tumor%2520growth%2520in%2520vivo%2520in%2520glioblastoma%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D4830%26epage%3D4840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Hagemann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anacker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riesner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schömig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernestus, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, G. H.</span><span> </span><span class="NLM_article-title">Comparative expression pattern of matrix-metalloproteinases in human glioblastoma cell-lines and primary cultures</span> <span class="citation_source-journal">BMC Res. Notes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1186%2F1756-0500-3-293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FhtlKitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=293-302&author=C.+Hagemannauthor=J.+Anackerauthor=S.+Haasauthor=D.+Riesnerauthor=B.+Sch%C3%B6migauthor=R.+I.+Ernestusauthor=G.+H.+Vince&title=Comparative+expression+pattern+of+matrix-metalloproteinases+in+human+glioblastoma+cell-lines+and+primary+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures</span></div><div class="casAuthors">Hagemann Carsten; Anacker Jelena; Haas Stefanie; Riesner Daniela; Schomig Beate; Ernestus Ralf-Ingo; Vince Giles H</div><div class="citationInfo"><span class="NLM_cas:title">BMC research notes</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">293</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Glioblastomas (GBM), the most frequent malignant brain tumors in adults, are characterized by an aggressive local growth pattern and highly invasive tumor cells.  This invasion is facilitated by expression of matrix metalloproteinases (MMPs), a family of zinc-dependent endopeptidases.  They mediate the degradation of protein components of the extracellular matrix.  Twenty-three family members are known.  Elevated levels of several of them have been reported in GBM.  GBM cell-lines are used for in vitro studies of cell migration and invasion.  Therefore, it is essential to know their MMP expression patterns.  Only limited data for some of the cell-lines are published, yet.  To fill the gaps in our knowledge would help to choose suitable model systems for analysis of regulation and function of MMPs during GBM tumorigenesis, cell migration and invasion.  FINDINGS:  We analysed MMP-1, -8, -9, -10, -11, -13, -17, -19, -20, -21, -23, -24, -26, -27, and MMP-28 expression in seven GBM cell-lines (SNB-19, GaMG, U251, U87, U373, U343, U138) and in four primary cell cultures by semiquantitative RT-PCR, followed changes in the MMP expression pattern with increasing passages of cell culture and examined the influence of TNF-α and TGF-β1 stimulation on the expression of selected MMPs in U251 and U373 cells.MMP-13, -17, -19 and -24 were expressed by all analyzed cell-lines, whereas MMP-20 and MMP-21 were not expressed by any of them.  The other MMPs showed variable expression, which was dependent on passage number.  Primary cells displayed a similar MMP-expression pattern as the cell-lines.  In U251 and U373 cells expression of MMP-9 and MMP-19 was stimulated by TNF-α.  MMP-1 mRNA expression was significantly increased in U373 cells, but not in U251 cells by this cytokine.  Whereas TGF-β1 had no impact on MMP expression in U251 cells, it significantly induced MMP-11 and MMP-24 expression in U373 cells.  CONCLUSIONS:  Literature-data and our own results suggest that the expression pattern of MMPs is highly variable, dependent on the cell-line and the cell-culture conditions used and that also regulation of MMP expression by cytokines is cell-line dependent.  This is of high impact for the transfer of cell-culture experiments to clinical implementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThq87MBnawGs-crCu0nI_sfW6udTcc2eZv0AalN4VB3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FhtlKitQ%253D%253D&md5=088dc409eb8656210335d6cce9acb8bc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1186%2F1756-0500-3-293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-0500-3-293%26sid%3Dliteratum%253Aachs%26aulast%3DHagemann%26aufirst%3DC.%26aulast%3DAnacker%26aufirst%3DJ.%26aulast%3DHaas%26aufirst%3DS.%26aulast%3DRiesner%26aufirst%3DD.%26aulast%3DSch%25C3%25B6mig%26aufirst%3DB.%26aulast%3DErnestus%26aufirst%3DR.%2BI.%26aulast%3DVince%26aufirst%3DG.%2BH.%26atitle%3DComparative%2520expression%2520pattern%2520of%2520matrix-metalloproteinases%2520in%2520human%2520glioblastoma%2520cell-lines%2520and%2520primary%2520cultures%26jtitle%3DBMC%2520Res.%2520Notes%26date%3D2010%26volume%3D3%26spage%3D293%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Aime, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digilio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasano, M.</span><span> </span><span class="NLM_article-title">Modulation of the antioxidant activity of HO<sup>•</sup> scavengers by albumin binding: a <sup>19</sup>F NMR study</span> <span class="citation_source-journal">Biochim. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">962</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2FS0006-291X%2803%2901307-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=12878205" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2003&pages=962-966&author=S.+Aimeauthor=G.+Digilioauthor=E.+Brunoauthor=V.+Maineroauthor=S.+Baroniauthor=M.+Fasano&title=Modulation+of+the+antioxidant+activity+of+HO%E2%80%A2+scavengers+by+albumin+binding%3A+a+19F+NMR+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2901307-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252901307-X%26sid%3Dliteratum%253Aachs%26aulast%3DAime%26aufirst%3DS.%26aulast%3DDigilio%26aufirst%3DG.%26aulast%3DBruno%26aufirst%3DE.%26aulast%3DMainero%26aufirst%3DV.%26aulast%3DBaroni%26aufirst%3DS.%26aulast%3DFasano%26aufirst%3DM.%26atitle%3DModulation%2520of%2520the%2520antioxidant%2520activity%2520of%2520HO%25E2%2580%25A2%2520scavengers%2520by%2520albumin%2520binding%253A%2520a%252019F%2520NMR%2520study%26jtitle%3DBiochim.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D307%26spage%3D962%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Rational design of diflunisal analogues with reduced affinity for human serum albumin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x"> (</span><span class="NLM_issue">43</span><span class="NLM_x">) </span> <span class="NLM_fpage">10429</span><span class="NLM_x">–</span> <span class="NLM_lpage">10435</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja015955b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=10429-10435&issue=43&author=H.+Maoauthor=P.+J.+Hajdukauthor=R.+Craigauthor=R.+Bellauthor=T.+Borreauthor=S.+W.+Fesik&title=Rational+design+of+diflunisal+analogues+with+reduced+affinity+for+human+serum+albumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja015955b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja015955b%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DH.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DCraig%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DR.%26aulast%3DBorre%26aufirst%3DT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DRational%2520design%2520of%2520diflunisal%2520analogues%2520with%2520reduced%2520affinity%2520for%2520human%2520serum%2520albumin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26issue%3D43%26spage%3D10429%26epage%3D10435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Ghuman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunszain, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petitpas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otagiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, S.</span><span> </span><span class="NLM_article-title">Structural basis of the drug-binding specificity of human serum albumin</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2Fj.jmb.2005.07.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=16169013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVensrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=38-52&author=J.+Ghumanauthor=P.+A.+Zunszainauthor=I.+Petitpasauthor=A.+A.+Bhattacharyaauthor=M.+Otagiriauthor=S.+Curry&title=Structural+basis+of+the+drug-binding+specificity+of+human+serum+albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of the Drug-binding Specificity of Human Serum Albumin</span></div><div class="casAuthors">Ghuman, Jamie; Zunszain, Patricia A.; Petitpas, Isabelle; Bhattacharya, Ananyo A.; Otagiri, Masaki; Curry, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-52</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human serum albumin (HSA) is an abundant plasma protein that binds a remarkably wide range of drugs, thereby restricting their free, active concns.  The problem of overcoming the binding affinity of lead compds. for HSA represents a major challenge in drug development.  Crystallog. anal. of 17 different complexes of HSA with a wide variety of drugs and small-mol. toxins reveals the precise architecture of the two primary drug-binding sites on the protein, identifying residues that are key determinants of binding specificity and illuminating the capacity of both pockets for flexible accommodation.  Numerous secondary binding sites for drugs distributed across the protein have also been identified.  The binding of fatty acids, the primary physiol. ligand for the protein, is shown to alter the polarity and increase the vol. of drug site 1.  These results clarify the interpretation of accumulated drug binding data and provide a valuable template for design efforts to modulate the interaction with HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyKWUfReJZ-bVg90H21EOLACvtfcHk0lgYMdNkNdk_-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVensrbJ&md5=d82105920c360292329bf509667df42f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.07.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.07.075%26sid%3Dliteratum%253Aachs%26aulast%3DGhuman%26aufirst%3DJ.%26aulast%3DZunszain%26aufirst%3DP.%2BA.%26aulast%3DPetitpas%26aufirst%3DI.%26aulast%3DBhattacharya%26aufirst%3DA.%2BA.%26aulast%3DOtagiri%26aufirst%3DM.%26aulast%3DCurry%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520of%2520the%2520drug-binding%2520specificity%2520of%2520human%2520serum%2520albumin%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D353%26spage%3D38%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Prante, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tietze, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harald, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-<i>a</i>]pyridine-based dopamine D4 receptor ligands: discovery of an inverse agonist radioligand for PET</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1800</span><span class="NLM_x">–</span> <span class="NLM_lpage">1810</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701375u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1800-1810&author=O.+Pranteauthor=R.+Tietzeauthor=C.+Hockeauthor=S.+L%C3%B6berauthor=H.+Haraldauthor=T.+Kuwertauthor=P.+Gmeiner&title=Synthesis%2C+radiofluorination%2C+and+in+vitro+evaluation+of+pyrazolo%5B1%2C5-a%5Dpyridine-based+dopamine+D4+receptor+ligands%3A+discovery+of+an+inverse+agonist+radioligand+for+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm701375u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701375u%26sid%3Dliteratum%253Aachs%26aulast%3DPrante%26aufirst%3DO.%26aulast%3DTietze%26aufirst%3DR.%26aulast%3DHocke%26aufirst%3DC.%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DHarald%26aufirst%3DH.%26aulast%3DKuwert%26aufirst%3DT.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520radiofluorination%252C%2520and%2520in%2520vitro%2520evaluation%2520of%2520pyrazolo%255B1%252C5-a%255Dpyridine-based%2520dopamine%2520D4%2520receptor%2520ligands%253A%2520discovery%2520of%2520an%2520inverse%2520agonist%2520radioligand%2520for%2520PET%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1800%26epage%3D1810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Snoek-van Beurden, P. A. M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von den Hoff, J. W.</span><span> </span><span class="NLM_article-title">Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors</span> <span class="citation_source-journal">BioTechniques</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.2144%2F05381RV01" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=15679089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptV2ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2005&pages=73-83&author=P.+A.+M+Snoek-van+Beurdenauthor=J.+W.+Von+den+Hoff&title=Zymographic+techniques+for+the+analysis+of+matrix+metalloproteinases+and+their+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors</span></div><div class="casAuthors">Snoek-van Beurden, Patricia A. M.; Von den Hoff, Johannes W.</div><div class="citationInfo"><span class="NLM_cas:title">BioTechniques</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-83</span>CODEN:
                <span class="NLM_cas:coden">BTNQDO</span>;
        ISSN:<span class="NLM_cas:issn">0736-6205</span>.
    
            (<span class="NLM_cas:orgname">Informa Life Sciences Publishing</span>)
        </div><div class="casAbstract">A review.  The balance between matrix metalloproteinases (MMPs) and their inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), is largely responsible for the remodeling of tissues.  Deregulation of this balance is a characteristic of extensive tissue degrdn. in certain degenerative diseases.  To analyze the role of MMPs and TIMPs in tissue remodeling under normal and pathol. conditions, it is important to have reliable detection methods.  This review will focus on zymog. techniques for the anal. of MMPs and TIMPs.  MMPs can be analyzed with several zymog. techniques, but substrate zymog. is the most commonly used.  This technique identifies MMPs by the degrdn. of their preferential substrate and by their mol. wt.  Several substrates that can be used for zymog. are described.  Reverse zymog., which detects TIMPs by their ability to inhibit MMPs, is also discussed.  Finally, in situ zymog. is described, which is used to localize MMPs in tissue sections.  Common problems encountered during sample prepn., zymog. itself, and the data anal. are discussed.  Hints are given to improve the sensitivity and accuracy of zymog. methods.  In conclusion, zymog. is a valuable tool for research purposes and for the development of new diagnostic techniques and therapies for pathol. conditions such as rheumatoid and osteoarthritis, and tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUS7ALr7ZTqLVg90H21EOLACvtfcHk0lgYMdNkNdk_-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptV2ltA%253D%253D&md5=94aeaaf26a5ac45a2fad863168228fac</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2144%2F05381RV01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2144%252F05381RV01%26sid%3Dliteratum%253Aachs%26aulast%3DSnoek-van%2BBeurden%26aufirst%3DP.%2BA.%2BM%26aulast%3DVon%2Bden%2BHoff%26aufirst%3DJ.%2BW.%26atitle%3DZymographic%2520techniques%2520for%2520the%2520analysis%2520of%2520matrix%2520metalloproteinases%2520and%2520their%2520inhibitors%26jtitle%3DBioTechniques%26date%3D2005%26volume%3D38%26spage%3D73%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Sprague, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achilefu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2Fj.nucmedbio.2005.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=16546677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ehsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=227-237&author=J.+E.+Spragueauthor=W.+P.+Liauthor=K.+Liangauthor=S.+Achilefuauthor=C.+J.+Anderson&title=In+vitro+and+in+vivo+investigation+of+matrix+metalloproteinase+expression+in+metastatic+tumor+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models</span></div><div class="casAuthors">Sprague, Jennifer E.; Li, Wen Ping; Liang, Kexian; Achilefu, Samuel; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-237</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: Overexpression of matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, has been correlated with poor prognosis in several cancer types including lung, colon and breast.  Noninvasive detection of MMP expression might allow physicians to better det. when more aggressive cancer therapy is appropriate.  The peptide CTT (CTTHWGFTLC) was identified as a selective inhibitor of MMP-2/9 that inhibits the growth of MDA-MB-435 human breast cancer xenografts.  Methods: CTT was conjugated with the bifunctional chelator DOTA (1,4,7,10-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid) for radiolabeling with 64Cu (t1/2=12.7 h, 17.4% β+, 39% β-), a radionuclide suitable for positron emission tomog. (PET).  In vitro affinity was detd. in a fluorogenic substrate assay.  Tumor gelatinase targeting was evaluated in both biodistribution and microPET imaging studies.  Results: Cu(II)-DOTA-CTT inhibited hMMP-2 (EC50=8.7 μM) and mMMP-9 (EC50=18.2 μM) with similar affinity to CTT (hMMP-2 EC50=13.2 μM; mMMP-9 EC50=11.0 μM).  In biodistribution and microPET imaging studies, 64Cu-DOTA-CTT was taken up by MMP-2/9-pos. B16F10 murine melanoma tumors.  Subsequently, imaging studies using 64Cu-DOTA-CTT were performed on MDA-MB-435 tumor-bearing mice.  With zymog., tumor MMP-2/9 expression in this model was shown to be inconsistent, resulting in microPET detection of the MDA-MB-435 tumor in only 1 of 24 imaged mice.  Following limited imaging success, 64Cu-DOTA-CTT was shown to have poor in vivo stability.  Conclusions: Despite some evidence for selective uptake of 64Cu-DOTA-CTT by gelatinase-expressing tumors, the low affinity for MMP-2 and MMP-9 and in vivo instability make this an inadequate radioligand for in vivo tumor evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojHVJUHQCiibVg90H21EOLACvtfcHk0lgYMdNkNdk_-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ehsbo%253D&md5=7370ca0758d2e32e2e2554fba34ca003</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2005.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2005.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DSprague%26aufirst%3DJ.%2BE.%26aulast%3DLi%26aufirst%3DW.%2BP.%26aulast%3DLiang%26aufirst%3DK.%26aulast%3DAchilefu%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520investigation%2520of%2520matrix%2520metalloproteinase%2520expression%2520in%2520metastatic%2520tumor%2520models%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2006%26volume%3D33%26spage%3D227%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Nakada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span> </span><span class="NLM_article-title">Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2FS0002-9440%2810%2965288-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=10027400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVCqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1999&pages=417-428&author=M.+Nakadaauthor=H.+Nakamuraauthor=E.+Ikedaauthor=N.+Fujimotoauthor=J.+Yamashitaauthor=H.+Satoauthor=M.+Seikiauthor=Y.+Okada&title=Expression+and+tissue+localization+of+membrane-type+1%2C+2%2C+and+3+matrix+metalloproteinases+in+human+astrocytic+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors</span></div><div class="casAuthors">Nakada, Mitsutoshi; Nakamura, Hiroyuki; Ikeda, Eiji; Fujimoto, Noboru; Yamashita, Junkoh; Sato, Hiroshi; Seiki, Motoharu; Okada, Yasunori</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">417-428</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Three different membrane-type matrix metalloproteinases (MT1-, MT2-, and MT3-MMPs) are known to activate in vitro the zymogen of MMP-2 (pro-MMP-2, progelatinase A), which is one of the key MMPs in invasion and metastasis of various cancers.  In the present study, we have examd. prodn. and activation of pro-MMP-2, expression of MT1-, MT2-, and MT3-MMPs and their correlation with pro-MMP-2 activation, and localization of MMP-2, MT1-MMP, and MT2-MMP in human astrocytic tumors.  The sandwich enzyme immunoassay demonstrates that the prodn. levels of pro-MMP-2 in the anaplastic astrocytomas and glioblastomas are significantly higher than that in the low-grade astrocytomas (P < 0.05 and P < 0.01, resp.), metastatic brain tumors (P < 0.05), or normal brains (P < 0.01).  Gelatin zymog. indicates that the pro-MMP-2 activation ratio is significantly higher in the glioblastomas than in other astrocytic tumors (P < 0.01), metastatic brain tumors (P < 0.01), and normal brains (P < 0.01).  The quant. reverse transcription polymerase chain reaction analyses demonstrate that MT1-MMP and MT2-MMP are expressed predominantly in glioblastoma tissues (17/17 and 12/17 cases, resp.), and their expression levels increase significantly as tumor grade increases.  MT3-MMP is detectable in both astrocytic tumor and normal brain tissues, but the mean expression level is approx. 50-fold lower compared with that of MT1-MMP and MT2-MMP in the glioblastomas.  The activation ratio of pro-MMP-2 correlates directly with the expression levels of MT1-MMP and MT2-MMP but not MT3-MMP.  In situ hybridization indicates that neoplastic astrocytes express MT1-MMP and MT2-MMP in the glioblastoma tissues (5/5 cases and 5/5 cases, resp.).  Immunohistochem., MT1-MMP and MT2-MMP are localized to the neoplastic astrocytes in glioblastoma samples (17/17 cases and 12/17 cases, resp.), which are also pos. for MMP-2.  In situ zymog. shows gelatinolytic activity in the glioblastoma tissue but not in the normal brain tissues.  These results suggest that both MT1-MMP and MT2-MMP play a key role in the activation of pro-MMP-2 in the human malignant astrocytic tumors and that the gelatinolytic activity is involved in the astrocytic tumor invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWKt8J-fK6gLVg90H21EOLACvtfcHk0li4Nt0zCjNsnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVCqsbc%253D&md5=3cf22920c1fe68f334e41edd3dba7003</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2965288-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252965288-1%26sid%3Dliteratum%253Aachs%26aulast%3DNakada%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DE.%26aulast%3DFujimoto%26aufirst%3DN.%26aulast%3DYamashita%26aufirst%3DJ.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DSeiki%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DY.%26atitle%3DExpression%2520and%2520tissue%2520localization%2520of%2520membrane-type%25201%252C%25202%252C%2520and%25203%2520matrix%2520metalloproteinases%2520in%2520human%2520astrocytic%2520tumors%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1999%26volume%3D154%26spage%3D417%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Somiari, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somiari, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shriver, C. D.</span><span> </span><span class="NLM_article-title">Circulating MMP2 and MMP9 in breast cancer—Potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1403</span><span class="NLM_x">–</span> <span class="NLM_lpage">1411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1002%2Fijc.21989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=16615109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVOqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2006&pages=1403-1411&author=S.+B.+Somiariauthor=R.+I.+Somiariauthor=C.+M.+Heckmanauthor=C.+H.+Olsenauthor=R.+M.+Jordanauthor=S.+J.+Russellauthor=C.+D.+Shriver&title=Circulating+MMP2+and+MMP9+in+breast+cancer%E2%80%94Potential+role+in+classification+of+patients+into+low+risk%2C+high+risk%2C+benign+disease+and+breast+cancer+categories"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Circulating MMP2 and MMP9 in breast cancer-potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories</span></div><div class="casAuthors">Somiari, Stella B.; Somiari, Richard I.; Heckman, Caroline M.; Olsen, Cara H.; Jordan, Rick M.; Russell, Stephen J.; Shriver, Craig D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1403-1411</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Matrix metalloproteinase (MMP) 2 and 9 are involved in cancer invasion and metastasis, and increased levels occur in serum and plasma of breast cancer (BC) patients.  It is, however, unclear whether changes in serum levels can be exploited for early detection or classification of patients into different risk/disease categories.  In our study, we measured concn. and activity of MMP2/9 in sera of 345 donors classified as low risk (Gail score < 1.7), high risk (HR) (Gail score ≥ 1.7), benign disease or BC.  Kruskal-Wallis and Mann-Whitney nonparametric tests showed that total MMP2 concn. is higher in HR compared to control (p = 0.012), benign (p = 0.001) and cancer (p = 0.007).  Active MMP2 (aMMP2) concn. is higher in control than benign and cancer (p < 0.001, resp.).  Total and aMMP9 concns. are higher in cancer than benign (p < 0.001, p = 0.002, resp.).  Total MMP2 and total-MMP9 activities are lower in control than benign (p < 0.001, p = 0.002, resp.) and cancer (p < 0.001, resp.).  Total MMP2 and MMP9 activities are also higher in cancer than benign (p = 0.004, p < 0.001) and HR (p = 0.008, p = 0.007, resp.).  These results were not affected by age or inclusion/exclusion of donors with noninvasive cancer or atypical hyperplasia.  Linear discriminant anal. revealed that HR donors are characterized by lower total MMP2 and higher aMMP2.  Overall group classification accuracy was 64.5%.  Independent validation based on the leave-one-out cross validation approach gave an overall classification of 63%.  Our study provides evidence supporting the potential role of serum MMP2/9 as biomarkers for breast disease classification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrURuiyLqW0tbVg90H21EOLACvtfcHk0li4Nt0zCjNsnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVOqs7s%253D&md5=525c15c0eeda1f940e82fdd159a12c18</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fijc.21989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.21989%26sid%3Dliteratum%253Aachs%26aulast%3DSomiari%26aufirst%3DS.%2BB.%26aulast%3DSomiari%26aufirst%3DR.%2BI.%26aulast%3DHeckman%26aufirst%3DC.%2BM.%26aulast%3DOlsen%26aufirst%3DC.%2BH.%26aulast%3DJordan%26aufirst%3DR.%2BM.%26aulast%3DRussell%26aufirst%3DS.%2BJ.%26aulast%3DShriver%26aufirst%3DC.%2BD.%26atitle%3DCirculating%2520MMP2%2520and%2520MMP9%2520in%2520breast%2520cancer%25E2%2580%2594Potential%2520role%2520in%2520classification%2520of%2520patients%2520into%2520low%2520risk%252C%2520high%2520risk%252C%2520benign%2520disease%2520and%2520breast%2520cancer%2520categories%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2006%26volume%3D119%26spage%3D1403%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Eckelman, W.</span><span> </span><span class="NLM_article-title">The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2F0969-8051%2894%2990047-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=9241652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADyaK2cXlslCjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1994&pages=759-769&author=W.+Eckelman&title=The+application+of+receptor+theory+to+receptor-binding+and+enzyme-binding+oncologic+radiopharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals</span></div><div class="casAuthors">Eckelman, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">759-69</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    </div><div class="casAbstract">The successful imaging of tumor biochem. using a receptor binding radiotracer is related to the affinity const. and the receptor concn.  The target to nontarget ratio can be predicted by steady state equations using in vitro data, although this is a necessary but not sufficient upper limit.  The prediction of the sensitivity of the radiopharmaceutical to changes in the tumor biochem. is not possible with this evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovFsE7elk1trVg90H21EOLACvtfcHk0li4Nt0zCjNsnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslCjurg%253D&md5=fb299f06ae2d8b06f41a3f9147955a2f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2F0969-8051%2894%2990047-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0969-8051%252894%252990047-7%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DW.%26atitle%3DThe%2520application%2520of%2520receptor%2520theory%2520to%2520receptor-binding%2520and%2520enzyme-binding%2520oncologic%2520radiopharmaceuticals%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1994%26volume%3D21%26spage%3D759%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Woessner, J. F.,  Jr.</span><span> </span><span class="NLM_article-title">Quantification of matrix metalloproteinases in tissue samples</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">510</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2F0076-6879%2895%2948033-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=7674942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADyaK2MXptVShsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1995&pages=510-528&author=J.+F.+Woessner&title=Quantification+of+matrix+metalloproteinases+in+tissue+samples"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of matrix metalloproteinases in tissue samples</span></div><div class="casAuthors">Woessner, J. Frederick Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue">Proteolytic Enzymes: Aspartic and Metallo Peptidases</span>),
    <span class="NLM_cas:pages">510-28</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A discussion of how to ext. matrix metalloproteinases, how to check for completeness of extn., how to activate latent forms, and how to remove or destroy inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFgq3KZW551rVg90H21EOLACvtfcHk0ljMS7K8abVjVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptVShsL4%253D&md5=d1165eb6377a87513c8d4578f54bffc6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2895%2948033-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252895%252948033-1%26sid%3Dliteratum%253Aachs%26aulast%3DWoessner%26aufirst%3DJ.%2BF.%26atitle%3DQuantification%2520of%2520matrix%2520metalloproteinases%2520in%2520tissue%2520samples%26jtitle%3DMethods%2520Enzymol.%26date%3D1995%26volume%3D248%26spage%3D510%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Fukuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, K.</span><span> </span><span class="NLM_article-title">New radiopharmaceuticals for cancer imaging and biological characterization using PET</span> <span class="citation_source-journal">Int. Congr. Ser.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1264</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2Fj.ics.2004.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVOgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1264&publication_year=2004&pages=158-165&author=H.+Fukudaauthor=S.+Furumotoauthor=R.+Iwataauthor=K.+Kubota&title=New+radiopharmaceuticals+for+cancer+imaging+and+biological+characterization+using+PET"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">New radiopharmaceuticals for cancer imaging and biological characterization using PET</span></div><div class="casAuthors">Fukuda, Hiroshi; Furumoto, Shozo; Iwata, Ren; Kubota, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">International Congress Series</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1264</span>
        (<span class="NLM_cas:issue">PET and Molecular Imaging</span>),
    <span class="NLM_cas:pages">158-165</span>CODEN:
                <span class="NLM_cas:coden">EXMDA4</span>;
        ISSN:<span class="NLM_cas:issn">0531-5131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Recent developments and future aspects of positron emission tomog. (PET) in oncol. were reviewed and discussed, focusing on the development of new radiopharmaceuticals for cancer imaging and its biol. characterization.  Because of increased amino acid transport and protein synthesis in cancers, amino acid tracers are useful for cancer imaging.  Unlike F-18 FDG, the uptake of amino acid tracers in inflammatory tissues is relatively low compared with that in tumor tissues.  We have recently synthesized F-18 fluoromethyltyrosine (F-18 FMT).  Biodistribution study and autoradiog. (ARG) revealed that its uptake in tumor tissues was sufficiently high with lower uptake in inflammatory tissues and normal organs, except the pancreas.  Extracellular matrix proteinase plays an important role in the invasion, metastasis and neovascularization of cancer cells.  To measure the enzyme activity in tumors using PET, we developed F-18 SAV03M, which is an inhibitor of matrix metalloproteinase inhibitor.  Biodistribution studies revealed that tumor-to-blood and tumor-to-muscle ratios of 2.8 and 13.9, resp., were obtained 120 min after tracer injection.  ARG showed inhomogeneous radioactivity within a tumor, which may reflect an inhomogeneous distribution of enzyme activity within a tumor tissue.  These results indicate that F-18 FMT and F-18 SAV03M will be promising for in vivo imaging and biol. characterization of cancer using PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7bkwO_cmAu7Vg90H21EOLACvtfcHk0ljMS7K8abVjVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVOgsL0%253D&md5=7ebb9fa13f81c5006e3b0be5d82ec58e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ics.2004.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ics.2004.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DFukuda%26aufirst%3DH.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DKubota%26aufirst%3DK.%26atitle%3DNew%2520radiopharmaceuticals%2520for%2520cancer%2520imaging%2520and%2520biological%2520characterization%2520using%2520PET%26jtitle%3DInt.%2520Congr.%2520Ser.%26date%3D2004%26volume%3D1264%26spage%3D158%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Galardy, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassabonne, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapierre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, Schaeffer, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tressler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellot, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barletta, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foellmer, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobelny, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holleran, W. M.</span><span> </span><span class="NLM_article-title">Low molecular weight inhibitors in corneal ulceration</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">732</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=732&publication_year=1994&pages=315-323&author=R.+E.+Galardyauthor=M.+E.+Cassabonneauthor=C.+Gieseauthor=J.+H.+Gilbertauthor=F.+Lapierreauthor=M.+E.+Lopez%2C+Schaefferauthor=R.+Stackauthor=M.+Sullivanauthor=B.+Summersauthor=R.+Tresslerauthor=D.+Tyrrellauthor=J.+Weeauthor=S.+D.+Allenauthor=J.+J.+Castellotauthor=J.+P.+Barlettaauthor=G.+S.+Schultzauthor=L.+A.+Fernandezauthor=S.+Fisherauthor=T.-Y.+Cuiauthor=H.+G.+Foellmerauthor=D.+Grobelnyauthor=W.+M.+Holleran&title=Low+molecular+weight+inhibitors+in+corneal+ulceration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalardy%26aufirst%3DR.%2BE.%26aulast%3DCassabonne%26aufirst%3DM.%2BE.%26aulast%3DGiese%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DJ.%2BH.%26aulast%3DLapierre%26aufirst%3DF.%26aulast%3DLopez%252C%2BSchaeffer%26aufirst%3DM.%2BE.%26aulast%3DStack%26aufirst%3DR.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DSummers%26aufirst%3DB.%26aulast%3DTressler%26aufirst%3DR.%26aulast%3DTyrrell%26aufirst%3DD.%26aulast%3DWee%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DS.%2BD.%26aulast%3DCastellot%26aufirst%3DJ.%2BJ.%26aulast%3DBarletta%26aufirst%3DJ.%2BP.%26aulast%3DSchultz%26aufirst%3DG.%2BS.%26aulast%3DFernandez%26aufirst%3DL.%2BA.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DT.-Y.%26aulast%3DFoellmer%26aufirst%3DH.%2BG.%26aulast%3DGrobelny%26aufirst%3DD.%26aulast%3DHolleran%26aufirst%3DW.%2BM.%26atitle%3DLow%2520molecular%2520weight%2520inhibitors%2520in%2520corneal%2520ulceration%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1994%26volume%3D732%26spage%3D315%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Gringeri, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menchise, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzitelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cittadino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catanzaro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaabane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digilio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aime, S.</span><span> </span><span class="NLM_article-title">Novel Gd(III)-based probes for MR molecular imaging of matrix metalloproteinases</span> <span class="citation_source-journal">Contrast Media Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1002%2Fcmmi.478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=22434630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFWntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=175-184&issue=2&author=C.+V.+Gringeriauthor=V.+Menchiseauthor=S.+Rizzitelliauthor=E.+Cittadinoauthor=V.+Catanzaroauthor=G.+Datiauthor=L.+Chaabaneauthor=G.+Digilioauthor=S.+Aime&title=Novel+Gd%28III%29-based+probes+for+MR+molecular+imaging+of+matrix+metalloproteinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Gd(III)-based probes for MR molecular imaging of matrix metalloproteinases</span></div><div class="casAuthors">Gringeri, Concetta V.; Menchise, Valeria; Rizzitelli, Silvia; Cittadino, Evelina; Catanzaro, Valeria; Dati, Gabriele; Chaabane, Linda; Digilio, Giuseppe; Aime, Silvio</div><div class="citationInfo"><span class="NLM_cas:title">Contrast Media & Molecular Imaging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-184</span>CODEN:
                <span class="NLM_cas:coden">CMMICO</span>;
        ISSN:<span class="NLM_cas:issn">1555-4309</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Two novel Gd-based contrast agents (CAs) for the mol. imaging of matrix metalloproteinases (MMPs) were synthesized and characterized in vitro and in vivo.  These probes were based on the PLG*LWAR peptide sequence, known to be hydrolyzed between Gly and Leu by a broad panel of MMPs.  A Gd-DOTA chelate was conjugated to the N-terminal position through an amide bond, either directly to proline (compd. Gd-K11) or through a hydrophilic spacer (compd. Gd-K11N).  Both CA were made strongly amphiphilic by conjugating an alkyl chain at the C-terminus of the peptide sequence.  Gd-K11 and Gd-K11N have a good affinity for β-cyclodextrins (KD 310 and 670 μM, resp.) and for serum albumin (KD 350 and 90 μM, resp.), and can be efficiently cleaved in vitro at the expected site by MMP-2 and MMP-12.  Upon MMP-dependent cleavage, the CAs lose the C-terminal tetrapeptide and the alkyl chain, thus undergoing to an amphiphilic-to-hydrophilic transformation that is expected to alter tissue pharmacokinetics.  To prove this, Gd-K11 was systemically administered to mice bearing a s.c. B16.F10 melanoma, either pre-treated or not with the broad spectrum MMP inhibitor GM6001 (Ilomastat).  The washout of the Gd-contrast enhancement in MR images was significantly faster for untreated subjects (displaying MMP activity) with respect to treated ones (MMP activity inhibited).  The washout kinetics of Gd-contrast enhancement from the tumor microenvironment could be then interpreted in terms of the local activity of MMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN-0RZaXwFdrVg90H21EOLACvtfcHk0ljMS7K8abVjVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFWntLw%253D&md5=39372b888bc63cd03e20216035d64b08</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fcmmi.478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmmi.478%26sid%3Dliteratum%253Aachs%26aulast%3DGringeri%26aufirst%3DC.%2BV.%26aulast%3DMenchise%26aufirst%3DV.%26aulast%3DRizzitelli%26aufirst%3DS.%26aulast%3DCittadino%26aufirst%3DE.%26aulast%3DCatanzaro%26aufirst%3DV.%26aulast%3DDati%26aufirst%3DG.%26aulast%3DChaabane%26aufirst%3DL.%26aulast%3DDigilio%26aufirst%3DG.%26aulast%3DAime%26aufirst%3DS.%26atitle%3DNovel%2520Gd%2528III%2529-based%2520probes%2520for%2520MR%2520molecular%2520imaging%2520of%2520matrix%2520metalloproteinases%26jtitle%3DContrast%2520Media%2520Mol.%2520Imaging%26date%3D2012%26volume%3D7%26issue%3D2%26spage%3D175%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Hugenberg, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyholz, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riemann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4714</span><span class="NLM_x">–</span> <span class="NLM_lpage">4727</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300199g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hugenberg%2C+V.%3B+Breyholz%2C+H.-J.%3B+Riemann%2C+B.%3B+Hermann%2C+S.%3B+Schober%2C+O.%3B+Sch%C3%A4fers%2C+M.%3B+Gangadharmath%2C+U.%3B+Mocharla%2C+V.%3B+Kolb%2C+H.%3B+Walsh%2C+J.%3B+Zhang%2C+W.%3B+Kopka%2C+K.%3B+Wagner%2C+S.J.+Med.+Chem.+2012%2C+55%2C+4714%E2%80%934727"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm300199g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300199g%26sid%3Dliteratum%253Aachs%26aulast%3DHugenberg%26aufirst%3DV.%26aulast%3DBreyholz%26aufirst%3DH.-J.%26aulast%3DRiemann%26aufirst%3DB.%26aulast%3DHermann%26aufirst%3DS.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DMocharla%26aufirst%3DV.%26aulast%3DKolb%26aufirst%3DH.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DKopka%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DS.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4714%26epage%3D4727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Zheng, Q.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGrado, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baity, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glick-Wilson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sledge, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, G. D.</span><span> </span><span class="NLM_article-title">Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2<i>R</i>)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [<sup>11</sup>C]methyl ester</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2FS0969-8051%2803%2900086-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=14499334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Gku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=753-760&author=Q.-H.+Zhengauthor=X.+Feiauthor=T.+R.+DeGradoauthor=J.-Q.+Wangauthor=K.+L.+Stoneauthor=T.+D.+Martinezauthor=D.+J.+Gayauthor=W.+L.+Baityauthor=B.+H.+Mockauthor=B.+E.+Glick-Wilsonauthor=M.+L.+Sullivanauthor=K.+D.+Millerauthor=G.+W.+Sledgeauthor=G.+D.+Hutchins&title=Synthesis%2C+biodistribution+and+micro-PET+imaging+of+a+potential+cancer+biomarker+carbon-11+labeled+MMP+inhibitor+%282R%29-2-%5B%5B4-%286-fluorohex-1-ynyl%29phenyl%5Dsulfonylamino%5D-3-methylbutyric+acid+%5B11C%5Dmethyl+ester"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester</span></div><div class="casAuthors">Zheng, Qi-Huang; Fei, Xiangshu; DeGrado, Timothy R.; Wang, Ji-Quan; Stone, K. Lee; Martinez, Tanya D.; Gay, Dawn J.; Baity, Winston L.; Mock, Bruce H.; Glick-Wilson, Barbara E.; Sullivan, Michael L.; Miller, Kathy D.; Sledge, George W.; Hutchins, Gary D.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">753-760</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">(2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester ([11C]FMAME), a novel carbon-11 labeled matrix metalloproteinase (MMP) inhibitor, has been synthesized for evaluation as new potential positron emission tomog. (PET) cancer biomarker.  [11C]FMAME was prepd. by appropriate precursor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid (FMA), which was synthesized in six steps from (D)-valine in 71% chem. yield.  This acid precursor was labeled by [11C]methyl triflate through O-[11C]methylation method under basic conditions and isolated by solid-phase extn. (SPE) purifn. to produce pure target compd. in 40-55% radiochem. yield, based on 11CO2, decay cor. to end of bombardment, and 15-20 min synthesis time.  The biodistribution of [11C]FMAME was detd. at 30 min post IV injection in breast cancer animal models MCF-7 transfected with IL-1α implanted athymic mice and MDA-MB-435 implanted athymic mice.  The results showed the uptakes of [11C]FMAME in these tumors were 1.13% dose/g in MCF-7 transfected with IL-1α implanted mice and 1.37% dose/g in MDA-MB-435 implanted mice, resp.; the ratios of tumor/muscle (T/M) and tumor/blood (T/B) were 1.05 ± 0.29 (T/M, MCF-7's), 0.77 ± 0.20 (T/B, MCF-7's) and 0.99 ± 0.35 (T/M, MDA-MB-435), 1.44 ± 0.69 (T/B, MDA-MB-435), resp.  Pretreatment of MCF-7 transfected with IL-1α tumor-bearing mice with MMP inhibitor FMA had no effect on [11C]FMAME biodistribution.  Likewise, pretreatment of MDA-MB-435 tumor-bearing mice with FMA also showed no effect on [11C]FMAME biodistribution.  The micro-PET images were acquired for 15 min from a MCF-7 transfected with IL-1α tumor-bearing mouse or a MDA-MB-435 tumor-bearing mouse at 30 min post IV injection of 1 mCi of [11C]FMAME using a dedicated high resoln. (<3 mm full-width at half-max.) PET imaging system (Indy-PET II scanner).  The initial dynamic micro-PET images of [11C]FMAME in a MCF-7 transfected with IL-1α tumor-bearing mouse during different time periods of 0-15, 15-30, 30-45 and 45-60 min were performed by Indy-PET II.  The PET images clearly showed both tumors were visible with [11C]FMAME.  These results suggest that the localization of [11C]FMAME in the tumor is mediated by non-specific processes, and the visualization of [11C]FMAME on the tumor using the Indy-PET II scanner is related to non-specific binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvapHaZb-5ULVg90H21EOLACvtfcHk0lhkaYzUVYkk1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Gku7w%253D&md5=30be8b901a1fd5bc5f253aa1c98ddbe3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2803%2900086-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252803%252900086-6%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DQ.-H.%26aulast%3DFei%26aufirst%3DX.%26aulast%3DDeGrado%26aufirst%3DT.%2BR.%26aulast%3DWang%26aufirst%3DJ.-Q.%26aulast%3DStone%26aufirst%3DK.%2BL.%26aulast%3DMartinez%26aufirst%3DT.%2BD.%26aulast%3DGay%26aufirst%3DD.%2BJ.%26aulast%3DBaity%26aufirst%3DW.%2BL.%26aulast%3DMock%26aufirst%3DB.%2BH.%26aulast%3DGlick-Wilson%26aufirst%3DB.%2BE.%26aulast%3DSullivan%26aufirst%3DM.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DSledge%26aufirst%3DG.%2BW.%26aulast%3DHutchins%26aufirst%3DG.%2BD.%26atitle%3DSynthesis%252C%2520biodistribution%2520and%2520micro-PET%2520imaging%2520of%2520a%2520potential%2520cancer%2520biomarker%2520carbon-11%2520labeled%2520MMP%2520inhibitor%2520%25282R%2529-2-%255B%255B4-%25286-fluorohex-1-ynyl%2529phenyl%255Dsulfonylamino%255D-3-methylbutyric%2520acid%2520%255B11C%255Dmethyl%2520ester%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D753%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Waschkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, C.</span><span> </span><span class="NLM_article-title">Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe</span> <span class="citation_source-journal">Contrast Media Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=23109387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOqtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1-11&author=B.+Waschkauauthor=A.+Faustauthor=M.+Sch%C3%A4fersauthor=C.+Bremer&title=Performance+of+a+new+fluorescence-labeled+MMP+inhibitor+to+image+tumor+MMP+activity+in+vivo+in+comparison+to+an+MMP-activatable+probe"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe</span></div><div class="casAuthors">Waschkau, Bianca; Faust, Andreas; Schaefers, Michael; Bremer, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Contrast Media & Molecular Imaging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">CMMICO</span>;
        ISSN:<span class="NLM_cas:issn">1555-4309</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are proteolytic enzymes that degrade structural components of the extracellular matrix and participate in pathologies such as cancer and inflammatory disorders.  The development of novel contrast agents for optical imaging of MMP activity in vivo is of great interest.  The commonly used near-IR fluorescence-compatible agents are dye-quenched probes that do not emit fluorescence until they interact with MMPs.  In contrast, fluorescent synthetic low-mol.-wt. MMP inhibitors have not been systematically employed.  The aim of this study was to evaluate the performance of our recently developed Cy5.5-labeled MMP inhibitor to image MMP activity in tumors in vivo compared with activatable fluorescent MMP-sensing probes.  The dynamic uptake of Cy5.5-AF489 into four different tumor entities was analyzed in xenografted mice by i.v. injection and subsequent fluorescence reflectance imaging.  Tumors were characterized in regard to their MMP-2 and -9 mRNA expressions (qRT-PCR anal.), proteins (immunohistochem.) and gelatinase/collagenase activities (in situ zymog.).  Cy5.5-AF489 was compared with MMPSenseTM 680 and MMPSenseTM 750 FAST, two com. available MMP-activatable probes.  Cy5.5-AF489 showed a specific tumor uptake, which was blocked by pre-injection of the unlabeled MMPI, and discriminated between tumors with high or low MMP-2/-9 expressions.  Our optical probe facilitated faster visualization of MMP-active tumors accompanied by excellent tumor-to-background ratios when compared with activatable probes.  The MMP inhibitor Cy5.5-AF489 permits fast in vivo imaging of MMP expression/activity in tumors.  Given its small mol. wt. and non-peptidic structure, translational imaging from a preclin. application to a diagnostic tool for MMP-related diseases seems feasible.  Copyright © 2012 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8s_5t8PFzqrVg90H21EOLACvtfcHk0lhkaYzUVYkk1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOqtLzI&md5=68cbc53e6f2c04ed66c1f09c0ce5e1ac</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaschkau%26aufirst%3DB.%26aulast%3DFaust%26aufirst%3DA.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DBremer%26aufirst%3DC.%26atitle%3DPerformance%2520of%2520a%2520new%2520fluorescence-labeled%2520MMP%2520inhibitor%2520to%2520image%2520tumor%2520MMP%2520activity%2520in%2520vivo%2520in%2520comparison%2520to%2520an%2520MMP-activatable%2520probe%26jtitle%3DContrast%2520Media%2520Mol.%2520Imaging%26date%3D2013%26volume%3D8%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Del Guerra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belcari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaiano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Domenico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabba, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavattini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzarotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larobina, M.</span><span> </span><span class="NLM_article-title">Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging</span> <span class="citation_source-journal">IEEE Trans. Nucl. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1078</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1109%2FTNS.2006.871900" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2006&pages=1078-1083&issue=3&author=A.+Del+Guerraauthor=A.+Bartoliauthor=N.+Belcariauthor=D.+J.+Herbertauthor=A.+Mottaauthor=A.+Vaianoauthor=G.+Di+Domenicoauthor=N.+Sabbaauthor=E.+Morettiauthor=G.+Zavattiniauthor=M.+Lazzarottiauthor=L.+Sensiauthor=M.+Larobina&title=Performance+evaluation+of+the+fully+engineered+YAP-%28S%29PET+scanner+for+small+animal+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1109%2FTNS.2006.871900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1109%252FTNS.2006.871900%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BGuerra%26aufirst%3DA.%26aulast%3DBartoli%26aufirst%3DA.%26aulast%3DBelcari%26aufirst%3DN.%26aulast%3DHerbert%26aufirst%3DD.%2BJ.%26aulast%3DMotta%26aufirst%3DA.%26aulast%3DVaiano%26aufirst%3DA.%26aulast%3DDi%2BDomenico%26aufirst%3DG.%26aulast%3DSabba%26aufirst%3DN.%26aulast%3DMoretti%26aufirst%3DE.%26aulast%3DZavattini%26aufirst%3DG.%26aulast%3DLazzarotti%26aufirst%3DM.%26aulast%3DSensi%26aufirst%3DL.%26aulast%3DLarobina%26aufirst%3DM.%26atitle%3DPerformance%2520evaluation%2520of%2520the%2520fully%2520engineered%2520YAP-%2528S%2529PET%2520scanner%2520for%2520small%2520animal%2520imaging%26jtitle%3DIEEE%2520Trans.%2520Nucl.%2520Sci.%26date%3D2006%26volume%3D53%26issue%3D3%26spage%3D1078%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Phelps, M. E.</span> <span class="citation_source-book">PET: Molecular Imaging and Its Biological Applications</span>; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1007%2F978-0-387-22529-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+E.+Phelps&title=PET%3A+Molecular+Imaging+and+Its+Biological+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-22529-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-22529-6%26sid%3Dliteratum%253Aachs%26aulast%3DPhelps%26aufirst%3DM.%2BE.%26btitle%3DPET%253A%2520Molecular%2520Imaging%2520and%2520Its%2520Biological%2520Applications%26pub%3DSpringer-Verlag%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Bernd Beutel, Jian Song, Christian Paul Konken, Eva Korpos, Benjamin Schinor, Hanna Gerwien, Reshma Vidyadharan, Miriam Burmeister, Lixia Li, Günter Haufe, <span class="NLM_string-name hlFld-ContribAuthor">Lydia Sorokin</span>. </span><span class="cited-content_cbyCitation_article-title">New in Vivo Compatible Matrix Metalloproteinase  (MMP)-2 and MMP-9 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2018,</strong> <em>29 </em>
                                    (11)
                                     , 3715-3725. <a href="https://doi.org/10.1021/acs.bioconjchem.8b00618" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.8b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.8b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.8b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DNew%252Bin%252BVivo%252BCompatible%252BMatrix%252BMetalloproteinase%252B%252528MMP%252529-2%252Band%252BMMP-9%252BInhibitors%26aulast%3DBeutel%26aufirst%3DBernd%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30082018%26date%3D01102018%26date%3D24102018%26date%3D02102018%26volume%3D29%26issue%3D11%26spage%3D3715%26epage%3D3725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elisa Nuti, Doretta Cuffaro, Elisa Bernardini, Caterina Camodeca, Laura Panelli, Sílvia Chaves, Lidia Ciccone, Livia Tepshi, Laura Vera, Elisabetta Orlandini, Susanna Nencetti, Enrico A. Stura, M. Amélia Santos, Vincent Dive, <span class="NLM_string-name hlFld-ContribAuthor">Armando Rossello</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (10)
                                     , 4421-4435. <a href="https://doi.org/10.1021/acs.jmedchem.8b00096" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00096%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BThioaryl-Based%252BMatrix%252BMetalloproteinase-12%252BInhibitors%252Bwith%252BAlternative%252BZinc-Binding%252BGroups%25253A%252BSynthesis%25252C%252BPotentiometric%25252C%252BNMR%25252C%252Band%252BCrystallographic%252BStudies%26aulast%3DNuti%26aufirst%3DElisa%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19012018%26date%3D16052018%26date%3D04052018%26volume%3D61%26issue%3D10%26spage%3D4421%26epage%3D4435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Viktoria Butsch, Frederik Börgel, Fabian Galla, Katrin Schwegmann, Sven Hermann, Michael Schäfers, Burkhard Riemann, Bernhard Wünsch, <span class="NLM_string-name hlFld-ContribAuthor">Stefan Wagner</span>. </span><span class="cited-content_cbyCitation_article-title">Design, (Radio)Synthesis, and in Vitro and in Vivo Evaluation of Highly Selective and Potent Matrix Metalloproteinase 12 (MMP-12) Inhibitors as Radiotracers for Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (9)
                                     , 4115-4134. <a href="https://doi.org/10.1021/acs.jmedchem.8b00200" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00200%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252B%252528Radio%252529Synthesis%25252C%252Band%252Bin%252BVitro%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252BHighly%252BSelective%252Band%252BPotent%252BMatrix%252BMetalloproteinase%252B12%252B%252528MMP-12%252529%252BInhibitors%252Bas%252BRadiotracers%252Bfor%252BPositron%252BEmission%252BTomography%26aulast%3DButsch%26aufirst%3DViktoria%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06022018%26date%3D27042018%26date%3D16042018%26volume%3D61%26issue%3D9%26spage%3D4115%26epage%3D4134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Bordenave</span>, <span class="hlFld-ContribAuthor ">Marion  Helle</span>, <span class="hlFld-ContribAuthor ">Fabrice  Beau</span>, <span class="hlFld-ContribAuthor ">Dimitris  Georgiadis</span>, <span class="hlFld-ContribAuthor ">Livia  Tepshi</span>, <span class="hlFld-ContribAuthor ">Mylène  Bernes</span>, <span class="hlFld-ContribAuthor ">Yunpeng  Ye</span>, <span class="hlFld-ContribAuthor ">Laure  Levenez</span>, <span class="hlFld-ContribAuthor ">Enora  Poquet</span>, <span class="hlFld-ContribAuthor ">Hervé  Nozach</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Razavian</span>, <span class="hlFld-ContribAuthor ">Jakub  Toczek</span>, <span class="hlFld-ContribAuthor ">Enrico A.  Stura</span>, <span class="hlFld-ContribAuthor ">Vincent  Dive</span>, <span class="hlFld-ContribAuthor ">Mehran M.  Sadeghi</span>, and <span class="hlFld-ContribAuthor ">Laurent  Devel</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2016,</strong> <em>27 </em>
                                    (10)
                                     , 2407-2417. <a href="https://doi.org/10.1021/acs.bioconjchem.6b00377" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.6b00377</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.6b00377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.6b00377%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DSynthesis%252Band%252Bin%252BVitro%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252BMMP-12%252BSelective%252BOptical%252BProbes%26aulast%3DBordenave%26aufirst%3DThomas%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D12072016%26date%3D25082016%26date%3D14092016%26date%3D19102016%26date%3D26082016%26volume%3D27%26issue%3D10%26spage%3D2407%26epage%3D2417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haibo  Mei</span>, <span class="hlFld-ContribAuthor ">Romana  Pajkert</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Ziyi  Li</span>, <span class="hlFld-ContribAuthor ">Gerd-Volker  Röschenthaler</span>, <span class="hlFld-ContribAuthor ">Jianlin  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Chemistry of electrochemical oxidative reactions of sulfinate salts. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2020,</strong> <em>22 </em>
                                    (10)
                                     , 3028-3059. <a href="https://doi.org/10.1039/D0GC01025A" title="DOI URL">https://doi.org/10.1039/D0GC01025A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0GC01025A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0GC01025A%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DChemistry%252Bof%252Belectrochemical%252Boxidative%252Breactions%252Bof%252Bsulfinate%252Bsalts%26aulast%3DMei%26aufirst%3DHaibo%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D10%26spage%3D3028%26epage%3D3059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangasamy</span>, <span class="hlFld-ContribAuthor ">Geronimo</span>, <span class="hlFld-ContribAuthor ">Ortín</span>, <span class="hlFld-ContribAuthor ">Coderch</span>, <span class="hlFld-ContribAuthor ">Zapico</span>, <span class="hlFld-ContribAuthor ">Ramos</span>, <span class="hlFld-ContribAuthor ">de Pascual-Teresa</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (16)
                                     , 2982. <a href="https://doi.org/10.3390/molecules24162982" title="DOI URL">https://doi.org/10.3390/molecules24162982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24162982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24162982%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMolecular%252BImaging%252BProbes%252BBased%252Bon%252BMatrix%252BMetalloproteinase%252BInhibitors%252B%252528MMPIs%252529%26aulast%3DRangasamy%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D16%26spage%3D2982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felicia  D'Andrea</span>, <span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Stefano  Becherini</span>, <span class="hlFld-ContribAuthor ">Doretta  Cuffaro</span>, <span class="hlFld-ContribAuthor ">Elena  Husanu</span>, <span class="hlFld-ContribAuthor ">Caterina  Camodeca</span>, <span class="hlFld-ContribAuthor ">Elena  De Vita</span>, <span class="hlFld-ContribAuthor ">Maria Raffaella  Zocchi</span>, <span class="hlFld-ContribAuthor ">Alessandro  Poggi</span>, <span class="hlFld-ContribAuthor ">Cristina  D'Arrigo</span>, <span class="hlFld-ContribAuthor ">Valentina  Cappello</span>, <span class="hlFld-ContribAuthor ">Mauro  Gemmi</span>, <span class="hlFld-ContribAuthor ">Susanna  Nencetti</span>, <span class="hlFld-ContribAuthor ">Cinzia  Chiappe</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Ionic Liquid‐Based Matrix Metalloproteinase Inhibitors (MMPIs): A Simple Approach to Increase Hydrophilicity and to Develop MMPI‐Coated Gold Nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (6)
                                     , 686-698. <a href="https://doi.org/10.1002/cmdc.201800733" title="DOI URL">https://doi.org/10.1002/cmdc.201800733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800733%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BIonic%252BLiquid%2525E2%252580%252590Based%252BMatrix%252BMetalloproteinase%252BInhibitors%252B%252528MMPIs%252529%25253A%252BA%252BSimple%252BApproach%252Bto%252BIncrease%252BHydrophilicity%252Band%252Bto%252BDevelop%252BMMPI%2525E2%252580%252590Coated%252BGold%252BNanoparticles%26aulast%3DD%2527Andrea%26aufirst%3DFelicia%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D6%26spage%3D686%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian P.  Rempel</span>, <span class="hlFld-ContribAuthor ">Eric W.  Price</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Phenix</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging</span><span> <strong>2017,</strong> <em>16 </em>, 153601211771785. <a href="https://doi.org/10.1177/1536012117717852" title="DOI URL">https://doi.org/10.1177/1536012117717852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1536012117717852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1536012117717852%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%26atitle%3DMolecular%252BImaging%252Bof%252BHydrolytic%252BEnzymes%252BUsing%252BPET%252Band%252BSPECT%26aulast%3DRempel%26aufirst%3DBrian%2BP.%26date%3D2017%26date%3D2017%26volume%3D16%26spage%3D153601211771785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sander M. J.  van Duijnhoven</span>, <span class="hlFld-ContribAuthor ">Marc S.  Robillard</span>, <span class="hlFld-ContribAuthor ">Klaas  Nicolay</span>, <span class="hlFld-ContribAuthor ">Holger  Grüll</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo
              biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice. </span><span class="cited-content_cbyCitation_journal-name">Contrast Media & Molecular Imaging</span><span> <strong>2015,</strong> <em>10 </em>
                                    (1)
                                     , 59-66. <a href="https://doi.org/10.1002/cmmi.1605" title="DOI URL">https://doi.org/10.1002/cmmi.1605</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmmi.1605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmmi.1605%26sid%3Dliteratum%253Aachs%26jtitle%3DContrast%2520Media%2520%2526%2520Molecular%2520Imaging%26atitle%3DIn%252Bvivo%252Bbiodistribution%252Bof%252Bradiolabeled%252BMMP-2%25252F9%252Bactivatable%252Bcell-penetrating%252Bpeptide%252Bprobes%252Bin%252Btumor-bearing%252Bmice%26aulast%3Dvan%2BDuijnhoven%26aufirst%3DSander%2BM.%2BJ.%26date%3D2015%26date%3D2014%26volume%3D10%26issue%3D1%26spage%3D59%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Burcu  Altıparmak</span>, <span class="hlFld-ContribAuthor ">Fatma Yurt  Lambrecht</span>, <span class="hlFld-ContribAuthor ">Asli  Citak</span>. </span><span class="cited-content_cbyCitation_article-title">Design of radiolabeled gelatinase inhibitor peptide (99mTc-CLP) and evaluation in rats. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2014,</strong> <em>89 </em>, 130-133. <a href="https://doi.org/10.1016/j.apradiso.2014.02.012" title="DOI URL">https://doi.org/10.1016/j.apradiso.2014.02.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2014.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2014.02.012%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DDesign%252Bof%252Bradiolabeled%252Bgelatinase%252Binhibitor%252Bpeptide%252B%25252899mTc-CLP%252529%252Band%252Bevaluation%252Bin%252Brats%26aulast%3DAlt%25C4%25B1parmak%26aufirst%3DBurcu%26date%3D2014%26volume%3D89%26spage%3D130%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Réjean  Lebel</span>, <span class="hlFld-ContribAuthor ">Martin  Lepage</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review on controls in molecular imaging: lessons from MMP-2 imaging. </span><span class="cited-content_cbyCitation_journal-name">Contrast Media & Molecular Imaging</span><span> <strong>2014,</strong> <em>9 </em>
                                    (3)
                                     , 187-210. <a href="https://doi.org/10.1002/cmmi.1555" title="DOI URL">https://doi.org/10.1002/cmmi.1555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmmi.1555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmmi.1555%26sid%3Dliteratum%253Aachs%26jtitle%3DContrast%2520Media%2520%2526%2520Molecular%2520Imaging%26atitle%3DA%252Bcomprehensive%252Breview%252Bon%252Bcontrols%252Bin%252Bmolecular%252Bimaging%25253A%252Blessons%252Bfrom%252BMMP-2%252Bimaging%26aulast%3DLebel%26aufirst%3DR%25C3%25A9jean%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D3%26spage%3D187%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Digilio</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Francesca  Casalini</span>, <span class="hlFld-ContribAuthor ">Claudio  Cassino</span>, <span class="hlFld-ContribAuthor ">David M.  Dias</span>, <span class="hlFld-ContribAuthor ">Carlos F.G.C.  Geraldes</span>, <span class="hlFld-ContribAuthor ">Valeria  Catanzaro</span>, <span class="hlFld-ContribAuthor ">Alessandro  Maiocchi</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>. </span><span class="cited-content_cbyCitation_article-title">Study of the binding interaction between fluorinated matrix metalloproteinase inhibitors and Human Serum Albumin. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>79 </em>, 13-23. <a href="https://doi.org/10.1016/j.ejmech.2014.03.064" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.03.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.03.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.03.064%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStudy%252Bof%252Bthe%252Bbinding%252Binteraction%252Bbetween%252Bfluorinated%252Bmatrix%252Bmetalloproteinase%252Binhibitors%252Band%252BHuman%252BSerum%252BAlbumin%26aulast%3DDigilio%26aufirst%3DGiuseppe%26date%3D2014%26volume%3D79%26spage%3D13%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1a</b>, <b>1b</b>, and <b>1c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KOH, Cu, H<sub>2</sub>O, MW. (b) <i>N</i>,<i>N</i>-Dimethylformamide di-<i>tert-</i>butylacetal, toluene, 90 °C. (c) Oxone, THF, MeOH, H<sub>2</sub>O. (d) 4-Hydroxy-phenylboronic acid (<b>6</b>), 4-(benzyloxy)phenylboronic acid (<b>5</b>), 4-fluorophenylboronic acid (<b>8</b>), or 4-amino-phenylboronic acid hydrochloride (<b>9</b>), Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, H<sub>2</sub>O, dioxane, 85 °C. (e) H<sub>2</sub>, Pd/C 10%, MeOH, AcOH. (f) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 82 °C. (g) TFA, DCM, 0 °C. (h) TFA, DCM, 0 °C. (i) Fluoroacetyl chloride, DIPEA, DMF. (l) TFA, DCM, 0 °C.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. <sup>19</sup>F NMR spectra of <b>1a</b> [1.0 mM, phosphate-buffered saline (PBS), pH 7.4] with increasing concentrations of defatted human serum albumin (HSA). The concentration of protein is given on the left as millimoles per liter.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Radiosynthesis of Tracers [<sup>18</sup>F]-<b>1a</b> and [<sup>18</sup>F]-<b>1c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1)C<sub>2</sub>H<sub>4</sub>(OTs)<sub>2</sub>, [<sup>18</sup>F]K(K 222)F, 100 °C; (2) MeONa, 120 °C. (b) TFA, CH<sub>3</sub>CN, rt. (c) C<sub>2</sub>H<sub>4</sub>(OTs)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 82 °C. (d) (1) [<sup>18</sup>F]K(K 222)F, 105 °C; (2) TFA, CH<sub>3</sub>CN, rt. (e) Chloroacetylchloride or bromoacetylbromide, DIPEA, DMF. (f) (1)[<sup>18</sup>F]K(K 222)F, 130 °C; (2) TFA, CH<sub>3</sub>CN, rt.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Section of U-87 MG tumor stained with hematoxylin/eosin taken across the boundary between the tumor core (Co) and the tumor rim (Ri). Scale bar 54.6 μm. (B) In situ DQ-gelatin zymography of a tumor section adjacent to that shown in panel A. Gelatinolytic activity by confocal fluorescence microscopy appears as green fluorescence on a black background. Scale bar 54.6 μm. (C) In situ DQ-gelatin zymography of a tumor section taken across a high cellularity tumor region, showing diffuse gelatinase activity. Scale bar 54.6 μm. (D) Gelatin zymography of U-87 MG tumor homogenates. Tumors were excised from mice within 12 h after [<sup>18</sup>F]-<b>1a</b> PET scans. Results from four individuals are shown. (E) Western blot assay for MMP-2. The lanes on the left are from four tumor extracts seeded at 20 μg of protein. Bands of active MMP-2 and proMMP-2 are visible. The lanes on the right are relative to true rhMMP-2 (active form) used to build a calibration curve, seeded at 10–60 ng of MMP-2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Biodistribution of (■) [<sup>18</sup>F]-<b>1a</b>, (*) [<sup>18</sup>F]-<b>7</b>, and (○) [<sup>18</sup>F]-<b>1c</b> in healthy nude mice. Time–activity curves for liver, gut, and gallbladder are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <sup>18</sup>F PET images of the abdomen of nude mice subcutaneously grafted with a human U-87 MG glioblastoma. Red arrows show the tumor in different slices. (A) PET images obtained by sequential administration of [<sup>18</sup>F]-<b>1a</b> (upper row) and [<sup>18</sup>F]FDG (bottom row), showing colocalization of tracer uptake. The [<sup>18</sup>F]-<b>1a</b> scan was acquired 100 min post-tracer injection; [<sup>18</sup>F]FDG was injected immediately after completion of the [<sup>18</sup>F]-<b>1a</b> scan and the image was acquired 45 min post-[<sup>18</sup>F]FDG injection. Both scans were static acquisitions (injected dose 7.4 MBq, acquisition time 30 min). (B) PET images obtained by sequential administration of [<sup>18</sup>F]-<b>1a</b> (upper row) and [<sup>18</sup>F]FDG (bottom row), in a mouse that received 40 mg/kg of the broad-spectrum MMP inhibitor ilomastat 30 min before injection of [<sup>18</sup>F]-<b>1a</b>. The timing scheme and injected doses are the same as in panel A. Percentage injected dose per gram of tissue (% ID/g) values from these images are detailed in Table S2 in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/medium/jm-2013-001743_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Average percentage injected dose per gram of tissue (% ID/g) measured in [<sup>18</sup>F]-<b>1a</b> PET images in mice pretreated (gray columns) or not (white columns) with the broad-spectrum MMP inhibitor ilomastat (data listed in Table S2 in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). (Left <i>y</i>-axis) Comparisons of the uptake of [<sup>18</sup>F]-<b>1a</b> over the whole tumor, the tumor rim, or the tumor core. (Right <i>y</i>-axis) Comparison of the uptake ratio UR is shown. (UR is defined as the ratio between uptake of [<sup>18</sup>F]-<b>1a</b> in the tumor rim and uptake of [<sup>18</sup>F]FDG within the whole tumor; see text for details.) Error bars represent standard errors. Student’s <i>t</i> test <i>p</i>-values are given where differences are statistically significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm4001743/production/images/large/jm-2013-001743_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001743&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80724" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80724" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 55 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Massova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotra, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases: structures, evolution, and diversification</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1096%2Ffasebj.12.12.1075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=9737711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADyaK1cXlvFWnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=1075-1095&author=I.+Massovaauthor=L.+P.+Kotraauthor=R.+Fridmanauthor=S.+Mobashery&title=Matrix+metalloproteinases%3A+structures%2C+evolution%2C+and+diversification"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases: structures, evolution, and diversification</span></div><div class="casAuthors">Massova, Irina; Kotra, Lakshmi P.; Fridman, Rafael; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1075-1095</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A comprehensive sequence alignment of 64 members of the family of matrix metalloproteinases (MMPs) for the entire sequences, and subsequently the catalytic and the hemopexin-like domains, was performed.  The 64 MMPs were selected from plants, invertebrates, and vertebrates.  The analyses disclosed that as many as 23 distinct subfamilies of these proteins are known to exist.  Information from the sequence alignments was correlated with structures, both crystallog. as well as computational, of the catalytic domains for the 23 representative members of the MMP family.  A survey of the metal-binding sites and 2 loops contg. variable sequences of amino acids, which are important for substrate interactions, are discussed.  The collective data support the proposal that the assembly of the domains into multidomain enzymes was likely to be an early evolutionary event.  This was followed by diversification, perhaps in parallel among the MMPs, in a subsequent evolutionary time scale.  Anal. indicates that a retrograde structure simplification may have accounted for the evolution of MMPs with simple domain constituents, such as matrilysin, from the larger and more elaborate enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpgSZYQa5oO7Vg90H21EOLACvtfcHk0lhBcT2NB4PwOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvFWnur4%253D&md5=764760a88db783063076c9c4c37f5757</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.12.12.1075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.12.12.1075%26sid%3Dliteratum%253Aachs%26aulast%3DMassova%26aufirst%3DI.%26aulast%3DKotra%26aufirst%3DL.%2BP.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DMatrix%2520metalloproteinases%253A%2520structures%252C%2520evolution%252C%2520and%2520diversification%26jtitle%3DFASEB%2520J.%26date%3D1998%26volume%3D12%26spage%3D1075%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Nagase, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woessner, J. F.,  Jr.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x"> (</span><span class="NLM_issue">31</span><span class="NLM_x">) </span> <span class="NLM_fpage">21491</span><span class="NLM_x">–</span> <span class="NLM_lpage">21494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=21491-21494&issue=31&author=H.+H.+Nagaseauthor=J.+F.+Woessner&title=Matrix+metalloproteinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DH.%2BH.%26aulast%3DWoessner%26aufirst%3DJ.%2BF.%26atitle%3DMatrix%2520metalloproteinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26issue%3D31%26spage%3D21491%26epage%3D21494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hoekstra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskens, F. A. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verweij, J.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinase inhibitors: Current developments and future perspectives</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=415-427&author=R.+Hoekstraauthor=F.+A.+L.+M.+Eskensauthor=J.+Verweij&title=Matrix+metalloproteinase+inhibitors%3A+Current+developments+and+future+perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoekstra%26aufirst%3DR.%26aulast%3DEskens%26aufirst%3DF.%2BA.%2BL.%2BM.%26aulast%3DVerweij%26aufirst%3DJ.%26atitle%3DMatrix%2520metalloproteinase%2520inhibitors%253A%2520Current%2520developments%2520and%2520future%2520perspectives%26jtitle%3DOncologist%26date%3D2001%26volume%3D6%26spage%3D415%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Parks, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Boado, Y. S.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases as modulators of inflammation and innate immunity</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1038%2Fnri1418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=15286728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=617-229&author=W.+C.+Parksauthor=C.+L.+Wilsonauthor=Y.+S.+L%C3%B3pez-Boado&title=Matrix+metalloproteinases+as+modulators+of+inflammation+and+innate+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases as modulators of inflammation and innate immunity</span></div><div class="casAuthors">Parks, William C.; Wilson, Carole L.; Lopez-Boado, Yolanda S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">617-629</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  As their name implies, matrix metalloproteinases are thought to be responsible for the turnover and degrdn. of the extracellular matrix.  However, matrix degrdn. is neither the sole nor the main function of these proteinases.  Indeed, as the authors discuss here, recent findings indicate that matrix metalloproteinases act on pro-inflammatory cytokines, chemokines and other proteins to regulate varied aspects of inflammation and immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBtb_YA4ZbNbVg90H21EOLACvtfcHk0li2Tuk7EAGLFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFWktrc%253D&md5=2f0172ac025916666fda425f6869c360</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnri1418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1418%26sid%3Dliteratum%253Aachs%26aulast%3DParks%26aufirst%3DW.%2BC.%26aulast%3DWilson%26aufirst%3DC.%2BL.%26aulast%3DL%25C3%25B3pez-Boado%26aufirst%3DY.%2BS.%26atitle%3DMatrix%2520metalloproteinases%2520as%2520modulators%2520of%2520inflammation%2520and%2520innate%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2004%26volume%3D4%26spage%3D617%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Egeblad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werb, Z.</span><span> </span><span class="NLM_article-title">New functions for the matrix metalloproteinases in cancer progression</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1038%2Fnrc745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=11990853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1KktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=161-174&author=M.+Egebladauthor=Z.+Werb&title=New+functions+for+the+matrix+metalloproteinases+in+cancer+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">New functions for the matrix metalloproteinases in cancer progression</span></div><div class="casAuthors">Egeblad, Mikala; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) have long been assocd. with cancer-cell invasion and metastasis.  This provided the rationale for clin. trials of MMP inhibitors, unfortunately with disappointing results.  We now know, however, that the MMPs have functions other than promotion of invasion, have substrates other than components of the extracellular matrix, and that they function before invasion in the development of cancer.  With this knowledge in hand, can we rethink the use of MMP inhibitors in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtDQGs5M_BzLVg90H21EOLACvtfcHk0li2Tuk7EAGLFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1KktL8%253D&md5=56dd558362155cb25c9adbea4d478aa8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc745%26sid%3Dliteratum%253Aachs%26aulast%3DEgeblad%26aufirst%3DM.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DNew%2520functions%2520for%2520the%2520matrix%2520metalloproteinases%2520in%2520cancer%2520progression%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lampert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machein, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machein, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conca, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, B.</span><span> </span><span class="NLM_article-title">Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2FS0002-9440%2810%2965586-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=9708803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADyaK1cXls1ejtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1998&pages=429-437&author=K.+Lampertauthor=U.+Macheinauthor=M.+R.+Macheinauthor=W.+Concaauthor=H.+H.+Peterauthor=B.+Volk&title=Expression+of+matrix+metalloproteinases+and+their+tissue+inhibitors+in+human+brain+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors</span></div><div class="casAuthors">Lampert, Klaus; Machein, Uwe; Machein, Marcia Regina; Conca, Walter; Peter, Hans Hartmut; Volk, Benedikt</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">429-437</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">The expression patterns of 15 matrix metalloproteinases (MMPs) and 3 TIMP proteins in gliomas, medulloblastomas, and normal brain tissue were investigated.  By Northern blot anal., the authors found increased levels of mRNAs encoding for gelatinase A, gelatinase B, 2 membrane-type MMPs (mt1- and mt2-MMP), and TIMP-1 in glioblastomas and medulloblastomas.  The authors obsd. a significant increase of mt1-MMP, gelatinase A, gelatinase B, and TIMP-1 in glioblastomas as compared with low-grade astrocytomas, anaplastic astrocytomas, and normal brain.  In medulloblastomas, the expression of mt1-MMP, mt2-MMP, and gelatinase A were also increased, but to a lesser extent than that obsd. in glioblastomas.  These data were confirmed at the protein level by immunostaining anal.  Moreover, substrate gel electrophoresis showed that the activated forms of gelatinases A and B were present in glioblastomas and medulloblastomas.  These results suggest that increased expression of mt1-MMP/gelatinase A is closely related to the malignant progression obsd. in gliomas.  Furthermore, the present study demonstrates, apparently for the 1st time, that medulloblastomas express high levels of MMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrknU4W5xX61rVg90H21EOLACvtfcHk0li2Tuk7EAGLFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls1ejtro%253D&md5=481a77b1d7826332056287d0d6ca8a2b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2965586-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252965586-1%26sid%3Dliteratum%253Aachs%26aulast%3DLampert%26aufirst%3DK.%26aulast%3DMachein%26aufirst%3DU.%26aulast%3DMachein%26aufirst%3DM.%2BR.%26aulast%3DConca%26aufirst%3DW.%26aulast%3DPeter%26aufirst%3DH.%2BH.%26aulast%3DVolk%26aufirst%3DB.%26atitle%3DExpression%2520of%2520matrix%2520metalloproteinases%2520and%2520their%2520tissue%2520inhibitors%2520in%2520human%2520brain%2520tumors%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1998%26volume%3D153%26spage%3D429%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sternlicht, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergers, G.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects</span> <span class="citation_source-journal">Emerging Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1517%2F14728222.4.5.609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1yntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2000&pages=609-633&author=M.+D.+Sternlichtauthor=G.+Bergers&title=Matrix+metalloproteinases+as+emerging+targets+in+anticancer+therapy%3A+status+and+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases as emerging targets in anticancer therapy: Status and prospects</span></div><div class="casAuthors">Sternlicht, Mark D.; Bergers, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Therapeutic Targets</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">609-633</span>CODEN:
                <span class="NLM_cas:coden">ETTAF7</span>;
        ISSN:<span class="NLM_cas:issn">1460-0412</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 193 refs.  A major hallmark of malignant disease is the capacity of cancer cells to cross tissue boundaries and spread to distant sites throughout the body.  Extracellular matrix-degrading enzymes are thus required to break down structural barriers to invasion and metastasis.  Extensive and compelling evidence indicates that several members of the matrix metalloproteinase (MMP) family of enzymes play a key role in this regard and forms the rationale for the development and testing of compds. that can inhibit their proteolytic activity.  In addn., data now indicate that MMPs contribute to other aspects of cancer, including angiogenesis and the initial stages of tumor development, thus expanding the potential clin. utility of MMP inhibitors (MMPIs).  Conversely, some MMPs may defy cancer progression and others may not participate in cancer, but undoubtedly play normal physiol. roles.  These possibilities and the mechanisms underlying the influence of MMPs in cancer must be understood and considered in the design of therapeutic agents in order to optimize their efficacy and minimize their toxicity.  Herein we review the biol. and regulation of the MMPs, their roles in cancer development and progression, the status of preclin. and clin. efforts aimed at inhibiting their activity and the challenges and promise ahead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1658CpkSWbLVg90H21EOLACvtfcHk0li-4AHwtRs4dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1yntrc%253D&md5=853b013d4eacb8c9dfd855cc4b03e690</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F14728222.4.5.609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.4.5.609%26sid%3Dliteratum%253Aachs%26aulast%3DSternlicht%26aufirst%3DM.%2BD.%26aulast%3DBergers%26aufirst%3DG.%26atitle%3DMatrix%2520metalloproteinases%2520as%2520emerging%2520targets%2520in%2520anticancer%2520therapy%253A%2520status%2520and%2520prospects%26jtitle%3DEmerging%2520Ther.%2520Targets%26date%3D2000%26volume%3D4%26spage%3D609%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Deryugina, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quigley, J. P.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases and tumor metastasis</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1007%2Fs10555-006-7886-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=16680569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28Xktlaksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=9-34&author=E.+I.+Deryuginaauthor=J.+P.+Quigley&title=Matrix+metalloproteinases+and+tumor+metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases and tumor metastasis</span></div><div class="casAuthors">Deryugina, Elena I.; Quigley, James P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-34</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Functions of individual matrix metalloproteinases (MMPs) differentially expressed by tumor cells and stromal cells, are finely regulated by their spatial as well as temporal interactions with distinct cellular and extracellular components of the tumor microenvironment and also distant pre-metastatic sites.  Certain aspects of MMP involvement in tumor metastasis such as tumor-induced angiogenesis, tumor invasion, and establishment of metastatic foci at the secondary site, have received extensive attention that resulted in an overwhelming amt. of exptl. and observational data in favor of crit. roles of MMPs in these processes.  In particular, dependency of tumor angiogenesis on the activity of MMPs, esp. that of MMP-9, renders this step possibly the most effective target of synthetic MMP inhibitors.  MMP functioning in other stages of metastasis, including the escape of individual tumor cells from the primary tumor, their intravasation, survival in circulation, and extravasation at the secondary site, have not yet received enough consideration, resulting in insufficient or controversial data.  The major pieces of evidence that are most compelling and clearly det. the role and involvement of MMPs in the metastatic cascade are provided by mol. genetic studies employing knock-out or transgenic animals and tumor cell lines, modified to overexpress or down-regulate a specific MMP.  Findings from all of these studies implicate different functional mechanisms for both tumor and stromal MMPs during distinct steps of the metastatic cascade and indicate that MMPs can exhibit pro-metastatic as well as anti-metastatic roles depending on their nature and the exptl. setting.  This dual function of individual MMPs in metastasis has become a major focus of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHgz1mKKQU_rVg90H21EOLACvtfcHk0li-4AHwtRs4dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xktlaksr4%253D&md5=3588c87412b94392428829338d4e0535</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs10555-006-7886-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-006-7886-9%26sid%3Dliteratum%253Aachs%26aulast%3DDeryugina%26aufirst%3DE.%2BI.%26aulast%3DQuigley%26aufirst%3DJ.%2BP.%26atitle%3DMatrix%2520metalloproteinases%2520and%2520tumor%2520metastasis%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2006%26volume%3D25%26spage%3D9%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">López-Otín, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palavalli, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span> </span><span class="NLM_article-title">Protective roles of matrix metalloproteinases: From mouse models to human cancer</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1-6&issue=22&author=C.+L%C3%B3pez-Ot%C3%ADnauthor=L.+H.+Palavalliauthor=Y.+Samuels&title=Protective+roles+of+matrix+metalloproteinases%3A+From+mouse+models+to+human+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Ot%25C3%25ADn%26aufirst%3DC.%26aulast%3DPalavalli%26aufirst%3DL.%2BH.%26aulast%3DSamuels%26aufirst%3DY.%26atitle%3DProtective%2520roles%2520of%2520matrix%2520metalloproteinases%253A%2520From%2520mouse%2520models%2520to%2520human%2520cancer%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26issue%3D22%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Martin, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matrisian, L. M.</span><span> </span><span class="NLM_article-title">The other side of MMPs: Protective roles in tumor progression</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1007%2Fs10555-007-9089-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=17717634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yktLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=717-724&author=M.+D.+Martinauthor=L.+M.+Matrisian&title=The+other+side+of+MMPs%3A+Protective+roles+in+tumor+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The other side of MMPs: Protective roles in tumor progression</span></div><div class="casAuthors">Martin, Michelle D.; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">717-724</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinase (MMP) family of extracellular proteinases have long been assocd. with cancer invasion and metastasis by virtue of their ability to collectively degrade all components of the extracellular matrix (ECM).  The general belief that overexpression of a specific MMP, either by tumor cells or the surrounding stroma, is pro-tumorigenic led to the development of synthetic MMP inhibitors for the treatment of cancer.  However, there is an increasing amt. of literature demonstrating that the expression of certain MMPs, either at the primary or the metastatic site, provides a beneficial and protective effect in multiple stages of cancer progression.  Here, we review the evidence for protective effects of MMPs and contrast this with pro-tumorigenic effects of either the same enzyme, or a different MMP of the same family.  These studies highlight the importance of targeting specific MMPs for cancer treatment, and point to a potential reason why clin. trials of pharmaceutical inhibitors for MMPs were disappointing.  In order to effectively target MMPs in cancer progression, a better understanding of both their pro- and anti-tumorigenic effects is required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqngvilAdN6_LVg90H21EOLACvtfcHk0li-4AHwtRs4dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yktLbK&md5=f661343c1137fcd0e2e6a5968e250476</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs10555-007-9089-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-007-9089-4%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BD.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DThe%2520other%2520side%2520of%2520MMPs%253A%2520Protective%2520roles%2520in%2520tumor%2520progression%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2007%26volume%3D26%26spage%3D717%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Overall, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleifeld, O.</span><span> </span><span class="NLM_article-title">Tumor microenvironment e opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1038%2Fnrc1821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=16498445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=227-239&author=C.+M.+Overallauthor=O.+Kleifeld&title=Tumor+microenvironment+e+opinion%3A+validating+matrix+metalloproteinases+as+drug+targets+and+anti-targets+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour microenvironment - Opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span></div><div class="casAuthors">Overall, Christopher M.; Kleifeld, Oded</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-239</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) mediate homeostasis of the extracellular environment.  They have multiple signaling activities that are commonly altered during tumorigenesis and that might serve as intervention points for anticancer drugs.  However, there are many criteria to consider in validating MMPs as drug targets and for the development of MMP inhibitors.  The inhibition of some MMPs could have pro-tumorigenic effects (making them anti-targets), counterbalancing the benefits of target inhibition.  These effects might partially account for the failure of MMP inhibitors in clin. trials.  What are the major challenges in MMP target validation and MMP-inhibitor-drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc3iBQEggRc7Vg90H21EOLACvtfcHk0lhGW_0YdnrTQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D&md5=3edfeca153a62c759443d0893a6212e2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrc1821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1821%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DKleifeld%26aufirst%3DO.%26atitle%3DTumor%2520microenvironment%2520e%2520opinion%253A%2520validating%2520matrix%2520metalloproteinases%2520as%2520drug%2520targets%2520and%2520anti-targets%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D227%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Whittaker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gearing, A. J. H.</span><span> </span><span class="NLM_article-title">Design and therapeutic application of matrix metalloproteinase inhibitors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2735</span><span class="NLM_x">–</span> <span class="NLM_lpage">2776</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr9804543" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADyaK1MXls1Kku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2735-2776&author=M.+Whittakerauthor=C.+D.+Floydauthor=P.+Brownauthor=A.+J.+H.+Gearing&title=Design+and+therapeutic+application+of+matrix+metalloproteinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors</span></div><div class="casAuthors">Whittaker, Mark; Floyd, Christopher D.; Brown, Peter; Gearing, Andrew J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2735-2776</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 389 refs.  MMP inhibitors may be an important new class of therapeutic agents for the treatment of diseases characterized by excessive extracellular matrix degrdn. and/or remodelling, such as cancer and chronic inflammatory diseases such as rheumatoid arthritis, atherosclerosis, and MS.  This review describes progress in the design of MMP inhibitors and outlines the results of early clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGACjaK8AEZbVg90H21EOLACvtfcHk0lhGW_0YdnrTQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXls1Kku7c%253D&md5=e226080188f791f5d1ce8c61b64ad33a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcr9804543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9804543%26sid%3Dliteratum%253Aachs%26aulast%3DWhittaker%26aufirst%3DM.%26aulast%3DFloyd%26aufirst%3DC.%2BD.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DGearing%26aufirst%3DA.%2BJ.%2BH.%26atitle%3DDesign%2520and%2520therapeutic%2520application%2520of%2520matrix%2520metalloproteinase%2520inhibitors%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26spage%3D2735%26epage%3D2776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span> </span><span class="NLM_article-title">Development of matrix metalloproteinase inhibitors in cancer therapy</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1093%2Fjnci%2F93.3.178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=11158186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlKiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2001&pages=178-193&issue=3&author=M.+Hidalgoauthor=S.+G.+Eckhardt&title=Development+of+matrix+metalloproteinase+inhibitors+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Development of matrix metalloproteinase inhibitors in cancer therapy</span></div><div class="casAuthors">Hidalgo, Manuel; Eckhardt, S. Gail</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">178-193</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 189 refs.  The matrix metalloproteinases (MMPs) are a family of zinc-dependent proteinases involved in the degrdn. of the extracellular matrix.  The MMPs have been implicated in the processes of tumor growth, invasion, and metastasis; are frequently over-expressed in malignant tumors; and have been assocd. with an aggressive malignant phenotype and adverse prognosis in patients with cancer.  A no. of MMP inhibitors are being developed for the treatment of cancer.  The most extensively studied class of MMP inhibitors includes collagen peptidomimetics and nonpeptidomimetic inhibitors of the MMP active site, tetracycline derivs., and bisphosphonates.  The hydroxamate peptidomimetic inhibitor batimastat and its orally bioavailable analog marimastat, which bind covalently to the zinc atom at the MMP-active site, were the first MMP inhibitors to be studied in detail.  Marimastat is currently being studied in randomized clin. trials.  The nonpeptidic MMP inhibitors were synthesized in an attempt to improve the oral bioavailability and pharmaceutical properties of the peptidic inhibitors.  Several members of this class of compds. are undergoing evaluation in phase III clin. trials.  The tetracyclines and, particularly, the nonantibiotic chem. modified tetracyclines, interfere with several aspects of MMP expression and activation and inhibit tumor growth and metastases in preclin. models.  A representative agent of this class, Col-3, is currently undergoing phase I clin. trials.  The development of the MMP inhibitors, like that of other targeted and predominantly antiproliferative compds., poses a challenge because the paradigms that have governed the design of clin. oncol. trials may not be relevant to this new class of agents.  The anticipated need for long-term administration of these drugs, together with their cytostatic mechanism of action, will require novel clin. trial design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgnRed5mDw9LVg90H21EOLACvtfcHk0lhGW_0YdnrTQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlKiurw%253D&md5=0094a1ba5e55ca5268f41eec2c8d8480</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F93.3.178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F93.3.178%26sid%3Dliteratum%253Aachs%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26atitle%3DDevelopment%2520of%2520matrix%2520metalloproteinase%2520inhibitors%2520in%2520cancer%2520therapy%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2001%26volume%3D93%26issue%3D3%26spage%3D178%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Scherer, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matrisian, L. M.</span><span> </span><span class="NLM_article-title">Imaging matrix metalloproteinases in cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1007%2Fs10555-008-9152-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=18465089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A280%3ADC%252BD1cnhtl2rug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=679-690&author=R.+L.+Schererauthor=J.+O.+McIntyreauthor=L.+M.+Matrisian&title=Imaging+matrix+metalloproteinases+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging matrix metalloproteinases in cancer</span></div><div class="casAuthors">Scherer Randy L; McIntyre J Oliver; Matrisian Lynn M</div><div class="citationInfo"><span class="NLM_cas:title">Cancer metastasis reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">679-90</span>
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    </div><div class="casAbstract">Early detection of both primary tumors and metastatic disease remains a major challenge in the diagnosis and staging of cancer.  The recognition of the role of MMPs in both the growth and metastasis of tumors has guided the development not only of therapeutic strategies utilizing synthetic, small-molecule MMP inhibitors (MMPIs), but has also catalyzed methods to detect and image tumors in vivo by means of tumor-associated proteolytic activity.  These imaging approaches target MMPs involved in cancer progression via contrast agents linked to MMPIs or to MMP selective and specific substrates with sensitivity enhanced by amplification during enzymatic processing.  This review draws attention to a variety of strategies utilized to image MMP activity in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCS5EIFkE3jzslzEEsg76ufW6udTcc2ebV-ezgNHiwc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cnhtl2rug%253D%253D&md5=c9bfca5d65fdb217296703dee9bfafdd</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9152-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9152-9%26sid%3Dliteratum%253Aachs%26aulast%3DScherer%26aufirst%3DR.%2BL.%26aulast%3DMcIntyre%26aufirst%3DJ.%2BO.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DImaging%2520matrix%2520metalloproteinases%2520in%2520cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D679%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, W.</span><span> </span><span class="NLM_article-title">Molecular imaging of proteases in cancer</span> <span class="citation_source-journal">Cancer Growth Metastasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGgtbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=13-27&author=Y.+Yangauthor=H.+Hongauthor=Y.+Zhangauthor=W.+Cai&title=Molecular+imaging+of+proteases+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular imaging of proteases in cancer</span></div><div class="casAuthors">Yang, Yunan; Hong, Hao; Zhang, Yin; Cai, Weibo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Growth and Metastasis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-27</span>CODEN:
                <span class="NLM_cas:coden">CGMACQ</span>;
        ISSN:<span class="NLM_cas:issn">1179-0644</span>.
    
            (<span class="NLM_cas:orgname">Libertas Academica</span>)
        </div><div class="casAbstract">A review.  Proteases play important roles during tumor angiogenesis, invasion, and metastasis.  Various mol. imaging techniques have been employed for protease imaging: optical (both fluorescence and bioluminescence), magnetic resonance imaging (MRI), single-photon emission computed tomog. (SPECT), and positron emission tomog. (PET).  In this review, we will summarize the current status of imaging proteases in cancer with these techniques.  Optical imaging of proteases, in particular with fluorescence, is the most intensively validated and many of the imaging probes are already com. available.  It is generally agreed that the use of activatable probes is the most accurate and appropriate means for measuring protease activity.  Mol. imaging of proteases with other techniques (i.e. MRI, SPECT, and PET) has not been well-documented in the literature which certainly deserves much future effort.  Optical imaging and mol. MRI of protease activity has very limited potential for clin. investigation.  PET/SPECT imaging is suitable for clin. investigation; however the optimal probes for PET/SPECT imaging of proteases in cancer have yet to be developed.  Successful development of protease imaging probes with optimal in vivo stability, tumor targeting efficacy, and desirable pharmacokinetics for clin. translation will eventually improve cancer patient management.  Not limited to cancer, these protease-targeted imaging probes will also have broad applications in other diseases such as arthritis, atherosclerosis, and myocardial infarction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTpa-8YaMCNrVg90H21EOLACvtfcHk0ljj7pP3fbKLUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGgtbrO&md5=bbe1c4cdb559b523ff6dbe42f3613244</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26atitle%3DMolecular%2520imaging%2520of%2520proteases%2520in%2520cancer%26jtitle%3DCancer%2520Growth%2520Metastasis%26date%3D2009%26volume%3D2%26spage%3D13%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyholz, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höltke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopka, K.</span><span> </span><span class="NLM_article-title">Molecular imaging of matrix metalloproteinases in vivo using small molecule inhibitors for SPECT and PET</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2819</span><span class="NLM_x">–</span> <span class="NLM_lpage">2838</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.2174%2F092986706778522002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=17073631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVamsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2819-2838&author=S.+Wagnerauthor=H.+J.+Breyholzauthor=A.+Faustauthor=C.+H%C3%B6ltkeauthor=B.+Levkauauthor=O.+Schoberauthor=M.+Sch%C3%A4fersauthor=K.+Kopka&title=Molecular+imaging+of+matrix+metalloproteinases+in+vivo+using+small+molecule+inhibitors+for+SPECT+and+PET"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular imaging of matrix metalloproteinases in vivo using small molecule inhibitors for SPECT and PET</span></div><div class="casAuthors">Wagner, S.; Breyholz, H.-J.; Faust, A.; Hoeltke, C.; Levkau, B.; Schober, O.; Schaefers, M.; Kopka, K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2819-2838</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a family of zinc- and calcium-dependent secreted or membrane anchored endopeptidases.  MMPs are involved in many physiol. processes but also take part in the pathophysiol. mechanisms responsible for a wide range of diseases.  Pathol. expression and activation of MMPs are assocd. with cancer, atherosclerosis, stroke, arthritis, periodontal disease, multiple sclerosis and liver fibrosis.  Thus, noninvasive visualisation and quantification of MMP activity in vivo are of great interest in basic research and clin. application.  This can be achieved by scintigraphic mol. imaging techniques such as single photon emission computed tomog. (SPECT) and positron emission tomog. (PET) provided suitable radiolabeled tracers exist, e.g. radioactive inhibitors of matrix metalloproteinases (MMPIs).  The approach to monitor MMP activity in vivo using radiolabeled small mol. inhibitors suitable for SPECT and PET is summarised in this review.  Briefly, latest advances in scintigraphic imaging are introduced and followed by a report about the enzyme class of MMPs.  The involvement of MMPs in cancer and atherosclerosis is exemplified and small mol. MMPIs are classified.  Subsequently, the development of radiolabeled small mol. MMPIs, their synthesis and in vitro and in vivo evaluation is reviewed.  Finally, an outlook on the clin. potential of labeled MMPIs in diagnostic algorithms is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxH3rvZ6YLa7Vg90H21EOLACvtfcHk0ljj7pP3fbKLUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVamsrbM&md5=ab3f540c8c740d3b7100e288d3699272</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F092986706778522002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706778522002%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DBreyholz%26aufirst%3DH.%2BJ.%26aulast%3DFaust%26aufirst%3DA.%26aulast%3DH%25C3%25B6ltke%26aufirst%3DC.%26aulast%3DLevkau%26aufirst%3DB.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DKopka%26aufirst%3DK.%26atitle%3DMolecular%2520imaging%2520of%2520matrix%2520metalloproteinases%2520in%2520vivo%2520using%2520small%2520molecule%2520inhibitors%2520for%2520SPECT%2520and%2520PET%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D2819%26epage%3D2838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Pimlott, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, A.</span><span> </span><span class="NLM_article-title">Molecular tracers for the PET and SPECT imaging of disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1039%2FB922628C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=20818455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=149-162&author=S.+L.+Pimlottauthor=A.+Sutherland&title=Molecular+tracers+for+the+PET+and+SPECT+imaging+of+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular tracers for the PET and SPECT imaging of disease</span></div><div class="casAuthors">Pimlott, Sally L.; Sutherland, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">149-162</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The development of positron emission tomog. (PET) and single photon emission computed tomog. (SPECT) imaging continues to grow due to the ability of these techniques to allow the non-invasive in vivo visualisation of biol. processes at the mol. and cellular levels.  As well as finding application for the diagnosis of disease, these techniques have also been used in the drug discovery process.  Crucial to the growth of these techniques is the continued development of mol. probes that can bind to the target biol. receptor with high selectivity.  This tutorial review describes the use of PET and SPECT for mol. imaging and highlights key strategies for the development of mol. probes for the imaging of both cancer and neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlgAhRywJDGLVg90H21EOLACvtfcHk0ljj7pP3fbKLUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7fN&md5=9c9fc25429408a89e9eaca6550fe7bad</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2FB922628C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB922628C%26sid%3Dliteratum%253Aachs%26aulast%3DPimlott%26aufirst%3DS.%2BL.%26aulast%3DSutherland%26aufirst%3DA.%26atitle%3DMolecular%2520tracers%2520for%2520the%2520PET%2520and%2520SPECT%2520imaging%2520of%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D149%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cherry, S. R.; Sorenson, J. A.; Phelps, M. E.</span> <span class="citation_source-book">Physics in Nuclear Medicine</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Saunders</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=S.+R.+Cherry&author=J.+A.+Sorenson&author=M.+E.+Phelps&title=Physics+in+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCherry%26aufirst%3DS.%2BR.%26btitle%3DPhysics%2520in%2520Nuclear%2520Medicine%26pub%3DSaunders%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kubota, K.</span><span> </span><span class="NLM_article-title">From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology</span> <span class="citation_source-journal">Ann. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1007%2FBF02988499" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=471-486&issue=15&author=K.+Kubota&title=From+tumor+biology+to+clinical+PET%3A+A+review+of+positron+emission+tomography+%28PET%29+in+oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2FBF02988499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02988499%26sid%3Dliteratum%253Aachs%26aulast%3DKubota%26aufirst%3DK.%26atitle%3DFrom%2520tumor%2520biology%2520to%2520clinical%2520PET%253A%2520A%2520review%2520of%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520in%2520oncology%26jtitle%3DAnn.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D6%26issue%3D15%26spage%3D471%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Cai, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambhir, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">How molecular imaging is speeding up antiangiogenic drug development</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2624</span><span class="NLM_x">–</span> <span class="NLM_lpage">2633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1158%2F1535-7163.MCT-06-0395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=17121909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1els7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2624-2633&issue=11&author=W.+Caiauthor=J.+Raoauthor=S.+G.+Gambhirauthor=X.+Chen&title=How+molecular+imaging+is+speeding+up+antiangiogenic+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">How molecular imaging is speeding up antiangiogenic drug development</span></div><div class="casAuthors">Cai, Weibo; Rao, Jianghong; Gambhir, Sanjiv S.; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2624-2633</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Drug development is a long process that generally spans about 10 to 15 years.  The shift in recent drug discovery to novel agents against specific mol. targets highlights the need for more robust mol. imaging platforms.  Using mol. probes, mol. imaging can aid in many steps of the drug development process, such as providing whole body readout in an intact system, decreasing the workload and speeding up drug development/validation, and facilitating individualized anticancer treatment monitoring and dose optimization.  The main focus of this review is the recent advances in tumor angiogenesis imaging, and the targets include vascular endothelial growth factor and vascular endothelial growth factor receptor, integrin αv{szligbeta}3, matrix metalloproteinase, endoglin (CD105), and E-selectin.  Through tumor angiogenesis imaging, it is expected that a robust platform for understanding the mechanisms of tumor angiogenesis and evaluating the efficacy of novel antiangiogenic therapies will be developed, which can help antiangiogenic drug development in both the preclin. stage and the clin. settings.  Mol. imaging has enormous potential in improving the efficiency of the drug development process, including the specific area of antiangiogenic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBkSAL-X0hILVg90H21EOLACvtfcHk0lgjzd1s-qZBzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1els7jE&md5=1c0d66d382ceb62a38d240d674be4e0a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0395%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DW.%26aulast%3DRao%26aufirst%3DJ.%26aulast%3DGambhir%26aufirst%3DS.%2BG.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DHow%2520molecular%2520imaging%2520is%2520speeding%2520up%2520antiangiogenic%2520drug%2520development%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26issue%3D11%26spage%3D2624%26epage%3D2633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kopka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyholz, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riemann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trub, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilbert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span> </span><span class="NLM_article-title">Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">31</span><span class="NLM_x">) </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2Fj.nucmedbio.2003.08.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=257-267&issue=31&author=K.+Kopkaauthor=H.+J.+Breyholzauthor=S.+Wagnerauthor=M.+P.+Lawauthor=B.+Riemannauthor=S.+Schr%C3%B6erauthor=M.+Trubauthor=B.+Guilbertauthor=B.+Levkauauthor=O.+Schoberauthor=M.+Sch%C3%A4fers&title=Synthesis+and+preliminary+biological+evaluation+of+new+radioiodinated+MMP+inhibitors+for+imaging+MMP+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2003.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2003.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DKopka%26aufirst%3DK.%26aulast%3DBreyholz%26aufirst%3DH.%2BJ.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DLaw%26aufirst%3DM.%2BP.%26aulast%3DRiemann%26aufirst%3DB.%26aulast%3DSchr%25C3%25B6er%26aufirst%3DS.%26aulast%3DTrub%26aufirst%3DM.%26aulast%3DGuilbert%26aufirst%3DB.%26aulast%3DLevkau%26aufirst%3DB.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520preliminary%2520biological%2520evaluation%2520of%2520new%2520radioiodinated%2520MMP%2520inhibitors%2520for%2520imaging%2520MMP%2520activity%2520in%2520vivo%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2004%26volume%3D2%26issue%3D31%26spage%3D257%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Fei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Q.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sledge, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, G. D.</span><span> </span><span class="NLM_article-title">Synthesis of MMP inhibitor radiotracer [<sup>11</sup>C]CGS-25966, a new potential PET tumor imaging agent</span> <span class="citation_source-journal">J. Label. Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1002%2Fjlcr.675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Wms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=343-351&author=X.+Feiauthor=Q.-H.+Zhengauthor=X.+Liuauthor=J.-Q.+Wangauthor=K.+L.+Stoneauthor=K.+D.+Millerauthor=G.+W.+Sledgeauthor=G.+D.+Hutchins&title=Synthesis+of+MMP+inhibitor+radiotracer+%5B11C%5DCGS-25966%2C+a+new+potential+PET+tumor+imaging+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of MMP inhibitor radiotracer [11C]CGS 25966, a new potential PET tumor imaging agent</span></div><div class="casAuthors">Fei, Xiangshu; Zheng, Qi-Huang; Liu, Xuan; Wang, Ji-Quan; Stone, K. Lee; Miller, Kathy D.; Sledge, George W.; Hutchins, Gary D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-351</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">[11C]CGS 25966, a novel radiolabeled matrix metalloproteinase (MMP) inhibitor, has been synthesized for evaluation as new potential positron emission tomog. (PET) tumor imaging agent.  The precursor was labeled by [11C]methyl triflate through O-[11C]methylation method at the hydroxyl position of phenol under basic conditions and isolated by HPLC purifn. to produce pure target compd. in 15-25% radiochem. yield, based on 11CO2, decay cor. to end of bombardment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp71kvLw0dgNrVg90H21EOLACvtfcHk0lgjzd1s-qZBzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Wms74%253D&md5=0f55e2dfc2d4caf18f89fc20093e3c32</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.675%26sid%3Dliteratum%253Aachs%26aulast%3DFei%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DQ.-H.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.-Q.%26aulast%3DStone%26aufirst%3DK.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DSledge%26aufirst%3DG.%2BW.%26aulast%3DHutchins%26aufirst%3DG.%2BD.%26atitle%3DSynthesis%2520of%2520MMP%2520inhibitor%2520radiotracer%2520%255B11C%255DCGS-25966%252C%2520a%2520new%2520potential%2520PET%2520tumor%2520imaging%2520agent%26jtitle%3DJ.%2520Label.%2520Compd.%2520Radiopharm.%26date%3D2003%26volume%3D46%26spage%3D343%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyholz, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höltke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haufe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopka, K.</span><span> </span><span class="NLM_article-title">Novel fluorinated derivatives of the broad-spectrum MMP inhibitors <i>N</i>-hydroxy-2(<i>R</i>)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5752</span><span class="NLM_x">–</span> <span class="NLM_lpage">5764</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0708533" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5752-5764&author=S.+Wagnerauthor=H.-J.+Breyholzauthor=M.+P.+Lawauthor=A.+Faustauthor=C.+H%C3%B6ltkeauthor=S.+Schr%C3%B6erauthor=G.+Haufeauthor=B.+Levkauauthor=O.+Schoberauthor=M.+Sch%C3%A4fersauthor=K.+Kopka&title=Novel+fluorinated+derivatives+of+the+broad-spectrum+MMP+inhibitors+N-hydroxy-2%28R%29-%5B%5B%284-methoxyphenyl%29sulfonyl%5D%28benzyl%29-+and+%283-picolyl%29-amino%5D-3-methyl-butanamide+as+potential+tools+for+the+molecular+imaging+of+activated+MMPs+with+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0708533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0708533%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DBreyholz%26aufirst%3DH.-J.%26aulast%3DLaw%26aufirst%3DM.%2BP.%26aulast%3DFaust%26aufirst%3DA.%26aulast%3DH%25C3%25B6ltke%26aufirst%3DC.%26aulast%3DSchr%25C3%25B6er%26aufirst%3DS.%26aulast%3DHaufe%26aufirst%3DG.%26aulast%3DLevkau%26aufirst%3DB.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DKopka%26aufirst%3DK.%26atitle%3DNovel%2520fluorinated%2520derivatives%2520of%2520the%2520broad-spectrum%2520MMP%2520inhibitors%2520N-hydroxy-2%2528R%2529-%255B%255B%25284-methoxyphenyl%2529sulfonyl%255D%2528benzyl%2529-%2520and%2520%25283-picolyl%2529-amino%255D-3-methyl-butanamide%2520as%2520potential%2520tools%2520for%2520the%2520molecular%2520imaging%2520of%2520activated%2520MMPs%2520with%2520PET%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5752%26epage%3D5764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyholz, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höltke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopka, K.</span><span> </span><span class="NLM_article-title">A new <sup>18</sup>F-labelled derivative of the MMP inhibitor CGS 27023A for PET: Radiosynthesis and initial small-animal PET studies</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2Fj.apradiso.2008.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=19167232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitVSjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2009&pages=606-610&author=S.+Wagnerauthor=H.-J.+Breyholzauthor=C.+H%C3%B6ltkeauthor=A.+Faustauthor=O.+Schoberauthor=M.+Sch%C3%A4fersauthor=K.+Kopka&title=A+new+18F-labelled+derivative+of+the+MMP+inhibitor+CGS+27023A+for+PET%3A+Radiosynthesis+and+initial+small-animal+PET+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A new 18F-labelled derivative of the MMP inhibitor CGS 27023A for PET: Radiosynthesis and initial small-animal PET studies</span></div><div class="casAuthors">Wagner, Stefan; Breyholz, Hans-Joerg; Hoeltke, Carsten; Faust, Andreas; Schober, Otmar; Schaefers, Michael; Kopka, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">606-610</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The CGS 27023A deriv. (R)-2-(N-((6-fluoropyridin-3-yl)methyl)-4-methoxyphenyl-sulfonamido)-N-hydroxy-3-methylbutanamide (1a) was identified as a very potent matrix metalloproteinase inhibitor.  Here, we describe a one-step radiosynthesis of the target compd. [18F]1a.  The syntheses of [18F]1a resulted in a radiochem. yield of 12.1±5.9% (decay-cor.), a radiochem. purity of 98.8±0.6%, and a specific activity of 39±27 GBq/μmol at the end of synthesis within 160±18 min from the end of radionuclide prodn. (n=5).  Initial small-animal PET studies in wild-type mice (C57/BL6) showed no unfavorable tissue accumulation of [18F]1a.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRtREV2ihWjLVg90H21EOLACvtfcHk0ljAyxGYV0eHqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitVSjs7Y%253D&md5=50db9034eb7927c2545f366ad45de56b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2008.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2008.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DBreyholz%26aufirst%3DH.-J.%26aulast%3DH%25C3%25B6ltke%26aufirst%3DC.%26aulast%3DFaust%26aufirst%3DA.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DKopka%26aufirst%3DK.%26atitle%3DA%2520new%252018F-labelled%2520derivative%2520of%2520the%2520MMP%2520inhibitor%2520CGS%252027023A%2520for%2520PET%253A%2520Radiosynthesis%2520and%2520initial%2520small-animal%2520PET%2520studies%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2009%26volume%3D67%26spage%3D606%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Van de Wiele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltenfreiter, R.</span><span> </span><span class="NLM_article-title">Imaging probes targeting matrix metalloproteinases</span> <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1089%2Fcbr.2006.21.409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=17105415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2ns7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=409-417&issue=5&author=C.+Van+de+Wieleauthor=R.+Oltenfreiter&title=Imaging+probes+targeting+matrix+metalloproteinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Update: Imaging Probes Targeting Matrix Metalloproteinases</span></div><div class="casAuthors">Van de Wiele, Christophe; Oltenfreiter, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">409-417</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  During the past few years, several imaging probes targeting matrix metalloproteinases (MMPs) have been developed.  Most of these probes have been validated in animal models.  Overall, results derived from most of these studies have been disappointing.  Whether or not this relates to shortcomings of the imaging probes used or to the set-up of the reported studies is currently unclear.  Firstly, MMPs targeted in these studies, MMP-1, -2 and -9, are cell secreted and their expression is known to vary extensively within one tumor type, depending on the stage of development of the tumor and on the presence of naturally occurring TIMPs.  Given the lack of data on the levels of MMP expression by inoculated tumor tissue at the time of imaging in most studies reported, it cannot be excluded that the neg. results reported are, in fact, false-neg. imaging results.  Secondly, given that most of the agents used for imaging are intrinsically broad-spectrum agents, their higher affinity for specific subsets of MMPs does not necessarily imply that a pos. imaging result also corresponds to overexpression of specific subsets of MMPs, as suggested in some papers published.  Accordingly, well-characterized tumor models need to be developed for the purpose of validating currently available, as well as future, MMP-imaging probes.  So far, only 111In-DTPA-N-TIMP-2 has been injected in patients, resp. suffering from Kaposi Sarcoma.  Imaging results obtained with this agent proved disappointing.  Imaging results obtained with other MMP-targeting probes in patients are awaited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD4ZDx2Fz6obVg90H21EOLACvtfcHk0ljAyxGYV0eHqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2ns7fN&md5=172e587433a288f9acef46f9befa7a00</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2006.21.409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2006.21.409%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWiele%26aufirst%3DC.%26aulast%3DOltenfreiter%26aufirst%3DR.%26atitle%3DImaging%2520probes%2520targeting%2520matrix%2520metalloproteinases%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2006%26volume%3D21%26issue%3D5%26spage%3D409%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Furomoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ido, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, H.</span><span> </span><span class="NLM_article-title">Tumor detection using <sup>18</sup>F-labeled matrix metalloproteinase-2 inhibitor</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2FS0969-8051%2802%2900393-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=12623110" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=119-125&author=S.+Furomotoauthor=K.+Takashimaauthor=K.+Kubotaauthor=T.+Idoauthor=R.+Iwataauthor=H.+Fukuda&title=Tumor+detection+using+18F-labeled+matrix+metalloproteinase-2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2802%2900393-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252802%252900393-1%26sid%3Dliteratum%253Aachs%26aulast%3DFuromoto%26aufirst%3DS.%26aulast%3DTakashima%26aufirst%3DK.%26aulast%3DKubota%26aufirst%3DK.%26aulast%3DIdo%26aufirst%3DT.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DFukuda%26aufirst%3DH.%26atitle%3DTumor%2520detection%2520using%252018F-labeled%2520matrix%2520metalloproteinase-2%2520inhibitor%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D119%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">auf dem Keller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellac, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ting, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harwig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappelhoff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruth, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bénard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overall, C. M.</span><span> </span><span class="NLM_article-title">Novel matrix metalloproteinase inhibitor [<sup>18</sup>F]marimastat-aryltrifluoroborate as a probe for in vivo positron emission tomography imaging in cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">7562</span><span class="NLM_x">–</span> <span class="NLM_lpage">7569</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=7562-7569&author=U.+auf+dem+Kellerauthor=C.+L.+Bellacauthor=Y.+Liauthor=Y.+Louauthor=P.+F.+Langeauthor=R.+Tingauthor=C.+Harwigauthor=R.+Kappelhoffauthor=S.+Dedharauthor=M.+J.+Adamauthor=T.+J.+Ruthauthor=F.+B%C3%A9nardauthor=D.+M.+Perrinauthor=C.+M.+Overall&title=Novel+matrix+metalloproteinase+inhibitor+%5B18F%5Dmarimastat-aryltrifluoroborate+as+a+probe+for+in+vivo+positron+emission+tomography+imaging+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dauf%2Bdem%2BKeller%26aufirst%3DU.%26aulast%3DBellac%26aufirst%3DC.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DLange%26aufirst%3DP.%2BF.%26aulast%3DTing%26aufirst%3DR.%26aulast%3DHarwig%26aufirst%3DC.%26aulast%3DKappelhoff%26aufirst%3DR.%26aulast%3DDedhar%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DM.%2BJ.%26aulast%3DRuth%26aufirst%3DT.%2BJ.%26aulast%3DB%25C3%25A9nard%26aufirst%3DF.%26aulast%3DPerrin%26aufirst%3DD.%2BM.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DNovel%2520matrix%2520metalloproteinase%2520inhibitor%2520%255B18F%255Dmarimastat-aryltrifluoroborate%2520as%2520a%2520probe%2520for%2520in%2520vivo%2520positron%2520emission%2520tomography%2520imaging%2520in%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D7562%26epage%3D7569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Skiles, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonnella, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeng, A. Y.</span><span> </span><span class="NLM_article-title">The design, structure and clinical update of small molecular weight matrix metalloproteinase inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2911</span><span class="NLM_x">–</span> <span class="NLM_lpage">2977</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.2174%2F0929867043364018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=15544483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVyntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=2911-2977&author=J.+W.+Skilesauthor=N.+C.+Gonnellaauthor=A.+Y.+Jeng&title=The+design%2C+structure+and+clinical+update+of+small+molecular+weight+matrix+metalloproteinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors</span></div><div class="casAuthors">Skiles, Jerry W.; Gonnella, Nina C.; Jeng, Arco Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2911-2977</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a family of zinc-contg. enzymes involved in the degrdn. and remodeling of extracellular matrix proteins.  Under normal physiol. conditions, the activities of these enzymes are well-regulated by endogenous tissue inhibitors of metalloproteinases (TIMPs).  Chronic stimulation of MMP activities due to an imbalance in the levels of MMPs and TIMPs was implicated in the pathogenesis of a variety of diseases such as cancer, osteoarthritis, and rheumatoid arthritis.  Thus, MMP inhibitors are expected to be useful for the treatment of these disorders.  Because of their importance in a variety of pathol. conditions, a no. of small mol. wt. MMP inhibitors have entered clin. trials in humans.  However, the results of these trials were extremely disappointing and have led many investigators to conclude that MMP inhibitors have no therapeutic benefit in human cancer.  To date, the 1st generation MMP inhibitors exhibited poor bioavailability while 2nd-generation compds. revealed that prolonged treatment caused musculoskeletal pain and inflammation or had a lack of efficacy.  This article describes the design of small mol. wt. MMP inhibitors, a brief description of available 3-dimensional MMP structures, a review of the proposed therapeutic utility of MMP inhibitors, and a clin. update of compds. that have entered clin. trials in humans.  The exptl. detd. structures used in the structure-based design of MMP inhibitors are thoroughly covered.  Major emphasis is on recently published and/or patented potent MMP inhibitors, from approx. Jan. 2000 to Apr. 2003, and their pharmacol. properties.  Protein inhibitors of these proteolytic enzymes, i.e. TIMPs, will not be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0LYPCikT-orVg90H21EOLACvtfcHk0ljAyxGYV0eHqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVyntbg%253D&md5=10e7288182d59fadf4691d1bf3795533</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F0929867043364018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364018%26sid%3Dliteratum%253Aachs%26aulast%3DSkiles%26aufirst%3DJ.%2BW.%26aulast%3DGonnella%26aufirst%3DN.%2BC.%26aulast%3DJeng%26aufirst%3DA.%2BY.%26atitle%3DThe%2520design%252C%2520structure%2520and%2520clinical%2520update%2520of%2520small%2520molecular%2520weight%2520matrix%2520metalloproteinase%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D2911%26epage%3D2977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Breyholz, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riemann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höltke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopka, K.</span><span> </span><span class="NLM_article-title">Radiofluorinated pyrimidine-2,4,6-triones as molecular probes for noninvasive MMP-targeted imaging</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=777-789&author=H.-J.+Breyholzauthor=S.+Wagnerauthor=A.+Faustauthor=B.+Riemannauthor=C.+H%C3%B6ltkeauthor=S.+Hermannauthor=O.+Schoberauthor=M.+Sch%C3%A4fersauthor=K.+Kopka&title=Radiofluorinated+pyrimidine-2%2C4%2C6-triones+as+molecular+probes+for+noninvasive+MMP-targeted+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreyholz%26aufirst%3DH.-J.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DFaust%26aufirst%3DA.%26aulast%3DRiemann%26aufirst%3DB.%26aulast%3DH%25C3%25B6ltke%26aufirst%3DC.%26aulast%3DHermann%26aufirst%3DS.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DKopka%26aufirst%3DK.%26atitle%3DRadiofluorinated%2520pyrimidine-2%252C4%252C6-triones%2520as%2520molecular%2520probes%2520for%2520noninvasive%2520MMP-targeted%2520imaging%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D777%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Nuti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casalini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avramova, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlandini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cercignani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amelio, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uggeri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossello, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6347</span><span class="NLM_x">–</span> <span class="NLM_lpage">6361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900335a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6347-6361&author=E.+Nutiauthor=L.+Panelliauthor=F.+Casaliniauthor=S.+I.+Avramovaauthor=E.+Orlandiniauthor=S.+Santamariaauthor=S.+Nencettiauthor=T.+Tuccinardiauthor=A.+Martinelliauthor=G.+Cercignaniauthor=N.+D%E2%80%99Amelioauthor=A.+Maiocchiauthor=F.+Uggeriauthor=A.+Rossello&title=Design%2C+synthesis%2C+biological+evaluation%2C+and+NMR+studies+of+a+new+series+of+arylsulfones+as+selective+and+potent+matrix+metalloproteinase-12+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm900335a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900335a%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DPanelli%26aufirst%3DL.%26aulast%3DCasalini%26aufirst%3DF.%26aulast%3DAvramova%26aufirst%3DS.%2BI.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DSantamaria%26aufirst%3DS.%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DCercignani%26aufirst%3DG.%26aulast%3DD%25E2%2580%2599Amelio%26aufirst%3DN.%26aulast%3DMaiocchi%26aufirst%3DA.%26aulast%3DUggeri%26aufirst%3DF.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520NMR%2520studies%2520of%2520a%2520new%2520series%2520of%2520arylsulfones%2520as%2520selective%2520and%2520potent%2520matrix%2520metalloproteinase-12%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6347%26epage%3D6361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uccello-Barretta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossello, A.</span><span> </span><span class="NLM_article-title">Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (<i>R</i>)- and (<i>S</i>)-<i>N</i>-hydroxy-2-(<i>N</i>-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4260</span><span class="NLM_x">–</span> <span class="NLM_lpage">4276</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=4260-4276&author=T.+Tuccinardiauthor=A.+Martinelliauthor=E.+Nutiauthor=P.+Carelliauthor=F.+Balzanoauthor=G.+Uccello-Barrettaauthor=G.+Murphyauthor=A.+Rossello&title=Amber+force+field+implementation%2C+molecular+modelling+study%2C+synthesis+and+MMP-1%2FMMP-2+inhibition+profile+of+%28R%29-+and+%28S%29-N-hydroxy-2-%28N-isopropoxybiphenyl-4-ylsulfonamido%29-3-methylbutanamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DCarelli%26aufirst%3DP.%26aulast%3DBalzano%26aufirst%3DF.%26aulast%3DUccello-Barretta%26aufirst%3DG.%26aulast%3DMurphy%26aufirst%3DG.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DAmber%2520force%2520field%2520implementation%252C%2520molecular%2520modelling%2520study%252C%2520synthesis%2520and%2520MMP-1%252FMMP-2%2520inhibition%2520profile%2520of%2520%2528R%2529-%2520and%2520%2528S%2529-N-hydroxy-2-%2528N-isopropoxybiphenyl-4-ylsulfonamido%2529-3-methylbutanamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D4260%26epage%3D4276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komurasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, M.</span><span> </span><span class="NLM_article-title">Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): <i>N</i>-sulfonylamino acid derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9707582" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=640-649&author=Y.+Tamuraauthor=F.+Watanabeauthor=T.+Nakataniauthor=K.+Yasuiauthor=M.+Fujiauthor=T.+Komurasakiauthor=H.+Tsuzukiauthor=R.+Maekawaauthor=T.+Yoshiokaauthor=K.+Kawadaauthor=K.+Sugitaauthor=M.+Ohtani&title=Highly+selective+and+orally+active+inhibitors+of+type+IV+collagenase+%28MMP-9+and+MMP-2%29%3A+N-sulfonylamino+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1021%2Fjm9707582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9707582%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DF.%26aulast%3DNakatani%26aufirst%3DT.%26aulast%3DYasui%26aufirst%3DK.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DKomurasaki%26aufirst%3DT.%26aulast%3DTsuzuki%26aufirst%3DH.%26aulast%3DMaekawa%26aufirst%3DR.%26aulast%3DYoshioka%26aufirst%3DT.%26aulast%3DKawada%26aufirst%3DK.%26aulast%3DSugita%26aufirst%3DK.%26aulast%3DOhtani%26aufirst%3DM.%26atitle%3DHighly%2520selective%2520and%2520orally%2520active%2520inhibitors%2520of%2520type%2520IV%2520collagenase%2520%2528MMP-9%2520and%2520MMP-2%2529%253A%2520N-sulfonylamino%2520acid%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D640%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yodo, M.</span><span> </span><span class="NLM_article-title">Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1723</span><span class="NLM_x">–</span> <span class="NLM_lpage">1738</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980514x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1723-1738&author=R.+Kiyamaauthor=Y.+Tamuraauthor=F.+Watanabeauthor=H.+Tsuzukiauthor=M.+Ohtaniauthor=M.+Yodo&title=Homology+modeling+of+gelatinase+catalytic+domains+and+docking+simulations+of+novel+sulfonamide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1021%2Fjm980514x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980514x%26sid%3Dliteratum%253Aachs%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DTamura%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DF.%26aulast%3DTsuzuki%26aufirst%3DH.%26aulast%3DOhtani%26aufirst%3DM.%26aulast%3DYodo%26aufirst%3DM.%26atitle%3DHomology%2520modeling%2520of%2520gelatinase%2520catalytic%2520domains%2520and%2520docking%2520simulations%2520of%2520novel%2520sulfonamide%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1723%26epage%3D1738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Becker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barta, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedell, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bond, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carron, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easton, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freskos, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funckes-Shippy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockerman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munie, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swearingen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villamil, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span> </span><span class="NLM_article-title">Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6653</span><span class="NLM_x">–</span> <span class="NLM_lpage">6680</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100669j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGjtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6653-6680&author=D.+P.+Beckerauthor=T.+E.+Bartaauthor=L.+J.+Bedellauthor=T.+L.+Boehmauthor=B.+R.+Bondauthor=J.+Carrollauthor=C.+P.+Carronauthor=G.+A.+DeCrescenzoauthor=A.+M.+Eastonauthor=J.+N.+Freskosauthor=C.+L.+Funckes-Shippyauthor=M.+Heronauthor=S.+Hockermanauthor=C.+P.+Howardauthor=J.+R.+Kieferauthor=M.+H.+Liauthor=K.+J.+Mathisauthor=J.+J.+McDonaldauthor=P.+P.+Mehtaauthor=G.+E.+Munieauthor=T.+Sunyerauthor=C.+A.+Swearingenauthor=C.+I.+Villamilauthor=D.+Welschauthor=J.+M.+Williamsauthor=Y.+Yuauthor=J.+Yao&title=Orally+active+MMP-1+sparing+%CE%B1-tetrahydropyranyl+and+%CE%B1-piperidinyl+sulfone+matrix+metalloproteinase+%28MMP%29+inhibitors+with+efficacy+in+cancer%2C+arthritis%2C+and+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Active MMP-1 Sparing α-Tetrahydropyranyl and α-Piperidinyl Sulfone Matrix Metalloproteinase (MMP) Inhibitors with Efficacy in Cancer, Arthritis, and Cardiovascular Disease</span></div><div class="casAuthors">Becker, Daniel P.; Barta, Thomas E.; Bedell, Louis J.; Boehm, Terri L.; Bond, Brian R.; Carroll, Jeffery; Carron, Chris P.; De Crescenzo, Gary A.; Easton, Alan M.; Freskos, John N.; Funckes-Shippy, Chris L.; Heron, Marcia; Hockerman, Susan; Howard, Carol Pearcy; Kiefer, James R.; Li, Madeleine H.; Mathis, Karl J.; McDonald, Joseph J.; Mehta, Pramod P.; Munie, Grace E.; Sunyer, Teresa; Swearingen, Craig A.; Villamil, Clara I.; Welsch, Dean; Williams, Jennifer M.; Yu, Ying; Yao, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6653-6680</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-hydroxy aryloxyarylsulfonyl pyrancarboxamides and piperidinecarboxamides such as I (R = MeOCH2CH2, cyclopropyl) are prepd. as selective matrix metalloproteinase (MMP) inhibitors avoiding nonselective MMP (in particular, MMP-1) inhibition for use as antitumor, antiarthritic, and cardiovascular agents.  The inhibition of MMPs 1, 2, 3, 7, 8, 9, 13, and 14 by N-hydroxy aryloxyarylsulfonyl pyrancarboxamides and piperidinecarboxamides is detd. as well as their calcd. lipophilicities; the pharmacokinetics, inhibition of human prostate, breast, and lung cancer cells, inhibition of cartilage degrdn., inhibition of ventricular dilation after myocardial infarction, and DSC calorimetric measurements for selected compds. are detd.  I (R = MeOCH2CH2) (SC-78080/SD-2590) was selected for development as an anticancer agent, while I (R = cyclopropyl) and an N-hydroxy trifluoromethylphenoxyphenylsulfonyl pyrancarboxamide were selected as backup compds.  The structure of I (R = MeOCH2CH2) bound to MMP-13 is detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY0b9GTt27EbVg90H21EOLACvtfcHk0lijMOVMX4toiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGjtbnJ&md5=0ee6c0fea7d5e86ff75095615dac8ec6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm100669j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100669j%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DD.%2BP.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DBedell%26aufirst%3DL.%2BJ.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DBond%26aufirst%3DB.%2BR.%26aulast%3DCarroll%26aufirst%3DJ.%26aulast%3DCarron%26aufirst%3DC.%2BP.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DEaston%26aufirst%3DA.%2BM.%26aulast%3DFreskos%26aufirst%3DJ.%2BN.%26aulast%3DFunckes-Shippy%26aufirst%3DC.%2BL.%26aulast%3DHeron%26aufirst%3DM.%26aulast%3DHockerman%26aufirst%3DS.%26aulast%3DHoward%26aufirst%3DC.%2BP.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DM.%2BH.%26aulast%3DMathis%26aufirst%3DK.%2BJ.%26aulast%3DMcDonald%26aufirst%3DJ.%2BJ.%26aulast%3DMehta%26aufirst%3DP.%2BP.%26aulast%3DMunie%26aufirst%3DG.%2BE.%26aulast%3DSunyer%26aufirst%3DT.%26aulast%3DSwearingen%26aufirst%3DC.%2BA.%26aulast%3DVillamil%26aufirst%3DC.%2BI.%26aulast%3DWelsch%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DJ.%26atitle%3DOrally%2520active%2520MMP-1%2520sparing%2520%25CE%25B1-tetrahydropyranyl%2520and%2520%25CE%25B1-piperidinyl%2520sulfone%2520matrix%2520metalloproteinase%2520%2528MMP%2529%2520inhibitors%2520with%2520efficacy%2520in%2520cancer%252C%2520arthritis%252C%2520and%2520cardiovascular%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6653%26epage%3D6680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Whittaker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gearing, A. J.</span><span> </span><span class="NLM_article-title">Design and therapeutic application of matrix metalloproteinase inhibitors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2735</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr9804543" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2735-76&issue=9&author=M.+Whittakerauthor=C.+D.+Floydauthor=P.+Brownauthor=A.+J.+Gearing&title=Design+and+therapeutic+application+of+matrix+metalloproteinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcr9804543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9804543%26sid%3Dliteratum%253Aachs%26aulast%3DWhittaker%26aufirst%3DM.%26aulast%3DFloyd%26aufirst%3DC.%2BD.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DGearing%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520therapeutic%2520application%2520of%2520matrix%2520metalloproteinase%2520inhibitors%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26issue%3D9%26spage%3D2735%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Rao, J. S.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of glioma invasiveness: the role of proteases</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1038%2Fnrc1121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=12835669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltVSqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=489-501&author=J.+S.+Rao&title=Molecular+mechanisms+of+glioma+invasiveness%3A+the+role+of+proteases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of glioma invasiveness: the role of proteases</span></div><div class="casAuthors">Rao, Jasti S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-501</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The invasive nature of brain-tumor cells makes an important contribution to the ineffectiveness of current treatment modalities, as the remaining tumor cells inevitably infiltrate the surrounding normal brain tissue, which leads to tumor recurrence.  Such local invasion remains an important cause of mortality and underscores the need to understand in more detail the mechanisms of tumor invasiveness.  Several proteases influence the malignant characteristics of gliomas - could their inhibition prove to be a useful therapeutic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0Ihtmy-XyXLVg90H21EOLACvtfcHk0lijMOVMX4toiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltVSqtr8%253D&md5=c4c2ca8344cdb4d7cac76899e319f7dc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrc1121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1121%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DJ.%2BS.%26atitle%3DMolecular%2520mechanisms%2520of%2520glioma%2520invasiveness%253A%2520the%2520role%2520of%2520proteases%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D489%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Kargiotis, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chetty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gondi, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsung, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gujrati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakka, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyritsis, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, J. S.</span><span> </span><span class="NLM_article-title">Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4830</span><span class="NLM_x">–</span> <span class="NLM_lpage">4840</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=4830-4840&author=O.+Kargiotisauthor=C.+Chettyauthor=C.+S.+Gondiauthor=A.+J.+Tsungauthor=D.+H.+Dinhauthor=M.+Gujratiauthor=S.+S.+Lakkaauthor=A.+P.+Kyritsisauthor=J.+S.+Rao&title=Adenovirus-mediated+transfer+of+siRNA+against+MMP-2+mRNA+results+in+impaired+invasion+and+tumor-induced+angiogenesis%2C+induces+apoptosis+in+vitro+and+inhibits+tumor+growth+in+vivo+in+glioblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKargiotis%26aufirst%3DO.%26aulast%3DChetty%26aufirst%3DC.%26aulast%3DGondi%26aufirst%3DC.%2BS.%26aulast%3DTsung%26aufirst%3DA.%2BJ.%26aulast%3DDinh%26aufirst%3DD.%2BH.%26aulast%3DGujrati%26aufirst%3DM.%26aulast%3DLakka%26aufirst%3DS.%2BS.%26aulast%3DKyritsis%26aufirst%3DA.%2BP.%26aulast%3DRao%26aufirst%3DJ.%2BS.%26atitle%3DAdenovirus-mediated%2520transfer%2520of%2520siRNA%2520against%2520MMP-2%2520mRNA%2520results%2520in%2520impaired%2520invasion%2520and%2520tumor-induced%2520angiogenesis%252C%2520induces%2520apoptosis%2520in%2520vitro%2520and%2520inhibits%2520tumor%2520growth%2520in%2520vivo%2520in%2520glioblastoma%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D4830%26epage%3D4840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Hagemann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anacker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riesner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schömig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernestus, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, G. H.</span><span> </span><span class="NLM_article-title">Comparative expression pattern of matrix-metalloproteinases in human glioblastoma cell-lines and primary cultures</span> <span class="citation_source-journal">BMC Res. Notes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1186%2F1756-0500-3-293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FhtlKitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=293-302&author=C.+Hagemannauthor=J.+Anackerauthor=S.+Haasauthor=D.+Riesnerauthor=B.+Sch%C3%B6migauthor=R.+I.+Ernestusauthor=G.+H.+Vince&title=Comparative+expression+pattern+of+matrix-metalloproteinases+in+human+glioblastoma+cell-lines+and+primary+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures</span></div><div class="casAuthors">Hagemann Carsten; Anacker Jelena; Haas Stefanie; Riesner Daniela; Schomig Beate; Ernestus Ralf-Ingo; Vince Giles H</div><div class="citationInfo"><span class="NLM_cas:title">BMC research notes</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">293</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Glioblastomas (GBM), the most frequent malignant brain tumors in adults, are characterized by an aggressive local growth pattern and highly invasive tumor cells.  This invasion is facilitated by expression of matrix metalloproteinases (MMPs), a family of zinc-dependent endopeptidases.  They mediate the degradation of protein components of the extracellular matrix.  Twenty-three family members are known.  Elevated levels of several of them have been reported in GBM.  GBM cell-lines are used for in vitro studies of cell migration and invasion.  Therefore, it is essential to know their MMP expression patterns.  Only limited data for some of the cell-lines are published, yet.  To fill the gaps in our knowledge would help to choose suitable model systems for analysis of regulation and function of MMPs during GBM tumorigenesis, cell migration and invasion.  FINDINGS:  We analysed MMP-1, -8, -9, -10, -11, -13, -17, -19, -20, -21, -23, -24, -26, -27, and MMP-28 expression in seven GBM cell-lines (SNB-19, GaMG, U251, U87, U373, U343, U138) and in four primary cell cultures by semiquantitative RT-PCR, followed changes in the MMP expression pattern with increasing passages of cell culture and examined the influence of TNF-α and TGF-β1 stimulation on the expression of selected MMPs in U251 and U373 cells.MMP-13, -17, -19 and -24 were expressed by all analyzed cell-lines, whereas MMP-20 and MMP-21 were not expressed by any of them.  The other MMPs showed variable expression, which was dependent on passage number.  Primary cells displayed a similar MMP-expression pattern as the cell-lines.  In U251 and U373 cells expression of MMP-9 and MMP-19 was stimulated by TNF-α.  MMP-1 mRNA expression was significantly increased in U373 cells, but not in U251 cells by this cytokine.  Whereas TGF-β1 had no impact on MMP expression in U251 cells, it significantly induced MMP-11 and MMP-24 expression in U373 cells.  CONCLUSIONS:  Literature-data and our own results suggest that the expression pattern of MMPs is highly variable, dependent on the cell-line and the cell-culture conditions used and that also regulation of MMP expression by cytokines is cell-line dependent.  This is of high impact for the transfer of cell-culture experiments to clinical implementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThq87MBnawGs-crCu0nI_sfW6udTcc2ebGvof5sEmQWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FhtlKitQ%253D%253D&md5=088dc409eb8656210335d6cce9acb8bc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1186%2F1756-0500-3-293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-0500-3-293%26sid%3Dliteratum%253Aachs%26aulast%3DHagemann%26aufirst%3DC.%26aulast%3DAnacker%26aufirst%3DJ.%26aulast%3DHaas%26aufirst%3DS.%26aulast%3DRiesner%26aufirst%3DD.%26aulast%3DSch%25C3%25B6mig%26aufirst%3DB.%26aulast%3DErnestus%26aufirst%3DR.%2BI.%26aulast%3DVince%26aufirst%3DG.%2BH.%26atitle%3DComparative%2520expression%2520pattern%2520of%2520matrix-metalloproteinases%2520in%2520human%2520glioblastoma%2520cell-lines%2520and%2520primary%2520cultures%26jtitle%3DBMC%2520Res.%2520Notes%26date%3D2010%26volume%3D3%26spage%3D293%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Aime, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digilio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasano, M.</span><span> </span><span class="NLM_article-title">Modulation of the antioxidant activity of HO<sup>•</sup> scavengers by albumin binding: a <sup>19</sup>F NMR study</span> <span class="citation_source-journal">Biochim. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">962</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2FS0006-291X%2803%2901307-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=12878205" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2003&pages=962-966&author=S.+Aimeauthor=G.+Digilioauthor=E.+Brunoauthor=V.+Maineroauthor=S.+Baroniauthor=M.+Fasano&title=Modulation+of+the+antioxidant+activity+of+HO%E2%80%A2+scavengers+by+albumin+binding%3A+a+19F+NMR+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2901307-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252901307-X%26sid%3Dliteratum%253Aachs%26aulast%3DAime%26aufirst%3DS.%26aulast%3DDigilio%26aufirst%3DG.%26aulast%3DBruno%26aufirst%3DE.%26aulast%3DMainero%26aufirst%3DV.%26aulast%3DBaroni%26aufirst%3DS.%26aulast%3DFasano%26aufirst%3DM.%26atitle%3DModulation%2520of%2520the%2520antioxidant%2520activity%2520of%2520HO%25E2%2580%25A2%2520scavengers%2520by%2520albumin%2520binding%253A%2520a%252019F%2520NMR%2520study%26jtitle%3DBiochim.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D307%26spage%3D962%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Rational design of diflunisal analogues with reduced affinity for human serum albumin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x"> (</span><span class="NLM_issue">43</span><span class="NLM_x">) </span> <span class="NLM_fpage">10429</span><span class="NLM_x">–</span> <span class="NLM_lpage">10435</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja015955b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=10429-10435&issue=43&author=H.+Maoauthor=P.+J.+Hajdukauthor=R.+Craigauthor=R.+Bellauthor=T.+Borreauthor=S.+W.+Fesik&title=Rational+design+of+diflunisal+analogues+with+reduced+affinity+for+human+serum+albumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja015955b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja015955b%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DH.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DCraig%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DR.%26aulast%3DBorre%26aufirst%3DT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DRational%2520design%2520of%2520diflunisal%2520analogues%2520with%2520reduced%2520affinity%2520for%2520human%2520serum%2520albumin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26issue%3D43%26spage%3D10429%26epage%3D10435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Ghuman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunszain, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petitpas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otagiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, S.</span><span> </span><span class="NLM_article-title">Structural basis of the drug-binding specificity of human serum albumin</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2Fj.jmb.2005.07.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=16169013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVensrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=38-52&author=J.+Ghumanauthor=P.+A.+Zunszainauthor=I.+Petitpasauthor=A.+A.+Bhattacharyaauthor=M.+Otagiriauthor=S.+Curry&title=Structural+basis+of+the+drug-binding+specificity+of+human+serum+albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of the Drug-binding Specificity of Human Serum Albumin</span></div><div class="casAuthors">Ghuman, Jamie; Zunszain, Patricia A.; Petitpas, Isabelle; Bhattacharya, Ananyo A.; Otagiri, Masaki; Curry, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-52</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human serum albumin (HSA) is an abundant plasma protein that binds a remarkably wide range of drugs, thereby restricting their free, active concns.  The problem of overcoming the binding affinity of lead compds. for HSA represents a major challenge in drug development.  Crystallog. anal. of 17 different complexes of HSA with a wide variety of drugs and small-mol. toxins reveals the precise architecture of the two primary drug-binding sites on the protein, identifying residues that are key determinants of binding specificity and illuminating the capacity of both pockets for flexible accommodation.  Numerous secondary binding sites for drugs distributed across the protein have also been identified.  The binding of fatty acids, the primary physiol. ligand for the protein, is shown to alter the polarity and increase the vol. of drug site 1.  These results clarify the interpretation of accumulated drug binding data and provide a valuable template for design efforts to modulate the interaction with HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyKWUfReJZ-bVg90H21EOLACvtfcHk0lifXhPP-kebaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVensrbJ&md5=d82105920c360292329bf509667df42f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.07.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.07.075%26sid%3Dliteratum%253Aachs%26aulast%3DGhuman%26aufirst%3DJ.%26aulast%3DZunszain%26aufirst%3DP.%2BA.%26aulast%3DPetitpas%26aufirst%3DI.%26aulast%3DBhattacharya%26aufirst%3DA.%2BA.%26aulast%3DOtagiri%26aufirst%3DM.%26aulast%3DCurry%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520of%2520the%2520drug-binding%2520specificity%2520of%2520human%2520serum%2520albumin%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D353%26spage%3D38%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Prante, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tietze, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harald, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-<i>a</i>]pyridine-based dopamine D4 receptor ligands: discovery of an inverse agonist radioligand for PET</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1800</span><span class="NLM_x">–</span> <span class="NLM_lpage">1810</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701375u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1800-1810&author=O.+Pranteauthor=R.+Tietzeauthor=C.+Hockeauthor=S.+L%C3%B6berauthor=H.+Haraldauthor=T.+Kuwertauthor=P.+Gmeiner&title=Synthesis%2C+radiofluorination%2C+and+in+vitro+evaluation+of+pyrazolo%5B1%2C5-a%5Dpyridine-based+dopamine+D4+receptor+ligands%3A+discovery+of+an+inverse+agonist+radioligand+for+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm701375u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701375u%26sid%3Dliteratum%253Aachs%26aulast%3DPrante%26aufirst%3DO.%26aulast%3DTietze%26aufirst%3DR.%26aulast%3DHocke%26aufirst%3DC.%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DHarald%26aufirst%3DH.%26aulast%3DKuwert%26aufirst%3DT.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520radiofluorination%252C%2520and%2520in%2520vitro%2520evaluation%2520of%2520pyrazolo%255B1%252C5-a%255Dpyridine-based%2520dopamine%2520D4%2520receptor%2520ligands%253A%2520discovery%2520of%2520an%2520inverse%2520agonist%2520radioligand%2520for%2520PET%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1800%26epage%3D1810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Snoek-van Beurden, P. A. M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von den Hoff, J. W.</span><span> </span><span class="NLM_article-title">Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors</span> <span class="citation_source-journal">BioTechniques</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.2144%2F05381RV01" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=15679089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptV2ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2005&pages=73-83&author=P.+A.+M+Snoek-van+Beurdenauthor=J.+W.+Von+den+Hoff&title=Zymographic+techniques+for+the+analysis+of+matrix+metalloproteinases+and+their+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors</span></div><div class="casAuthors">Snoek-van Beurden, Patricia A. M.; Von den Hoff, Johannes W.</div><div class="citationInfo"><span class="NLM_cas:title">BioTechniques</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-83</span>CODEN:
                <span class="NLM_cas:coden">BTNQDO</span>;
        ISSN:<span class="NLM_cas:issn">0736-6205</span>.
    
            (<span class="NLM_cas:orgname">Informa Life Sciences Publishing</span>)
        </div><div class="casAbstract">A review.  The balance between matrix metalloproteinases (MMPs) and their inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), is largely responsible for the remodeling of tissues.  Deregulation of this balance is a characteristic of extensive tissue degrdn. in certain degenerative diseases.  To analyze the role of MMPs and TIMPs in tissue remodeling under normal and pathol. conditions, it is important to have reliable detection methods.  This review will focus on zymog. techniques for the anal. of MMPs and TIMPs.  MMPs can be analyzed with several zymog. techniques, but substrate zymog. is the most commonly used.  This technique identifies MMPs by the degrdn. of their preferential substrate and by their mol. wt.  Several substrates that can be used for zymog. are described.  Reverse zymog., which detects TIMPs by their ability to inhibit MMPs, is also discussed.  Finally, in situ zymog. is described, which is used to localize MMPs in tissue sections.  Common problems encountered during sample prepn., zymog. itself, and the data anal. are discussed.  Hints are given to improve the sensitivity and accuracy of zymog. methods.  In conclusion, zymog. is a valuable tool for research purposes and for the development of new diagnostic techniques and therapies for pathol. conditions such as rheumatoid and osteoarthritis, and tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUS7ALr7ZTqLVg90H21EOLACvtfcHk0lgk1x0lfm_Oew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptV2ltA%253D%253D&md5=94aeaaf26a5ac45a2fad863168228fac</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2144%2F05381RV01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2144%252F05381RV01%26sid%3Dliteratum%253Aachs%26aulast%3DSnoek-van%2BBeurden%26aufirst%3DP.%2BA.%2BM%26aulast%3DVon%2Bden%2BHoff%26aufirst%3DJ.%2BW.%26atitle%3DZymographic%2520techniques%2520for%2520the%2520analysis%2520of%2520matrix%2520metalloproteinases%2520and%2520their%2520inhibitors%26jtitle%3DBioTechniques%26date%3D2005%26volume%3D38%26spage%3D73%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Sprague, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achilefu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2Fj.nucmedbio.2005.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=16546677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ehsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=227-237&author=J.+E.+Spragueauthor=W.+P.+Liauthor=K.+Liangauthor=S.+Achilefuauthor=C.+J.+Anderson&title=In+vitro+and+in+vivo+investigation+of+matrix+metalloproteinase+expression+in+metastatic+tumor+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models</span></div><div class="casAuthors">Sprague, Jennifer E.; Li, Wen Ping; Liang, Kexian; Achilefu, Samuel; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-237</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: Overexpression of matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, has been correlated with poor prognosis in several cancer types including lung, colon and breast.  Noninvasive detection of MMP expression might allow physicians to better det. when more aggressive cancer therapy is appropriate.  The peptide CTT (CTTHWGFTLC) was identified as a selective inhibitor of MMP-2/9 that inhibits the growth of MDA-MB-435 human breast cancer xenografts.  Methods: CTT was conjugated with the bifunctional chelator DOTA (1,4,7,10-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid) for radiolabeling with 64Cu (t1/2=12.7 h, 17.4% β+, 39% β-), a radionuclide suitable for positron emission tomog. (PET).  In vitro affinity was detd. in a fluorogenic substrate assay.  Tumor gelatinase targeting was evaluated in both biodistribution and microPET imaging studies.  Results: Cu(II)-DOTA-CTT inhibited hMMP-2 (EC50=8.7 μM) and mMMP-9 (EC50=18.2 μM) with similar affinity to CTT (hMMP-2 EC50=13.2 μM; mMMP-9 EC50=11.0 μM).  In biodistribution and microPET imaging studies, 64Cu-DOTA-CTT was taken up by MMP-2/9-pos. B16F10 murine melanoma tumors.  Subsequently, imaging studies using 64Cu-DOTA-CTT were performed on MDA-MB-435 tumor-bearing mice.  With zymog., tumor MMP-2/9 expression in this model was shown to be inconsistent, resulting in microPET detection of the MDA-MB-435 tumor in only 1 of 24 imaged mice.  Following limited imaging success, 64Cu-DOTA-CTT was shown to have poor in vivo stability.  Conclusions: Despite some evidence for selective uptake of 64Cu-DOTA-CTT by gelatinase-expressing tumors, the low affinity for MMP-2 and MMP-9 and in vivo instability make this an inadequate radioligand for in vivo tumor evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojHVJUHQCiibVg90H21EOLACvtfcHk0lgk1x0lfm_Oew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ehsbo%253D&md5=7370ca0758d2e32e2e2554fba34ca003</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2005.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2005.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DSprague%26aufirst%3DJ.%2BE.%26aulast%3DLi%26aufirst%3DW.%2BP.%26aulast%3DLiang%26aufirst%3DK.%26aulast%3DAchilefu%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520investigation%2520of%2520matrix%2520metalloproteinase%2520expression%2520in%2520metastatic%2520tumor%2520models%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2006%26volume%3D33%26spage%3D227%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Nakada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span> </span><span class="NLM_article-title">Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2FS0002-9440%2810%2965288-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=10027400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVCqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1999&pages=417-428&author=M.+Nakadaauthor=H.+Nakamuraauthor=E.+Ikedaauthor=N.+Fujimotoauthor=J.+Yamashitaauthor=H.+Satoauthor=M.+Seikiauthor=Y.+Okada&title=Expression+and+tissue+localization+of+membrane-type+1%2C+2%2C+and+3+matrix+metalloproteinases+in+human+astrocytic+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors</span></div><div class="casAuthors">Nakada, Mitsutoshi; Nakamura, Hiroyuki; Ikeda, Eiji; Fujimoto, Noboru; Yamashita, Junkoh; Sato, Hiroshi; Seiki, Motoharu; Okada, Yasunori</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">417-428</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Three different membrane-type matrix metalloproteinases (MT1-, MT2-, and MT3-MMPs) are known to activate in vitro the zymogen of MMP-2 (pro-MMP-2, progelatinase A), which is one of the key MMPs in invasion and metastasis of various cancers.  In the present study, we have examd. prodn. and activation of pro-MMP-2, expression of MT1-, MT2-, and MT3-MMPs and their correlation with pro-MMP-2 activation, and localization of MMP-2, MT1-MMP, and MT2-MMP in human astrocytic tumors.  The sandwich enzyme immunoassay demonstrates that the prodn. levels of pro-MMP-2 in the anaplastic astrocytomas and glioblastomas are significantly higher than that in the low-grade astrocytomas (P < 0.05 and P < 0.01, resp.), metastatic brain tumors (P < 0.05), or normal brains (P < 0.01).  Gelatin zymog. indicates that the pro-MMP-2 activation ratio is significantly higher in the glioblastomas than in other astrocytic tumors (P < 0.01), metastatic brain tumors (P < 0.01), and normal brains (P < 0.01).  The quant. reverse transcription polymerase chain reaction analyses demonstrate that MT1-MMP and MT2-MMP are expressed predominantly in glioblastoma tissues (17/17 and 12/17 cases, resp.), and their expression levels increase significantly as tumor grade increases.  MT3-MMP is detectable in both astrocytic tumor and normal brain tissues, but the mean expression level is approx. 50-fold lower compared with that of MT1-MMP and MT2-MMP in the glioblastomas.  The activation ratio of pro-MMP-2 correlates directly with the expression levels of MT1-MMP and MT2-MMP but not MT3-MMP.  In situ hybridization indicates that neoplastic astrocytes express MT1-MMP and MT2-MMP in the glioblastoma tissues (5/5 cases and 5/5 cases, resp.).  Immunohistochem., MT1-MMP and MT2-MMP are localized to the neoplastic astrocytes in glioblastoma samples (17/17 cases and 12/17 cases, resp.), which are also pos. for MMP-2.  In situ zymog. shows gelatinolytic activity in the glioblastoma tissue but not in the normal brain tissues.  These results suggest that both MT1-MMP and MT2-MMP play a key role in the activation of pro-MMP-2 in the human malignant astrocytic tumors and that the gelatinolytic activity is involved in the astrocytic tumor invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWKt8J-fK6gLVg90H21EOLACvtfcHk0lgk1x0lfm_Oew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVCqsbc%253D&md5=3cf22920c1fe68f334e41edd3dba7003</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2965288-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252965288-1%26sid%3Dliteratum%253Aachs%26aulast%3DNakada%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DE.%26aulast%3DFujimoto%26aufirst%3DN.%26aulast%3DYamashita%26aufirst%3DJ.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DSeiki%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DY.%26atitle%3DExpression%2520and%2520tissue%2520localization%2520of%2520membrane-type%25201%252C%25202%252C%2520and%25203%2520matrix%2520metalloproteinases%2520in%2520human%2520astrocytic%2520tumors%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1999%26volume%3D154%26spage%3D417%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Somiari, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somiari, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shriver, C. D.</span><span> </span><span class="NLM_article-title">Circulating MMP2 and MMP9 in breast cancer—Potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1403</span><span class="NLM_x">–</span> <span class="NLM_lpage">1411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1002%2Fijc.21989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=16615109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVOqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2006&pages=1403-1411&author=S.+B.+Somiariauthor=R.+I.+Somiariauthor=C.+M.+Heckmanauthor=C.+H.+Olsenauthor=R.+M.+Jordanauthor=S.+J.+Russellauthor=C.+D.+Shriver&title=Circulating+MMP2+and+MMP9+in+breast+cancer%E2%80%94Potential+role+in+classification+of+patients+into+low+risk%2C+high+risk%2C+benign+disease+and+breast+cancer+categories"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Circulating MMP2 and MMP9 in breast cancer-potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories</span></div><div class="casAuthors">Somiari, Stella B.; Somiari, Richard I.; Heckman, Caroline M.; Olsen, Cara H.; Jordan, Rick M.; Russell, Stephen J.; Shriver, Craig D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1403-1411</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Matrix metalloproteinase (MMP) 2 and 9 are involved in cancer invasion and metastasis, and increased levels occur in serum and plasma of breast cancer (BC) patients.  It is, however, unclear whether changes in serum levels can be exploited for early detection or classification of patients into different risk/disease categories.  In our study, we measured concn. and activity of MMP2/9 in sera of 345 donors classified as low risk (Gail score < 1.7), high risk (HR) (Gail score ≥ 1.7), benign disease or BC.  Kruskal-Wallis and Mann-Whitney nonparametric tests showed that total MMP2 concn. is higher in HR compared to control (p = 0.012), benign (p = 0.001) and cancer (p = 0.007).  Active MMP2 (aMMP2) concn. is higher in control than benign and cancer (p < 0.001, resp.).  Total and aMMP9 concns. are higher in cancer than benign (p < 0.001, p = 0.002, resp.).  Total MMP2 and total-MMP9 activities are lower in control than benign (p < 0.001, p = 0.002, resp.) and cancer (p < 0.001, resp.).  Total MMP2 and MMP9 activities are also higher in cancer than benign (p = 0.004, p < 0.001) and HR (p = 0.008, p = 0.007, resp.).  These results were not affected by age or inclusion/exclusion of donors with noninvasive cancer or atypical hyperplasia.  Linear discriminant anal. revealed that HR donors are characterized by lower total MMP2 and higher aMMP2.  Overall group classification accuracy was 64.5%.  Independent validation based on the leave-one-out cross validation approach gave an overall classification of 63%.  Our study provides evidence supporting the potential role of serum MMP2/9 as biomarkers for breast disease classification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrURuiyLqW0tbVg90H21EOLACvtfcHk0lgk1x0lfm_Oew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVOqs7s%253D&md5=525c15c0eeda1f940e82fdd159a12c18</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fijc.21989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.21989%26sid%3Dliteratum%253Aachs%26aulast%3DSomiari%26aufirst%3DS.%2BB.%26aulast%3DSomiari%26aufirst%3DR.%2BI.%26aulast%3DHeckman%26aufirst%3DC.%2BM.%26aulast%3DOlsen%26aufirst%3DC.%2BH.%26aulast%3DJordan%26aufirst%3DR.%2BM.%26aulast%3DRussell%26aufirst%3DS.%2BJ.%26aulast%3DShriver%26aufirst%3DC.%2BD.%26atitle%3DCirculating%2520MMP2%2520and%2520MMP9%2520in%2520breast%2520cancer%25E2%2580%2594Potential%2520role%2520in%2520classification%2520of%2520patients%2520into%2520low%2520risk%252C%2520high%2520risk%252C%2520benign%2520disease%2520and%2520breast%2520cancer%2520categories%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2006%26volume%3D119%26spage%3D1403%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Eckelman, W.</span><span> </span><span class="NLM_article-title">The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2F0969-8051%2894%2990047-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=9241652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADyaK2cXlslCjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1994&pages=759-769&author=W.+Eckelman&title=The+application+of+receptor+theory+to+receptor-binding+and+enzyme-binding+oncologic+radiopharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals</span></div><div class="casAuthors">Eckelman, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">759-69</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    </div><div class="casAbstract">The successful imaging of tumor biochem. using a receptor binding radiotracer is related to the affinity const. and the receptor concn.  The target to nontarget ratio can be predicted by steady state equations using in vitro data, although this is a necessary but not sufficient upper limit.  The prediction of the sensitivity of the radiopharmaceutical to changes in the tumor biochem. is not possible with this evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovFsE7elk1trVg90H21EOLACvtfcHk0lgdt1bs3aPTVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslCjurg%253D&md5=fb299f06ae2d8b06f41a3f9147955a2f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2F0969-8051%2894%2990047-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0969-8051%252894%252990047-7%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DW.%26atitle%3DThe%2520application%2520of%2520receptor%2520theory%2520to%2520receptor-binding%2520and%2520enzyme-binding%2520oncologic%2520radiopharmaceuticals%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1994%26volume%3D21%26spage%3D759%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Woessner, J. F.,  Jr.</span><span> </span><span class="NLM_article-title">Quantification of matrix metalloproteinases in tissue samples</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">510</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2F0076-6879%2895%2948033-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=7674942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADyaK2MXptVShsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1995&pages=510-528&author=J.+F.+Woessner&title=Quantification+of+matrix+metalloproteinases+in+tissue+samples"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of matrix metalloproteinases in tissue samples</span></div><div class="casAuthors">Woessner, J. Frederick Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue">Proteolytic Enzymes: Aspartic and Metallo Peptidases</span>),
    <span class="NLM_cas:pages">510-28</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A discussion of how to ext. matrix metalloproteinases, how to check for completeness of extn., how to activate latent forms, and how to remove or destroy inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFgq3KZW551rVg90H21EOLACvtfcHk0lgdt1bs3aPTVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptVShsL4%253D&md5=d1165eb6377a87513c8d4578f54bffc6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2895%2948033-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252895%252948033-1%26sid%3Dliteratum%253Aachs%26aulast%3DWoessner%26aufirst%3DJ.%2BF.%26atitle%3DQuantification%2520of%2520matrix%2520metalloproteinases%2520in%2520tissue%2520samples%26jtitle%3DMethods%2520Enzymol.%26date%3D1995%26volume%3D248%26spage%3D510%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Fukuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, K.</span><span> </span><span class="NLM_article-title">New radiopharmaceuticals for cancer imaging and biological characterization using PET</span> <span class="citation_source-journal">Int. Congr. Ser.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1264</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2Fj.ics.2004.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVOgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1264&publication_year=2004&pages=158-165&author=H.+Fukudaauthor=S.+Furumotoauthor=R.+Iwataauthor=K.+Kubota&title=New+radiopharmaceuticals+for+cancer+imaging+and+biological+characterization+using+PET"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">New radiopharmaceuticals for cancer imaging and biological characterization using PET</span></div><div class="casAuthors">Fukuda, Hiroshi; Furumoto, Shozo; Iwata, Ren; Kubota, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">International Congress Series</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1264</span>
        (<span class="NLM_cas:issue">PET and Molecular Imaging</span>),
    <span class="NLM_cas:pages">158-165</span>CODEN:
                <span class="NLM_cas:coden">EXMDA4</span>;
        ISSN:<span class="NLM_cas:issn">0531-5131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Recent developments and future aspects of positron emission tomog. (PET) in oncol. were reviewed and discussed, focusing on the development of new radiopharmaceuticals for cancer imaging and its biol. characterization.  Because of increased amino acid transport and protein synthesis in cancers, amino acid tracers are useful for cancer imaging.  Unlike F-18 FDG, the uptake of amino acid tracers in inflammatory tissues is relatively low compared with that in tumor tissues.  We have recently synthesized F-18 fluoromethyltyrosine (F-18 FMT).  Biodistribution study and autoradiog. (ARG) revealed that its uptake in tumor tissues was sufficiently high with lower uptake in inflammatory tissues and normal organs, except the pancreas.  Extracellular matrix proteinase plays an important role in the invasion, metastasis and neovascularization of cancer cells.  To measure the enzyme activity in tumors using PET, we developed F-18 SAV03M, which is an inhibitor of matrix metalloproteinase inhibitor.  Biodistribution studies revealed that tumor-to-blood and tumor-to-muscle ratios of 2.8 and 13.9, resp., were obtained 120 min after tracer injection.  ARG showed inhomogeneous radioactivity within a tumor, which may reflect an inhomogeneous distribution of enzyme activity within a tumor tissue.  These results indicate that F-18 FMT and F-18 SAV03M will be promising for in vivo imaging and biol. characterization of cancer using PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7bkwO_cmAu7Vg90H21EOLACvtfcHk0lgdt1bs3aPTVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVOgsL0%253D&md5=7ebb9fa13f81c5006e3b0be5d82ec58e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ics.2004.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ics.2004.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DFukuda%26aufirst%3DH.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DKubota%26aufirst%3DK.%26atitle%3DNew%2520radiopharmaceuticals%2520for%2520cancer%2520imaging%2520and%2520biological%2520characterization%2520using%2520PET%26jtitle%3DInt.%2520Congr.%2520Ser.%26date%3D2004%26volume%3D1264%26spage%3D158%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Galardy, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassabonne, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapierre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, Schaeffer, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tressler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellot, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barletta, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foellmer, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobelny, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holleran, W. M.</span><span> </span><span class="NLM_article-title">Low molecular weight inhibitors in corneal ulceration</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">732</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=732&publication_year=1994&pages=315-323&author=R.+E.+Galardyauthor=M.+E.+Cassabonneauthor=C.+Gieseauthor=J.+H.+Gilbertauthor=F.+Lapierreauthor=M.+E.+Lopez%2C+Schaefferauthor=R.+Stackauthor=M.+Sullivanauthor=B.+Summersauthor=R.+Tresslerauthor=D.+Tyrrellauthor=J.+Weeauthor=S.+D.+Allenauthor=J.+J.+Castellotauthor=J.+P.+Barlettaauthor=G.+S.+Schultzauthor=L.+A.+Fernandezauthor=S.+Fisherauthor=T.-Y.+Cuiauthor=H.+G.+Foellmerauthor=D.+Grobelnyauthor=W.+M.+Holleran&title=Low+molecular+weight+inhibitors+in+corneal+ulceration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalardy%26aufirst%3DR.%2BE.%26aulast%3DCassabonne%26aufirst%3DM.%2BE.%26aulast%3DGiese%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DJ.%2BH.%26aulast%3DLapierre%26aufirst%3DF.%26aulast%3DLopez%252C%2BSchaeffer%26aufirst%3DM.%2BE.%26aulast%3DStack%26aufirst%3DR.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DSummers%26aufirst%3DB.%26aulast%3DTressler%26aufirst%3DR.%26aulast%3DTyrrell%26aufirst%3DD.%26aulast%3DWee%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DS.%2BD.%26aulast%3DCastellot%26aufirst%3DJ.%2BJ.%26aulast%3DBarletta%26aufirst%3DJ.%2BP.%26aulast%3DSchultz%26aufirst%3DG.%2BS.%26aulast%3DFernandez%26aufirst%3DL.%2BA.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DT.-Y.%26aulast%3DFoellmer%26aufirst%3DH.%2BG.%26aulast%3DGrobelny%26aufirst%3DD.%26aulast%3DHolleran%26aufirst%3DW.%2BM.%26atitle%3DLow%2520molecular%2520weight%2520inhibitors%2520in%2520corneal%2520ulceration%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1994%26volume%3D732%26spage%3D315%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Gringeri, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menchise, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzitelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cittadino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catanzaro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaabane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digilio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aime, S.</span><span> </span><span class="NLM_article-title">Novel Gd(III)-based probes for MR molecular imaging of matrix metalloproteinases</span> <span class="citation_source-journal">Contrast Media Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1002%2Fcmmi.478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=22434630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFWntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=175-184&issue=2&author=C.+V.+Gringeriauthor=V.+Menchiseauthor=S.+Rizzitelliauthor=E.+Cittadinoauthor=V.+Catanzaroauthor=G.+Datiauthor=L.+Chaabaneauthor=G.+Digilioauthor=S.+Aime&title=Novel+Gd%28III%29-based+probes+for+MR+molecular+imaging+of+matrix+metalloproteinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Gd(III)-based probes for MR molecular imaging of matrix metalloproteinases</span></div><div class="casAuthors">Gringeri, Concetta V.; Menchise, Valeria; Rizzitelli, Silvia; Cittadino, Evelina; Catanzaro, Valeria; Dati, Gabriele; Chaabane, Linda; Digilio, Giuseppe; Aime, Silvio</div><div class="citationInfo"><span class="NLM_cas:title">Contrast Media & Molecular Imaging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-184</span>CODEN:
                <span class="NLM_cas:coden">CMMICO</span>;
        ISSN:<span class="NLM_cas:issn">1555-4309</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Two novel Gd-based contrast agents (CAs) for the mol. imaging of matrix metalloproteinases (MMPs) were synthesized and characterized in vitro and in vivo.  These probes were based on the PLG*LWAR peptide sequence, known to be hydrolyzed between Gly and Leu by a broad panel of MMPs.  A Gd-DOTA chelate was conjugated to the N-terminal position through an amide bond, either directly to proline (compd. Gd-K11) or through a hydrophilic spacer (compd. Gd-K11N).  Both CA were made strongly amphiphilic by conjugating an alkyl chain at the C-terminus of the peptide sequence.  Gd-K11 and Gd-K11N have a good affinity for β-cyclodextrins (KD 310 and 670 μM, resp.) and for serum albumin (KD 350 and 90 μM, resp.), and can be efficiently cleaved in vitro at the expected site by MMP-2 and MMP-12.  Upon MMP-dependent cleavage, the CAs lose the C-terminal tetrapeptide and the alkyl chain, thus undergoing to an amphiphilic-to-hydrophilic transformation that is expected to alter tissue pharmacokinetics.  To prove this, Gd-K11 was systemically administered to mice bearing a s.c. B16.F10 melanoma, either pre-treated or not with the broad spectrum MMP inhibitor GM6001 (Ilomastat).  The washout of the Gd-contrast enhancement in MR images was significantly faster for untreated subjects (displaying MMP activity) with respect to treated ones (MMP activity inhibited).  The washout kinetics of Gd-contrast enhancement from the tumor microenvironment could be then interpreted in terms of the local activity of MMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN-0RZaXwFdrVg90H21EOLACvtfcHk0lglO4GFZgNtbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFWntLw%253D&md5=39372b888bc63cd03e20216035d64b08</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fcmmi.478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmmi.478%26sid%3Dliteratum%253Aachs%26aulast%3DGringeri%26aufirst%3DC.%2BV.%26aulast%3DMenchise%26aufirst%3DV.%26aulast%3DRizzitelli%26aufirst%3DS.%26aulast%3DCittadino%26aufirst%3DE.%26aulast%3DCatanzaro%26aufirst%3DV.%26aulast%3DDati%26aufirst%3DG.%26aulast%3DChaabane%26aufirst%3DL.%26aulast%3DDigilio%26aufirst%3DG.%26aulast%3DAime%26aufirst%3DS.%26atitle%3DNovel%2520Gd%2528III%2529-based%2520probes%2520for%2520MR%2520molecular%2520imaging%2520of%2520matrix%2520metalloproteinases%26jtitle%3DContrast%2520Media%2520Mol.%2520Imaging%26date%3D2012%26volume%3D7%26issue%3D2%26spage%3D175%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Hugenberg, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyholz, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riemann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4714</span><span class="NLM_x">–</span> <span class="NLM_lpage">4727</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300199g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hugenberg%2C+V.%3B+Breyholz%2C+H.-J.%3B+Riemann%2C+B.%3B+Hermann%2C+S.%3B+Schober%2C+O.%3B+Sch%C3%A4fers%2C+M.%3B+Gangadharmath%2C+U.%3B+Mocharla%2C+V.%3B+Kolb%2C+H.%3B+Walsh%2C+J.%3B+Zhang%2C+W.%3B+Kopka%2C+K.%3B+Wagner%2C+S.J.+Med.+Chem.+2012%2C+55%2C+4714%E2%80%934727"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm300199g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300199g%26sid%3Dliteratum%253Aachs%26aulast%3DHugenberg%26aufirst%3DV.%26aulast%3DBreyholz%26aufirst%3DH.-J.%26aulast%3DRiemann%26aufirst%3DB.%26aulast%3DHermann%26aufirst%3DS.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DMocharla%26aufirst%3DV.%26aulast%3DKolb%26aufirst%3DH.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DKopka%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DS.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4714%26epage%3D4727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Zheng, Q.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGrado, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baity, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glick-Wilson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sledge, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, G. D.</span><span> </span><span class="NLM_article-title">Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2<i>R</i>)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [<sup>11</sup>C]methyl ester</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1016%2FS0969-8051%2803%2900086-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=14499334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Gku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=753-760&author=Q.-H.+Zhengauthor=X.+Feiauthor=T.+R.+DeGradoauthor=J.-Q.+Wangauthor=K.+L.+Stoneauthor=T.+D.+Martinezauthor=D.+J.+Gayauthor=W.+L.+Baityauthor=B.+H.+Mockauthor=B.+E.+Glick-Wilsonauthor=M.+L.+Sullivanauthor=K.+D.+Millerauthor=G.+W.+Sledgeauthor=G.+D.+Hutchins&title=Synthesis%2C+biodistribution+and+micro-PET+imaging+of+a+potential+cancer+biomarker+carbon-11+labeled+MMP+inhibitor+%282R%29-2-%5B%5B4-%286-fluorohex-1-ynyl%29phenyl%5Dsulfonylamino%5D-3-methylbutyric+acid+%5B11C%5Dmethyl+ester"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester</span></div><div class="casAuthors">Zheng, Qi-Huang; Fei, Xiangshu; DeGrado, Timothy R.; Wang, Ji-Quan; Stone, K. Lee; Martinez, Tanya D.; Gay, Dawn J.; Baity, Winston L.; Mock, Bruce H.; Glick-Wilson, Barbara E.; Sullivan, Michael L.; Miller, Kathy D.; Sledge, George W.; Hutchins, Gary D.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">753-760</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">(2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester ([11C]FMAME), a novel carbon-11 labeled matrix metalloproteinase (MMP) inhibitor, has been synthesized for evaluation as new potential positron emission tomog. (PET) cancer biomarker.  [11C]FMAME was prepd. by appropriate precursor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid (FMA), which was synthesized in six steps from (D)-valine in 71% chem. yield.  This acid precursor was labeled by [11C]methyl triflate through O-[11C]methylation method under basic conditions and isolated by solid-phase extn. (SPE) purifn. to produce pure target compd. in 40-55% radiochem. yield, based on 11CO2, decay cor. to end of bombardment, and 15-20 min synthesis time.  The biodistribution of [11C]FMAME was detd. at 30 min post IV injection in breast cancer animal models MCF-7 transfected with IL-1α implanted athymic mice and MDA-MB-435 implanted athymic mice.  The results showed the uptakes of [11C]FMAME in these tumors were 1.13% dose/g in MCF-7 transfected with IL-1α implanted mice and 1.37% dose/g in MDA-MB-435 implanted mice, resp.; the ratios of tumor/muscle (T/M) and tumor/blood (T/B) were 1.05 ± 0.29 (T/M, MCF-7's), 0.77 ± 0.20 (T/B, MCF-7's) and 0.99 ± 0.35 (T/M, MDA-MB-435), 1.44 ± 0.69 (T/B, MDA-MB-435), resp.  Pretreatment of MCF-7 transfected with IL-1α tumor-bearing mice with MMP inhibitor FMA had no effect on [11C]FMAME biodistribution.  Likewise, pretreatment of MDA-MB-435 tumor-bearing mice with FMA also showed no effect on [11C]FMAME biodistribution.  The micro-PET images were acquired for 15 min from a MCF-7 transfected with IL-1α tumor-bearing mouse or a MDA-MB-435 tumor-bearing mouse at 30 min post IV injection of 1 mCi of [11C]FMAME using a dedicated high resoln. (<3 mm full-width at half-max.) PET imaging system (Indy-PET II scanner).  The initial dynamic micro-PET images of [11C]FMAME in a MCF-7 transfected with IL-1α tumor-bearing mouse during different time periods of 0-15, 15-30, 30-45 and 45-60 min were performed by Indy-PET II.  The PET images clearly showed both tumors were visible with [11C]FMAME.  These results suggest that the localization of [11C]FMAME in the tumor is mediated by non-specific processes, and the visualization of [11C]FMAME on the tumor using the Indy-PET II scanner is related to non-specific binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvapHaZb-5ULVg90H21EOLACvtfcHk0lglO4GFZgNtbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Gku7w%253D&md5=30be8b901a1fd5bc5f253aa1c98ddbe3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2803%2900086-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252803%252900086-6%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DQ.-H.%26aulast%3DFei%26aufirst%3DX.%26aulast%3DDeGrado%26aufirst%3DT.%2BR.%26aulast%3DWang%26aufirst%3DJ.-Q.%26aulast%3DStone%26aufirst%3DK.%2BL.%26aulast%3DMartinez%26aufirst%3DT.%2BD.%26aulast%3DGay%26aufirst%3DD.%2BJ.%26aulast%3DBaity%26aufirst%3DW.%2BL.%26aulast%3DMock%26aufirst%3DB.%2BH.%26aulast%3DGlick-Wilson%26aufirst%3DB.%2BE.%26aulast%3DSullivan%26aufirst%3DM.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DSledge%26aufirst%3DG.%2BW.%26aulast%3DHutchins%26aufirst%3DG.%2BD.%26atitle%3DSynthesis%252C%2520biodistribution%2520and%2520micro-PET%2520imaging%2520of%2520a%2520potential%2520cancer%2520biomarker%2520carbon-11%2520labeled%2520MMP%2520inhibitor%2520%25282R%2529-2-%255B%255B4-%25286-fluorohex-1-ynyl%2529phenyl%255Dsulfonylamino%255D-3-methylbutyric%2520acid%2520%255B11C%255Dmethyl%2520ester%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D753%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Waschkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, C.</span><span> </span><span class="NLM_article-title">Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe</span> <span class="citation_source-journal">Contrast Media Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm4001743&amp;key=23109387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4001743&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOqtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1-11&author=B.+Waschkauauthor=A.+Faustauthor=M.+Sch%C3%A4fersauthor=C.+Bremer&title=Performance+of+a+new+fluorescence-labeled+MMP+inhibitor+to+image+tumor+MMP+activity+in+vivo+in+comparison+to+an+MMP-activatable+probe"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe</span></div><div class="casAuthors">Waschkau, Bianca; Faust, Andreas; Schaefers, Michael; Bremer, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Contrast Media & Molecular Imaging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">CMMICO</span>;
        ISSN:<span class="NLM_cas:issn">1555-4309</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are proteolytic enzymes that degrade structural components of the extracellular matrix and participate in pathologies such as cancer and inflammatory disorders.  The development of novel contrast agents for optical imaging of MMP activity in vivo is of great interest.  The commonly used near-IR fluorescence-compatible agents are dye-quenched probes that do not emit fluorescence until they interact with MMPs.  In contrast, fluorescent synthetic low-mol.-wt. MMP inhibitors have not been systematically employed.  The aim of this study was to evaluate the performance of our recently developed Cy5.5-labeled MMP inhibitor to image MMP activity in tumors in vivo compared with activatable fluorescent MMP-sensing probes.  The dynamic uptake of Cy5.5-AF489 into four different tumor entities was analyzed in xenografted mice by i.v. injection and subsequent fluorescence reflectance imaging.  Tumors were characterized in regard to their MMP-2 and -9 mRNA expressions (qRT-PCR anal.), proteins (immunohistochem.) and gelatinase/collagenase activities (in situ zymog.).  Cy5.5-AF489 was compared with MMPSenseTM 680 and MMPSenseTM 750 FAST, two com. available MMP-activatable probes.  Cy5.5-AF489 showed a specific tumor uptake, which was blocked by pre-injection of the unlabeled MMPI, and discriminated between tumors with high or low MMP-2/-9 expressions.  Our optical probe facilitated faster visualization of MMP-active tumors accompanied by excellent tumor-to-background ratios when compared with activatable probes.  The MMP inhibitor Cy5.5-AF489 permits fast in vivo imaging of MMP expression/activity in tumors.  Given its small mol. wt. and non-peptidic structure, translational imaging from a preclin. application to a diagnostic tool for MMP-related diseases seems feasible.  Copyright © 2012 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8s_5t8PFzqrVg90H21EOLACvtfcHk0liULdNqtNgqVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOqtLzI&md5=68cbc53e6f2c04ed66c1f09c0ce5e1ac</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaschkau%26aufirst%3DB.%26aulast%3DFaust%26aufirst%3DA.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DBremer%26aufirst%3DC.%26atitle%3DPerformance%2520of%2520a%2520new%2520fluorescence-labeled%2520MMP%2520inhibitor%2520to%2520image%2520tumor%2520MMP%2520activity%2520in%2520vivo%2520in%2520comparison%2520to%2520an%2520MMP-activatable%2520probe%26jtitle%3DContrast%2520Media%2520Mol.%2520Imaging%26date%3D2013%26volume%3D8%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Del Guerra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belcari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaiano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Domenico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabba, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavattini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzarotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larobina, M.</span><span> </span><span class="NLM_article-title">Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging</span> <span class="citation_source-journal">IEEE Trans. Nucl. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1078</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1109%2FTNS.2006.871900" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2006&pages=1078-1083&issue=3&author=A.+Del+Guerraauthor=A.+Bartoliauthor=N.+Belcariauthor=D.+J.+Herbertauthor=A.+Mottaauthor=A.+Vaianoauthor=G.+Di+Domenicoauthor=N.+Sabbaauthor=E.+Morettiauthor=G.+Zavattiniauthor=M.+Lazzarottiauthor=L.+Sensiauthor=M.+Larobina&title=Performance+evaluation+of+the+fully+engineered+YAP-%28S%29PET+scanner+for+small+animal+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1109%2FTNS.2006.871900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1109%252FTNS.2006.871900%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BGuerra%26aufirst%3DA.%26aulast%3DBartoli%26aufirst%3DA.%26aulast%3DBelcari%26aufirst%3DN.%26aulast%3DHerbert%26aufirst%3DD.%2BJ.%26aulast%3DMotta%26aufirst%3DA.%26aulast%3DVaiano%26aufirst%3DA.%26aulast%3DDi%2BDomenico%26aufirst%3DG.%26aulast%3DSabba%26aufirst%3DN.%26aulast%3DMoretti%26aufirst%3DE.%26aulast%3DZavattini%26aufirst%3DG.%26aulast%3DLazzarotti%26aufirst%3DM.%26aulast%3DSensi%26aufirst%3DL.%26aulast%3DLarobina%26aufirst%3DM.%26atitle%3DPerformance%2520evaluation%2520of%2520the%2520fully%2520engineered%2520YAP-%2528S%2529PET%2520scanner%2520for%2520small%2520animal%2520imaging%26jtitle%3DIEEE%2520Trans.%2520Nucl.%2520Sci.%26date%3D2006%26volume%3D53%26issue%3D3%26spage%3D1078%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Phelps, M. E.</span> <span class="citation_source-book">PET: Molecular Imaging and Its Biological Applications</span>; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm4001743&amp;key=10.1007%2F978-0-387-22529-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+E.+Phelps&title=PET%3A+Molecular+Imaging+and+Its+Biological+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-22529-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-22529-6%26sid%3Dliteratum%253Aachs%26aulast%3DPhelps%26aufirst%3DM.%2BE.%26btitle%3DPET%253A%2520Molecular%2520Imaging%2520and%2520Its%2520Biological%2520Applications%26pub%3DSpringer-Verlag%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i45"><a href="/doi/suppl/10.1021/jm4001743">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_47142"></div></div></div></div></div><hr /></hr><p class="last">Two tables, listing inhibitor potency as <i>K</i><sub>i</sub> and % ID/g after tumor uptake of [<sup>18</sup>F]-<b>1a</b> and [<sup>18</sup>F]FDG; one figure with PET images showing passage of the tracers through the gallbladder; and additional text with analytical and spectroscopic data for compounds <b>2</b>–<b>10</b> and <b>13</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4001743/suppl_file/jm4001743_si_001.pdf">jm4001743_si_001.pdf (266.01 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4001743&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm4001743%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-6%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4001743" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a6b3d9a99248d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
